IMS HEOR Bibliographies

Search criteria


Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Authors: Avraham Karasik (1), Stefanie Lanzinger (2,3), Elise Chia-Hui Tan (4), Daisuke Yabe (5,6,7 8), Dae Jung Kim (9), Wayne H-H Sheu (10), Cheli Melzer-Cohen (1), Reinhard W. Holl (2), Kyoung-Hwa Ha (9), Kamlesh Khunti (11), Francesco Zaccardi (11), Anuradhaa Subramanian (12), Krishnarajah Nirantharakumar (12,13,14), Thomas NystrÃ¶m (15), Leo Niskanen (16), Majken Linnemann Jensen (17), Fabian Hoti (18), Riho Klement (19), Anouk DÃ©ruaz-Luyet (20), Moe H.Kyaw (21), Lisette Koeneman (22), Dorte Vistisen (23, 24) Bendix Carstensen (23), Sigrun Halvorsen (25), Gisle Langslet (26), Soulmaz Fazeli Farsani (20), Elisabetta Patorno (27), JÃºlio NÃºÃ±ez (28), EMPRISE Europe and Asia Study Group
Affiliations: "1 Maccabi Institute for Research and Innovation Center, Tel Aviv University, Tel Aviv, Israel 2 Institute for Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany 3 German Centre for Diabetes Research (DZD), MÃ¼nchen-Neuherberg, Germany 4 Department of Health Service Administration, China Medical University, Taichung, Taiwan 5 Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kyoto, Japan 6 Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan 7 Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan 8 Preemptive Food Research Center, Gifu University Institute for Advanced Study, Gifu, Japan 9 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea 10 Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan 11 Leicester Real World Evidence Unit, Leicester Diabetes Centre, University of Leicester, Leicester, UK 12 Institute of Applied Health Research, University of Birmingham, Birmingham, UK 13 Midlands Health Data Research UK, Birmingham, UK 14 DEMAND Hub, University of Birmingham, Birmingham, UK 15 Department of Clinical Science and Education, SÃ¶dersjukhuset, Karolinska Institutet, Sweden 16 PÃ¤ijÃ¤t-HÃ¤me Joint Authority for Health and Wellbeing, PÃ¤ijÃ¤t-HÃ¤me Central Hospital, Lahti Finland and University of Eastern Finland, Kuopio, Finland 17 IQVIA Solutions Denmark A/S, Copenhagen, Denmark 18 IQVIA, Espoo, Finland 19 IQVIA, Tartu, Estonia 20 Boehringer Ingelheim International GmbH, Ingelheim, Germany 21 Boehringer Ingelheim International GmbH, US 22 Lilly Deutschland GmbH, Bad Homburg, Germany 23 Steno Diabetes Center Copenhagen, Herlev, Denmark 24 Department of Public Health, University of Copenhagen, Copenhagen, Denmark 25 Department of Cardiology, Oslo University Hospital UllevÃ¥l, and University of Oslo, Oslo, Norway 26 Lipid Clinic, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway 27 Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA 28 Department of Cardiology, Hospital ClÃnico Universitario de Valencia, INCLIVA, Universidad de Valencia, CIBER Cardiovascular, Valencia, Spain"
Publications: "Diabetes & Metabolism. 2023 Jan; 101418; ISSN 1262-3636 Virtual Conference: American Diabetes Association, 25-29 June 2021 and EASD 27 September -01 October"
Document Types: , Article
Countries: , Denmark, Finland, Germany, Norway, Spain, Sweden, UK
Abstract: https://doi.org/10.1016/j.diabet.2022.101418 (https://www.sciencedirect.com/science/article/pii/S1262363622000994)
Condition	Year	Language	Analysis type
, Cardiovascular disease, Diabetes, Drug safety, Drug Utlization Study	2023	English	, Clinical setting: hospital, Clinical setting: Primary care


Empagliflozin is Associated with Lower Risk of Cardiovascular Events and All-Cause Mortality in Routine Care in East Asia: Results from the EMPRISE Study
Authors: Dae Jung Kim (1), Wayne H-H Sheu (2), Wook-Jin Chung (3), Daisuke Yabe (4-7), Kyoung Hwa Ha (1), Masaomi Nangaku (8), Elise Chia-Hui Tan (9), Koichi Node (10), Atsutaka Yasui (11), Weiyu Lei (12), Sunwoo Lee (13), Laura Saarelainen (14), Anouk Deruaz-Luyet (15), Moe H. Kyaw (16) and Yutaka Seino (4,17), EMPRISE East Asia Study Group
Affiliations: "1 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea 2 Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan 3 Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon, South Korea 4 Kansai Electric Power Medical Research Institute, Kobe, Japan 5 Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan 6 Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan 7 Division of Metabolism and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan 8 Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan 9 National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan, and Institute of Hospital and Healthcare Administration, National Yang-Ming University, Taipei, Taiwan 10 Department of Cardiovascular Medicine, Saga University, Saga, Japan 11 Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan 12 Boehringer Ingelheim Taiwan Ltd., Taipei, Taiwan 13 Boehringer Ingelheim Korea Ltd, Seoul, Korea 14 IQVIA, Espoo, Finland 15 Boehringer Ingelheim International GmbH, Ingelheim, Germany 16 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA 17 Kansai Electric Power Hospital, Osaka, Japan "
Publications: "JDI journal Virtual Conference: ACC, May 2021"
Document Types: , Article
Countries: , Japan, Korea, Taiwan
Abstract: https://doi.org/10.1111/jdi.13959
Condition	Year	Language	Analysis type
, Cardiovascular disease, Diabetes, Drug safety, Drug Utlization Study	2023	English	, Clinical setting: hospital, Clinical setting: Primary care, Retrospective cohort analysis


Hypercholesterolaemia control in Spain: The same situation with different regional realities
Authors: Juan Pedro-Botet, NÃºria Plana, JosÃ© MarÃa Mostaza, Juan JosÃ© GÃ³mez-Doblas, MarÃa Rosa FernÃ¡ndez Olmo, Carlos Escobar Cervantes, JosÃ© Luis DÃaz-DÃaz, Raquel Campuzano Ruiz, Pedro Valdivielso, Juan CosÃn-Sales
Affiliations: Unidad de LÃpidos y Riesgo Vascular, Hospital del Mar, Universitat AutÃ²noma de Barcelona, Barcelona, EspaÃ±a
Publications: Clinica e investigacion en arteriosclerosis: publicacion oficial de la Sociedad Espanola de Arteriosclerosis, S0214-9168(23)00027-X. 27 Apr. 2023, doi:10.1016/j.arteri.2023.04.001
Document Types: , Abstract
Countries: , Spain
Abstract: https://doi.org/10.1016/j.arteri.2023.04.001
Condition	Year	Language	Analysis type
, Cardiovascular disease	2023	Spanish	, Clinical setting: Primary care, Public Health, Quality of life, Survey research


Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions
Authors: Oriol Sola- Morales (1), Lesley H. Curtis (2), Julien Heidt (3),*, Laura Walsh (4), Deborah Casso (5),?, Susan Oliveria (6),?, Patrick Saunders- Hastings (7), Yufei Song (8),?, Tiffany Mercado (3), Robbert Zusterzeel (3),?, Vera Mastey (9), James Harnett (9) and Ruben G. W. Quek (9)
Affiliations: (1) FundaciÃ³ Health Innovation Technology Transfer and International, University of Catalonia, Barcelona, Spain; (2) Duke Clinical Research Institute, Durham, North Carolina, USA; (3) IQVIA, Regulatory Science and Strategy, Falls Church, Virginia, USA; (4) IQVIA, Epidemiology and Drug Safety Practice, Boston, Massachusetts, USA; (5) IQVIA, Epidemiology and Drug Safety Practice, Seattle, Washington, USA; (6) IQVIA, Epidemiology and Drug Safety Practice, New York, New York, USA; (7) Epi Excellence LLC, Garnet Valley, Pennsylvania, USA; (8) IQVIA, Epidemiology and Drug Safety Practice, Beijing, China; (9) Regeneron Pharmaceuticals Inc., Health Economics & Outcomes Research, Tarrytown, New York, USA
Publications: Clinical pharmacology and therapeutics vol. 114,2 (2023): 325-355. doi:10.1002/cpt.2914
Document Types: , Article
Countries: , Europe, USA
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/cpt.2914
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Methodology, Regulatory	2023	English	, Review


Regulatory and HTA Considerations for Development of Real- World Data Derived External Controls
Authors: Lesley H. Curtis (1), Oriol Sola-Morales (2), Julien Heidt (3),*, Patrick Saunders- Hastings (4), Laura Walsh (5), Deborah Casso (6),?, Susan Oliveria (7),?, Tiffany Mercado (3), Robbert Zusterzeel (3),?, Rachel E. Sobel (8), Jessica J. Jalbert (9), Vera Mastey (9), James Harnett (9) and Ruben G. W. Quek (9)
Affiliations: 1Duke Department of Population Health Sciences and Duke Clinical Research Institute, Durham, North Carolina, USA; 2FundaciÃ³ HiTT and Universitat Internacional de Catalunya (UIC), Barcelona, Spain; 3IQVIA, Regulatory Science and Strategy, Falls Church, Virginia, USA; 4Epi Excellence LLC, Garnet Valley, Pennsylvania, USA; 5IQVIA, Epidemiology and Drug Safety Practice, Boston, Massachusetts, USA; 6IQVIA, Epidemiology and Drug Safety Practice, Seattle, Washington, USA; 7IQVIA, Epidemiology and Drug Safety Practice, New York, New York, USA; 8Regeneron Pharmaceuticals Inc., Pharmacoepidemiology, Tarrytown, New York, USA; 9Regeneron Pharmaceuticals Inc., Health Economics & Outcomes Research, Tarrytown, New York, USA.
Publications: Clin Pharmacol Ther, 114: 303-315. https://doi.org/10.1002/cpt.2913
Document Types: , Article
Countries: , USA
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/cpt.2913
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Methodology, Regulatory	2023	English	, Review


Cost-effectiveness analysis of ranibizumab biosimilar for neovascular age-related macular degeneration in Japan
Authors: Yasuo Yanagi 1, Kanji Takahashi 2, Tomohiro Iida 3, Fumi Gomi 4, Junko Morii 5, Eriko Kunikane 6, Taiji Sakamoto 7 (rwesheorj 5)
Affiliations: 1 Department of Ophthalmology and Microtechnology, Yokohama City University, Kanagawa, Japan. yanagi-tky@umin.ac.jp. 2 Department of Ophthalmology, Kansai Medical University, Osaka, Japan. 3 Department of Ophthalmology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan. 4 Department of Ophthalmology, Hyogo Medical University, Hyogo, Japan. 5 IQVIA Solutions Japan, K.K., Tokyo, Japan. 6 Senju Pharmaceutical Co., Ltd., Osaka, Japan. 7 Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Publications: Ophthalmology and Therapy
Document Types: , Article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007/s40123-023-00715-y
Condition	Year	Language	Analysis type
, Vascular disease	2023	English	, Cost analysis, Cost effectiveness


Assessing definitions and incentives adopted for innovation for pharmaceutical products in five high-income countries: a systematic literature review
Authors: Naohiko Wakutsu 1, Emi Hirose 2, Naohiro Yonemoto 3, Sven Demiya 4 (rwesheorj 4)
Affiliations: 1 Graduate School of Economics, Nagoya City University, Nagoya, Japan. 2 Health & Value, Pfizer Japan Inc., Tokyo, Japan. emi.hirose@pfizer.com. 3 Health & Value, Pfizer Japan Inc., Tokyo, Japan. 4 IQVIA Solutions Japan K.K., Tokyo, Japan.
Publications: Pharmaceutical Medicine
Document Types: , Article
Countries: , France, Germany, Japan, UK, USA
Abstract: https://link.springer.com/article/10.1007/s40290-022-00457-5
Condition	Year	Language	Analysis type
, Miscellaneous	2023	English	, Literature Review


Patient burden associated with treatment-resistant or unexplained chronic cough - a qualitative study based on focus group interviews
Authors: Naoya Ueda 1, Anzu Yakushiji 2, Shigeru Tokita 1, Takekazu Kubo 1 (rwesheorj 2)
Affiliations: 1) MSD Co., Ltd., Medical Affairs 2) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: Progress in Medicine
Document Types: , Article
Countries: , Japan
Abstract: https://mp.medicalonline.jp/products/detail.php?content_kind=0&content_detail_key=ai5prmda%2F2023%2F004302%2F014%2F0167-0181
Condition	Year	Language	Analysis type
, Respiratory disease	2023	Japanese	, Burden of illness, Patient questionnaire


Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements
Authors: Masataka Kuwana 1, Masashi Bando 2, Yutaka Kawahito 3, Shinji Sato 4, Takafumi Suda 5, Yasuhiro Kondoh 6; CTD-ILD Delphi Collaborators (rwesheorj A)
Affiliations: 1) Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan. 2) Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan. 3) Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. 4) Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan. 5) Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan. 6) Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.
Publications: Expert Review of Respiratory Medicine
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/17476348.2023.2176303
Condition	Year	Language	Analysis type
, Respiratory disease	2023	English	, Literature Review, Survey research


Exploring current practice, knowledge, and challenges of sexually transmitted infection/HIV management and pre-exposure prophylaxis among Japanese health care professionals: a cross-sectional web survey
Authors: Mayuko Kamakura 1, Daisuke Fukuda 1, Naho Kuroishi 1, Dilinuer Ainiwaer 2, Junko Hattori 1 (rwesheorj 2)
Affiliations: 1) Medical Affairs, MSD K.K., Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: AIDS Patient Care and STDs
Document Types: , Article
Countries: , Japan
Abstract: https://www.liebertpub.com/doi/10.1089/apc.2023.0013
Condition	Year	Language	Analysis type
, HIV AIDS	2023	English	, Survey research


Comparison of depression trends in the Japanese and US populations before and during the COVID-19 pandemic: a retrospective observational study using real-world data
Authors: Sven Demiya 1, Shujiro Takeno 1, Louis P. Watanabe 1, Wen Shi Lee 1, Yuri Sakai 1, Todd D. Taylor 1, Seok-Won Kim 1 (rwesheorj 1)
Affiliations: 1) IQVIA Solutions Japan KK, Tokyo Japan
Publications: Value & Outcomes Spotlight
Document Types: , Article
Countries: , Japan, USA
Abstract: https://www.ispor.org/publications/journals/value-outcomes-spotlight/vos-archives/issue/view/mental-health-the-silent-pandemic/comparison-of-depression-trends-in-the-japanese-and-us-populations-before-and-during-the-covid-19-pandemic-a-retrospective-observational-study-using-real-world-data
Condition	Year	Language	Analysis type
, Mental health	2023	English	, Database Study, Observational study, Retrospective database analysis


Cost of illness: estimating direct healthcare costs related to obesity in a Japanese clinical setting
Authors: Riku Ota 1, Koki Idehara 2, Hiroyuki Matsuda 2, Ronald Filomeno 2, J Baker-Knight 3 (rwesheorj 2)
Affiliations: 1) Novo Nordisk Pharma Ltd., Nerima, 13, Japan 2) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan 3) Novo Nordisk, 2900, Denmark
Publications: ISPOR Value in Health
Document Types: , Abstract, Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2023-3669/124060
Condition	Year	Language	Analysis type
, Endocrinology	2023	English	, Cost of illness, Database Study


Real-world trends of patients with syphilis in Japan using integrated data of IQVIA Claims, JAST data and DeSC database
Authors: Yuki Kado 1, Seok-Won Kim 2, T Ishii 3 (rwesheorj 1-3)
Affiliations: 1) IQVIA Solutions Japan, Minato-ku, 13, Japan 2) IQVIA Solutions Japan, Minato, 13, Japan 3) IQVIA Solutions Japan, Minato-ku, Tokyo, Japan
Publications: ISPOR Value in Health
Document Types: , Abstract, Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2023-3668/124021
Condition	Year	Language	Analysis type
, Infectious disease	2023	English	, Database Study


Real-world clinical practice of pulmonary arterial hypertension in Japan: Insights from a large administrative database
Authors: Junichi Omura 1, Kazuki Kitahara 1, Masashi Takano 1, Koki Idehara 2, Seok-Won Kim 2 (rwesheorj 2)
Affiliations: 1) Medical Affairs Janssen Pharmaceutical K. K. Tokyo Japan 2) RWES/HEOR IQVIA Solutions Japan K. K. Tokyo Japan
Publications: Pulmonary Circulation
Document Types: , Article
Countries: , Japan
Abstract: https://onlinelibrary.wiley.com/doi/10.1002/pul2.12275
Condition	Year	Language	Analysis type
, Cardiovascular disease	2023	English	, Database Study, Retrospective cohort analysis


The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis
Authors: Helmut Butzkueven, Jan Hillert, Merja Soilu-HÃ¤nninen, Tjalf Ziemssen, Jens Kuhle, Stig Wergeland, Melinda Magyari, Joseph R. Berger, Nicholas Moore, Aida Aydemir, Irene Bezemer & Meritxell SabidÃ³
Affiliations: "a Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia; b The Alfred Hospital, Melbourne, VIC, Australia; c Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; d Turku University Hospital Neurocenter and Division of Clinical Neurosciences, University of Turku, Turku, Finland; e Center of Clinical Neuroscience, Department of Neurology, Dresden University of Technology, Dresden, Germany; f Multiple Sclerosis Center and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland; g Department of Neurology, University Hospital and University of Basel, Basel, Switzerland; h Norwegian MS Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway; i Department of Clinical Medicine, University of Bergen, Bergen, Norway; j Danish Multiple Sclerosis Center and the Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; k Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; l Bordeaux PharmacoEpi (BPE), Universitï¿½e de Bordeaux, Bordeaux, France; m EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA; n Global Epidemiology, IQVIA, Amsterdam, The Netherlands; o Merck Healthcare KGaA, Darmstadt, Germany"
Publications:
Document Types: , Article
Countries: , Australia, Denmark, Finland, Germany, Norway, Sweden, Switzerland, Turkey
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2023.2256220
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Drug safety, Neurological disorders	2023	English	, clinical setting: Secondary care, Epidemiological study, Population Based Study


The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making
Authors: Paul Cottu 1, Scott David Ramsey 2, Oriol SolÃ -Morales 3, Patricia A Spears 4, Lockwood Taylor 5
Affiliations: 1Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005, Paris, France. Electronic address: paul.cottu@curie.fr. 2Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M2-B232, Seattle, WA, 98155, USA. Electronic address: sramsey@fredhutch.org. 3Health Innovation Technology Transfer Foundation, AragÃ³ 60, E-08015, Barcelona, Spain. Electronic address: osola@fhitt.org. 48605 Carolingian Court, Raleigh, NC, 27615, USA. Electronic address: paspears88@gmail.com. 5Epidemiology, Real World Solutions at IQVIA, 4820 Emperor Boulevard, Durham, NC, 27703, USA. Electronic address: lockwood.taylor@iqvia.com.
Publications: Breast. 2021 Dec 22;61:118-122. doi: 10.1016/j.breast.2021.12.015.
Document Types: , Article
Countries: , France, Italy, USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/34959093/
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Drug safety, Oncology, Regulatory	2022	English	, Review


Burden of Hospitalizations and Outpatient Visits Associated With Moderate and Severe Acute Graft-Versus-Host Disease in Finland and Sweden: A Real-World Data Analysis
Authors: Lorenzo Sabatelli, PhD,1 Mikko KerÃ¤nen, MD, PhD,2 Elisabet Viayna, PhD,3 Montserrat Roset, BSc Stats,3 Nuria Lara, MD, MSc,3 Daniel ThunstrÃ¶m, MSc Pharm,1 Minja Pfeiffer, PhD,1 Malin Nicklasson, MSc Pharm,4 Maija ItÃ¤lÃ¤-Remes, MD, PhD5
Affiliations: "1Incyte Biosciences International SÃ rl, Morges, Switzerland; 2Helsinki University Hospital, Helsinki, Finland; 3IQVIA Real World Solutions, Barcelona, Spain; 4Department of Hematology and Coagulation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 5Turku University Hospital, Turku, Finland "
Publications: Supportive Care in Cancer
Document Types: , Article
Countries: , Finland, Spain, Sweden, Switzerland
Condition	Year	Language	Analysis type
, Health economics, Transplant	2022	English	, Clinical setting: hospital, Observational study, Population Based Study


Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study
Authors: "Kerstin M G Brand, Laura Saarelainen, Jaak Sonajalg, Emmanuelle Boutmy, Caroline Foch, Marja VÃ¤Ã¤rÃ¤smÃ¤ki, Laure Morin-Papunen, Judith Schlachter, CLUE Study Group, Katja M Hakkarainen, Pasi Korhonen CLUE Study Group: Minna Vehkala, Robyn ThorÃ©n, Henrik SvanstrÃ¶m "
Affiliations: "Leading author: Kerstin Brand: Merck KGaA, Darmstadt, Germany IQVIA author affiliations: Global Database Studies, IQVIA, Espoo, Finland; Global Database Studies, IQVIA, Tartu, Estonia; Global Database Studies, IQVIA, Solna, Sweden; Global Database Studies, IQVIA"
Publications: BMJ Open Diab Res Care 2022;10:e002363. doi:10.1136/bmjdrc-2021-002363
Document Types: , Article
Countries: , Finland
Abstract: https://drc.bmj.com/content/10/1/e002363.full
Condition	Year	Language	Analysis type
, Diabetes, Obesity	2022	English	, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective cohort analysis


Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
Authors: Jonathan Gladstone 1, Sameer Chhibber 2, Jagdeep Minhas 3, Calum S Neish 3, G Sarah Power 3, Zhiyi Lan 3, Driss Rochdi 4, Jessica Lanthier-Martel 4, Natacha Bastien 4
Affiliations: 1Neurology, Cleveland Clinic Canada, Toronto, Ontario, Canada. 2Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 3Real-world Solutions, IQVIA, Kirkland, QuÃ©bec, Canada. 4Neuroscience, Novartis Pharmaceuticals Canada Inc., Dorval, QuÃ©bec, Canada.
Publications: Headache The Journal of Head and Face Pain PMID: 34807454 DOI: 10.1111/head.14218
Document Types: , Article
Countries: , Canada
Abstract: https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14218
Condition	Year	Language	Analysis type
, Health status & patient reported outcomes	2022	English	, Clinical setting: Primary care, direct to patient research


Real-world 12-month Retention on Secukinumab Among Axial Spondyloarthritis Patients within the Canadaian Spondyloarthritis (CanSpA) Research Network
Authors: Dr. Robert Inman, Dr. Denis Choquette, Dr. Majed Khraishi, Dr. Dafna Gladman, Shamiza Hussein, Drew Neish, Patrick Leclerc
Affiliations: Robert Inman (Toronto Western Hospital, Toronto); Denis Choquette (Institut de Rhumatologie de MontrÃ©al, MontrÃ©al); Majed Khraishi (Department of Medicine, Memorial University of Newfoundland, St. John's); Dafna Gladman (Krembil Research Institute, Toronto Western Hospital, Toronto); Shamiza Hussein (Novartis, Montreal); Drew Neish (IQVIA, Montreal); Patrick Leclerc (Novartis Canada, Montreal)
Publications:
Document Types: , Poster
Countries: , Canada
Abstract: https://asm.rheum.ca/wp-content/uploads/2022/01/2022-Poster-Presentations.pdf
Condition	Year	Language	Analysis type
, Clinical practice	2022	English	, Clinical setting: hospital


Concomitant Medication Use in the Treatment Journey of Pulmonary Arterial Hypertension Patients: A Canadian Retrospective Claims Analysis
Authors: Essam Ibrahim1, Assem Al-Akabawi1, Moses Dawodu1, Juejing Ling2, Irene Wang2, Brad Millson3
Affiliations: 1Janssen Canada Inc, Toronto, ON, Canada; 2IQVIA Solutions Canada Inc., Mississauga, ON, Canada; 3IQVIA Solutions Canada Inc., Kanata, ON, Canada
Publications:
Document Types: , Poster
Countries: , Canada
Condition	Year	Language	Analysis type
, Endocrinology	2022	English	, Clinical setting: hospital, Clinical setting: Primary care, direct to patient research, Observational study


Real-World Drug Retention and Initiation of Combination Drug Therapy for Patients with Pulmonary Arterial Hypertension in Canada: A Retrospective Prescription Claims Database Study
Authors: Essam Ibrahim1, Assem Al-Akabawi1, Moses Dawodu1, Juejing Ling2, Jillian Murray2, Brad Millson3
Affiliations: 1Janssen Canada Inc, Toronto, ON, Canada; 2IQVIA Solutions Canada Inc., Mississauga, ON, Canada; 3IQVIA Solutions Canada Inc., Kanata, ON, Canada
Publications: IQVIA Canadian Private Drug Plan (PDP) databases
Document Types: , Poster
Countries: , Canada
Condition	Year	Language	Analysis type
	2022	English	, direct to patient research


Georgraphic Variation in the Use of Gabapentinoids and Opioids for Pain in a Commercially Insured Adult Population in the United States
Authors: Danni Zhao, Jonggyu Baek, Anne L Hume, Emily A McPhillips, and Kate L Lapane
Affiliations: 1Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, USA. 2Department of Family Medicine, Alpert Medical School, Brown University, Memorial Hospital of Rhode Island, Providence, RI, USA. 3Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.
Publications: J Pain Res . 2022 Feb 11;15:443-454. doi: 10.2147/JPR.S345521. eCollection 2022.
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/35177933/
Condition	Year	Language	Analysis type
, Drug Utlization Study, Pain	2022	English	, Epidemiological study, Observational study, Public Health


Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons
Authors: Taisuke Ito 1, Kazumasa Kamei 2, Akira Yuasa 3, Fumihiro Matsumoto 2, Yayoi Hoshi 4, Masafumi Okada 4, Shinichi Noto 5 (rwesheorj 4)
Affiliations: 1) Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan 2) Inflammation and Immunology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan 3) Health and Value, Pfizer Japan Inc., Tokyo, Japan 4) Real-World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: The Journal of Dermatology
Document Types: , Article
Countries: , Japan
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1111/1346-8138.16364
Condition	Year	Language	Analysis type
, Dermatology, Mental health	2022	English	, Patient questionnaire, Quality of life, Survey research


A real-world, observational study of erenumab for migraine prevention in Canadian patients
Authors: Werner J Becker 1, Sian Spacey 2, Elizabeth Leroux 3, Rose Giammarco 4, Jonathan Gladstone 5, Suzanne Christie 6, Arash Akaberi 7, G Sarah Power 8, Jagdeep K Minhas 9, Johanna Mancini 7, Driss Rochdi 10, Ayca Filiz 10, Natacha Bastien 10
Affiliations: 1Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 2Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada. 3Brunswick Medical Center, Montreal, Quebec, Canada. 4Hamilton Headache Clinic, Hamilton, Ontario, Canada. 5Gladstone Headache Clinic, Toronto, Ontario, Canada. 6Ottawa Headache Centre Inc., Ottawa, Ontario, Canada. 7IQVIA Solutions Canada Inc., Montreal, Quebec, Canada. 8IQVIA Solutions Canada Inc., Mississauga, Ontario, Canada. 9IQVIA Solutions Canada Inc., Ottawa, Ontario, Canada. 10Novartis Canada, Dorval, Quebec, Canada.
Publications: Headache. 2022 Apr;62(4):522-529. doi: 10.1111/head.14291. Epub 2022 Apr 10. PMID: 35403223.
Document Types: , Article
Countries: , Canada
Abstract: https://pubmed.ncbi.nlm.nih.gov/35403223/
Condition	Year	Language	Analysis type
, Neurological disorders	2022	English	, Observational study


The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly started on cladribine tablets
Authors: Helmut Butzkueven 1 2, Nicholas Moore 3, Aida Aydemir 4, Jaak SÃµnajalg 5, Irene Bezemer 6, Pasi Korhonen 7, Meritxell SabidÃ³ 8, CLARION Study Group
Affiliations: 1Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia. 2The Alfred Hospital, Melbourne, Australia. 3Bordeaux PharmacoEpi (BPE), UniversitÃ© de Bordeaux, Bordeaux, France. 4Global Biostatistics, EMD Serono Research & Development Institute, Inc, Billerica, MA, USA (an affiliate of Merck KGaA). 5Global Database Studies, IQVIA, Tartu, Estonia. 6Global Epidemiology and Outcomes Research, IQVIA, Amsterdam, The Netherlands. 7IQVIA (former EPID Research), Espoo, Finland. 8Global Epidemiology, Merck Healthcare KGaA, Darmstadt, Germany.
Publications: Current Medical Research and Opinion, DOI: 10.1080/03007995.2022.2059977
Document Types: , Article
Countries: , Australia, Denmark, Finland, Germany, Norway, Sweden, Switzerland, Turkey
Abstract: https://pubmed.ncbi.nlm.nih.gov/35357268/
Condition	Year	Language	Analysis type
, Drug safety, Neurological disorders	2022	English	, clinical setting: Secondary care, Epidemiological study, Observational study, Population Based Study, Retrospective database analysis


Estimating the burden of influenza-related and associated hospitalizations and deaths in France: An eight-season data study, 2010-2018
Authors: Magali Lemaitre 1, Fayssoil Fouad 1, Fabrice Carrat 2 3, Pascal CrÃ©pey 4, Jacques Gaillat 5, GaÃ«tan Gavazzi 6, Odile Launay 7 8, Anne Mosnier 9, Marie-CÃ©cile Levant 10, Mathieu Uhart 10
Affiliations: 1 IQVIA, Courbevoie, France. 2 Sorbonne UniversitÃ©, Institut National de la SantÃ© et de la Recherche MÃ©dicale (Inserm), Institut Pierre Louis d'EpidÃ©miologie et de SantÃ© Publique, Paris, France. 3 Assistance Publique-HÃ´pitaux de Paris (AP-HP), HÃ´pital Saint-Antoine, UnitÃ© de SantÃ© Publique, Paris, France. 4 UniversitÃ© de Rennes, EHESP, REPERES-EA 7449, Rennes, France. 5 Centre Hospitalier Annecy-Genevois, Metz-Tessy, France. 6 CHU Grenoble Alpes, Clinique Universitaire de GÃ©riatrie, Pavillon ElisÃ©e-Chatin, and GREPI EA 7408, UniversitÃ© Grenoble Alpes, Grenoble, France. 7 FacultÃ© de MÃ©decine Paris Descartes, UniversitÃ© de Paris, Paris, France. 8 Inserm, CIC 1417, F-CRIN I-REIVAC, Assistance Publique-HÃ´pitaux de Paris, CIC Cochin-Pasteur, Paris, France. 9 Open Rome & RÃ©seau des GROG, Paris, France. 10 Sanofi Pasteur, Lyon, France.
Publications: Influenza Other Respir Viruses . 2022 Jan 10. doi: 10.1111/irv.12962.
Document Types: , Abstract
Countries: , France
Abstract: https://pubmed.ncbi.nlm.nih.gov/35014194/
Condition	Year	Language	Analysis type
, Infectious disease, Respiratory disease	2022	English	, Methodology, Population Based Study


Physician awareness and understanding of hereditary angioedema: a web-based study in Japan
Authors: Atsushi Fukunaga 1,2, Miwa Kishimoto 3*, Akinori Oh 3, Takeshi Akiyama 4, Ippei Kotera 3, Yoichi Inoue 3, Junichi Maehara 5 (rwesheorj 4)
Affiliations: 1) Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo, Japan 2) Division of Medicine for Function and Morphology of Sensory Organs, Department of Dermatology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan 3) Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan 4) Real World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan 5) Department of Acute Care and General Medicine, Emergency and Critical Care Center, Saiseikai Kumamoto Hospital, Kumamoto, Japan
Publications: Journal of Cutaneous Immunology and Allergy.
Document Types: , Article
Countries: , Japan
Abstract: https://onlinelibrary.wiley.com/doi/10.1002/cia2.12265
Condition	Year	Language	Analysis type
, Rare disease	2022	English	, Survey research


Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study
Authors: Kjell Larsson,1 Karin Lisspers,2 BjÃ¶rn StÃ¤llberg,2 Gunnar Johansson,2 Florian S Gutzwiller,3 Karen Mezzi,3 Bine Kjoeller Bjerregaard,4 Leif Jorgensen,4 Hyewon Koo,5 Christer Janson6
Affiliations: 1Integrative Toxicology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 2Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden; 3Novartis Pharma AG, Basel, Switzerland; 4IQVIA Solutions, Copenhagen, Denmark; 5IQVIA Solutions, Solna, Sweden; 6Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden
Publications: International Journal of Chronic Obstructive Pulmonary Disease 2022:17 1409?1421 https://doi.org/10.2147/COPD.S364932 PMID 35761954
Document Types: , Article
Countries: , Sweden
Abstract: https://www.dovepress.com/articles.php?article_id=76070
Condition	Year	Language	Analysis type
, Respiratory disease	2022	English	, Clinical setting: Primary care, Epidemiological study, Population Based Study, Real World Data, Retrospective cohort analysis


Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan
Authors: Masaki Shiota 1, Raf De Moor 2, Yosuke Koroki 2, Dae Young Yu 3, David Bin-Chia Wu 4 (rwesheorj A)
Affiliations: 1) Department of Urology, Graduate School of Medical Sciences, Kyushu University Hospital, Fukuoka, Japan 2) Integrated Market Access, Janssen Pharmaceutical KK, Tokyo, Japan 3) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore 4) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore;e Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore;f School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia
Publications: Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2022.2096353
Condition	Year	Language	Analysis type
, Oncology	2022	English	, Database Study


A cross-sectional survey to evaluate prescribers' knowledge and understanding of safety messages following DengvaxiaÂ® product information update
Authors: Mariana F Almas 1, Massoud Toussi 2, Elisa Valero 3, Annick Moureau 4, Lydie Marcelon
Affiliations: 1IQVIA Real World Solutions, Porto Salvo, Portugal. 2IQVIA Real World &Analytics Solutions, La DÃ©fense, France. 3Global Pharmacovigilance, Sanofi Pasteur, Lyon, France. 4Global Biostatistical Sciences, Sanofi Pasteur, Marcy l'Etoile, France. 5Epidemiology and Benefit Risk, Global Pharmacovigilance, Sanofi Pasteur, Lyon, France.
Publications: Pharmacoepidemiol Drug Saf . 2022 Jul;31(7):758-768. doi: 10.1002/pds.5447. Epub 2022 May 13
Document Types: , Article
Countries: , Brazil, Thailand
Abstract: https://pubmed.ncbi.nlm.nih.gov/35505623/
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Risk Management & REMS	2022	English	, Clinical setting: Primary care, Epidemiological study, Survey research


The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a
Authors: Hanne van Ballegooijen, Karin van der Hiele, Christian Enzinger, Gert de Voer, Leo H. Visser, on behalf of the CONFIDENCE Study Group
Affiliations: IQVIA Netherlands, Real World Evidence, Netherlands b Department of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, Netherlands c Medical University of Graz, Graz, Austria d Merck BV, Schiphol-Rijk, The Netherlands, an affiliate of Merck KGaA, Germany e St Elisabeth Tweesteden Hospital, Tilburg, the Netherlands
Publications: eNeurologicalSci, Volume 28, 2022, 100409, ISSN 2405-6502, https://doi.org/10.1016/j.ensci.2022.100409. (https://www.sciencedirect.com/science/article/pii/S2405650222000181)
Document Types: , Article
Countries: , Austria, Belgium, Netherlands , Slovakia
Abstract: https://www.sciencedirect.com/science/article/pii/S2405650222000181
Condition	Year	Language	Analysis type
, Drug safety, Drug Utlization Study, Neurological disorders	2022	English	, Clinical setting: hospital, clinical setting: Secondary care, Epidemiological study, Population Based Study, Prospective study


Cost-effectiveness of vonoprazan compared with proton pump Inhibitors in patients taking low-dose aspirin for secondary prevention of cardiovascular events in Japan
Authors: Masanobu Ishii 1, Takashi Kawai 2, Kenichi Tsujita 3*, Ataru Igarashi 4, Manabu Suzuki 5, Hisato Deguchi 5, Jovelle Fernandez 5 (rwesheorj A)
Affiliations: 1) Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan 2) Department of Gastroenterological Endoscopy, Tokyo Medical University, Japan 3) Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan 4) Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan 5) Japan Medical Office, Takeda Pharmaceutical Company Limited, Japan
Publications: Circulation Journal
Document Types: , Article
Countries: , Japan
Abstract: https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-22-0127/_html/-char/en
Condition	Year	Language	Analysis type
, Cardiovascular disease	2022	English	, Cost effectiveness


Prognosis of lung cancer patients treated with immune checkpoint inhibitors with or without antimicrobial history
Authors: Ryohei Kobayashi 1, Kenji Kanagawa 1, Sanesue Yasukawa 1, Takuma Kondo 1, Shingo Wada 2 (rwesheorj 2)
Affiliations: 1) IQVIA Services Japan K.K. 2) IQVIA Solutions Japan K.K.
Publications: The 27th Annual Meeting of the Japanese Society for Pharmacoepidemiology
Document Types: , Conference, Oral presentation
Countries: , Japan
Abstract: https://www.jspe.jp/meeting/soukai/272022.html
Condition	Year	Language	Analysis type
, Oncology	2022	Japanese	, Database Study, Retrospective cohort analysis


Development of a clinical prediction model for recurrence and mortality outcomes after Clostridioides difficile infection using a machine learning approach
Authors: Daniel Ruzicka 1, Takayuki Kondo 1, Go Fujimoto 1, Andrew P.Craig 2, Seok-Won Kim 2, Hiroshige Mikamo 3 (rwesheorj 2)
Affiliations: 1) Medical Affairs, MSD K.K., Tokyo, Japan, Kitanomaru Square, 1-13-12 Kudan-kita, Chiyoda-ku, Tokyo, 102-8667, Japan 2) Real World Evidence Solutions, IQVIA Solutions Japan K.K., Takanawa 4-10-18, Minato-ku, Tokyo, 108-0074, Japan 3) Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine, 1-1, Yazakokarimata, Nagakute, Aichi, 480-1195, Japan
Publications: Anaerobe
Document Types: , Article
Countries: , Japan
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1075996422001214?via%3Dihub
Condition	Year	Language	Analysis type
, Infectious disease	2022	English	, Methodology


CO71 Investigating the Secondary Care System Burden of Glycogen Storage Disease Type IA (GSDIA) Using the HES Database
Authors: E Kruger S Chavda RN Gupta V Valayannopoulos
Affiliations: Ultragenyx Pharmaceutical Inc., Novato, CA, USA IQVIA, London, UK Ultragenyx Pharmaceutical Inc., Cambridge, MA, USA
Publications: Kruger, E et al. Value in Health, Volume 25, Issue 7, S317
Document Types: , Abstract, Article
Countries: , England
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(22)00370-9/pdf#%20
Condition	Year	Language	Analysis type
, Metabolic Disorders , Rare disease, Rare Diseases	2022	English	, Burden of illness, clinical setting: Secondary care, Quality of life


English demographics and cost of HIV-associated comorbidities in individuals over the age of 35: an investigation using the Hospital Episode Statistics (HES) database
Authors: Wild L, Smith A, Sathia L, Davies S, Fernandez DP, Lawrence D.
Affiliations: 1Gilead Sciences, London, UK, 2IQVIA, London, UK
Publications: HIV MEDICINE 2018 Apr 1 (Vol. 19, pp. S76-S77).
Document Types: , Abstract, Poster
Countries: , England
Abstract: https://onlinelibrary.wiley.com/doi/10.1111/hiv.12614
Condition	Year	Language	Analysis type
, HIV AIDS	2022	English	, Cost consequence, Cost of illness, Database Study, Population Based Study


POSB392 Understanding the Secondary Care Characteristics and Pathways of Multiple Myeloma Patients Who Reach Second-Line Therapy Using the Hospital Episode Statistics (HES) Database
Authors: E Mary Babu S Fermahan S Chavda M Chetty S Navani A Matthew R Hudson
Affiliations: Sanofi, Reading, RDG, UK IQVIA, London, UK
Publications: Mary Babu, E et al. Value in Health, Volume 25, Issue 1, S257
Document Types: , Abstract, Article
Countries: , England
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(21)03050-3/fulltext#%20
Condition	Year	Language	Analysis type
, Oncology	2022	English	, Burden of illness, clinical setting: Secondary care, Database Study, Population Based Study, Retrospective database analysis


Investigating the secondary care system burden of CRSwNP in sinus surgery patients with clinically relevant comorbidities using the HES database
Authors: C. Hopkins - S. Conlon - S. Chavda - R. Hudson - R. Rout
Affiliations: Guy's and St. Thomas' Hospital, Kings college, London, UK. Sanofi Genzyme UK, Reading, UK. IQVIA, London, UK.
Publications: Rhinology 60-4: 252-260, 2022
Document Types: , Article
Countries: , England
Abstract: https://www.rhinologyjournal.com/Abstract.php?id=2979
Condition	Year	Language	Analysis type
, Respiratory disease, Surgery	2022	English	, Budget impact, Burden of illness, Cost analysis, Retrospective database analysis


Nutritional status and use of health resources after the implementation of an enteral nutrition program by PEG probe for neurological patients with home hospitalization
Authors: Blanco Ramos B, Lopez Garcia B, GÃ³mez Bellvert N.
Affiliations: Hospital General Universitario de Elda (Alicante). Carretera Elda-Sax SN. 03600
Publications: Nutr Hosp . 2022 Jun 24;39(3):489-498. doi: 10.20960/nh.03813.
Document Types: , Article
Countries: , Spain
Abstract: https://www.nutricionhospitalaria.org/articles/03813/show
Condition	Year	Language	Analysis type
, Neurological disorders, Nutritional Disorders	2022	Spanish	, Clinical setting: hospital, Cost benefit, Observational study, Population Based Study, Quality of life


Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018
Authors: Janet Sultana 1 2, Salvatore Crisafulli 3, Mariana Almas 4, Ippazio Cosimo Antonazzo 5 6, Esme Baan 7, Claudia Bartolini 6, Maria Paola Bertuccio 3, Fedele Bonifazi 8 9, Annalisa Capuano 10 11, Antonella Didio 8 9, Vera Ehrenstein 12, Mariagrazia Felisi 8 13, Carmen Ferrajolo 10 11, Andrea Fontana 14, Remy Francisca 7, Annie Fourrier-Reglat 15, Joan Fortuny 16, Rosa Gini 6, Giulia Hyeraci 6, Christel Hoeve 7, Christos Kontogiorgis 17, Valentina IsgrÃ² 18, Panagiotis-Nikolaos Lalagkas 17, Luca L'Abbate 18, Deborah Layton 19, Annalisa Landi 8 9, Silvia Narduzzi 19, Leonardo Roque Pereira 20, Georgios Poulentzas 17, Concetta Rafaniello 10 11, Giuseppe Roberto 6, Giulia Scondotto 3, Liberata Sportiello 10 11, Maddalena Toma 8 9, Massoud Toussi 19, Katia Verhamme 7, Elisabetta Volpe 8 9, Gianluca TrifirÃ² 18,
Affiliations: Pharmacy Department, Mater Dei Hospital, Msida, Malta. 2Exeter College of Medicine and Health, Exeter, UK. 3Department of Medicine, University of Verona, Verona, Italy. 4Real World Solutions Department, IQVIA, Lisbon, Portugal. 5Research Centre on Public Health (CESP), University of Milan-Bicocca, Milan, Italy. 6Agenzia Regionale di SanitÃ della Toscana, Florence, Italy. 7Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, The Netherlands. 8TEDDY European Network of Excellence for Paediatric Clinical Research, Pavia, Italy. 9Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Bari, Italy. 10Department of Experimental Medicine, University of Campania "Vanvitelli", Naples, Italy. 11Campania Regional Center of Pharmacovigilance and Pharmacoepidemiology, Naples, Italy. 12Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark. 13CVBF Consorzio per Valutazioni Biologiche e Farmacologiche, Pavia, Italy. 14Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. 15Univ. Bordeaux, INSERM, Bordeaux Population Health Research Center, Team of Pharmacoepidemiology, UMR 1219, Bordeaux, France. 16RTI Health Solutions, Barcelona, Spain. 17Democritus University of Thrace, Alexandroupolis, Greece. 18Department of Diagnostics and Public Health, University of Verona, Verona, Italy. 19Data Science Hub, Real World Solutions, IQVIA, London, UK. 20Department of Datascience & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands.
Publications: Pharmacoepidemiol Drug Saf . 2022 Jun;31(6):689-705. doi: 10.1002/pds.5413. Epub 2022 Feb 11.
Document Types: , Article
Countries: , Denmark, France, Italy, Netherlands, Portugal, Spain, UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/35092329/
Condition	Year	Language	Analysis type
, Drug safety, Drug Utlization Study	2022	English	, Database Study, Review


Insights from a review of publicly available information on Post Authorisation Safety Studies (PASS)
Authors: Almas MF, Hoogendoorn WE, Sayeed S, Blackburn S, Bosco J, Parmenter L
Affiliations: IQVIA
Publications:
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Drug safety, Risk Management & REMS	2022	English	, Review


Factors and their weight in reducing life expectancy in schizophrenia
Authors: Correll CU, Bitter I, Hoti F, MehtÃ¤lÃ¤ J, Wooller A, Pungor K, Tiihonen J
Affiliations: 1.The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; CharitÃ© UniversitÃ¤tsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany. Electronic address: ccorrell@northwell.edu. 2.Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary. 3.EPID Research, Finland (an IQVIA company). 4.Janssen, Medical Affairs EMEA, High Wycombe, United Kingdom. 5.Janssen-Cilag, Medical Affairs EMEA, Dusseldorf, Germany. 6.Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland; Center for Psychiatry Research, Stockholm City Council, Stockholm, Sweden; Neuroscience Center, Helsinki, Finland.
Publications: Schizophr Res. 2022 Nov 8;250:67-75.
Document Types: , Article
Countries: , Finland
Abstract: https://www.sciencedirect.com/science/article/pii/S0920996422004030
Condition	Year	Language	Analysis type
, Mental health	2022	English	, clinical setting: Secondary care, Epidemiological study, Observational study


Validation of safety outcomes in routinely collected data: lessons learned from a multinational post-approval safety study
Authors: Arena PJ, Huang K, LÃ¶fling L, Bahmanyar S, Mo J, Schachterle SE, Nunes AP, Smits E, Juuti R, Hoti F, Korhonen P, Adelborg K, SundbÃ¸ll J, Rasmussen TR, LÃ¸kke A, Ehrenstein V.
Affiliations: "Pfizer Inc., New York, New York, United States of America. Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, United States of America. EPID Research (an IQVIA company), Espoo, Finland."
Publications: Pharmacoepidemiol Drug Saf. 2022 Dec 10. doi: 10.1002/pds.5582
Document Types: , Article
Countries: , Denmark, Finland, Netherlands , Sweden, USA
Abstract: https://onlinelibrary.wiley.com/doi/10.1002/pds.5582
Condition	Year	Language	Analysis type
, Database Validity and methodology, Drug safety, Oncology	2022	English	, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis


Metformin in pregnancy and risk of abnormal growth outcomes at birth: a register-based cohort study
Authors: Kerstin MG Brand1, Robyn Thoren2, Jaak SÃµnajalg3, Emmanuelle Boutmy1, http://orcid.org/0000-0002-0254-5560Caroline Foch1, Judith Schlachter1, Katja M Hakkarainen2, Laura Saarelainen4
Affiliations: Merck KGaA, Darmstadt, Germany Global Database Studies, IQVIA, Solna, Sweden Global Database Studies, IQVIA, Tartu, Estonia Global Database Studies, IQVIA, Espoo, Finland
Publications: BMJ Open Diab Res Care 2022;10:e003056. doi:10.1136/bmjdrc-2022-003056
Document Types: , Article
Countries: , Finland
Abstract: https://drc.bmj.com/content/10/6/e003056
Condition	Year	Language	Analysis type
, Diabetes	2022	English	, Observational study, Population Based Study


Healthcare resource utilization and quality of life in patients with sarcoidosis-associated pulmonary hypertension
Authors: Allan Lawrie1,2\|Neil Hamilton3\|Steven Wood2,4\|Fernando Exposto5\|Ruvimbo Muzwidzwa5\|Louise Raiteri5\|AmÃ©lie Beaudet6\|Audrey Muller6\|Rafael Sauter6\|Nadia Pillai6\|David G. Kiel
Affiliations: 1National Heart and Lung Institute,Imperial College London, London, UK2Insigneo Institute for Inâ€Silico Medicine,University of Sheffield, Sheffield, UK3Sheffield Pulmonary Vascular DiseaseUnit, Sheffield Teaching Hospitals NHSFoundation Trust, Royal HallamshireHospital, Sheffield, UK4Scientific Computing, Sheffield TeachingHospitals NHS Foundation Trust, RoyalHallamshire Hospital, Sheffield, UK5IQVIA, London, UK6Actelion Pharmaceuticals Ltd.,Allschwil, Switzerland7Department of Infection, Immunity andCardiovascular Disease, University ofSheffield, Sheffield, UK
Publications: Pulmonary Circulation. 2022;12:e12136.wileyonlinelibrary.com/journal/pul2\|1of10https://doi.org/10.1002/pul2.12136
Document Types: , Article
Countries: , Switzerland, UK
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/pul2.12136
Condition	Year	Language	Analysis type
, Cardiovascular disease, Respiratory disease	2022	English	, Observational study, Retrospective cohort analysis


Database study on background information and first-line drug treatment of patients with early-onset Alzheimer's disease
Authors: Shingo Wada 1, Ryosuke Miyagawa 2, Ai Inada 2, Yugo Namiya 2, Komei Iwasaki 2, Ryohei Kobayashi 2, Kaiwei Yan 1 (rwesheorj 1)
Affiliations: 1) IQVIA Solutions Japan K.K. 2) IQVIA Services Japan K.K.
Publications: The 27th Annual Meeting of the Japanese Society for Pharmacoepidemiology
Document Types: , Conference, Oral presentation
Countries: , Japan
Abstract: https://www.jspe.jp/meeting/soukai/272022.html
Condition	Year	Language	Analysis type
, Neurological disorders	2022	Japanese	, Database Study


Impact of refractory and unexplained chronic cough on disease burden: a qualitative study
Authors: Naoya Ueda 1, Anzu Yakushiji 2, Jonathan Schelfhout 3, Shigeru Tokita 1, Takekazu Kubo 4* (rwesheorj 2)
Affiliations: 1) Medical Affairs, MSD K.K., Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan 3) Merck & Co Inc, Rahway, NJ, USA 4) Medical Affairs, MSD K.K., Tokyo, Japan
Publications: BMC Pulmonary Medicine
Document Types: , Article
Countries: , Japan
Abstract: https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-022-02171-z
Condition	Year	Language	Analysis type
, Respiratory disease	2022	English	, Burden of illness, Patient questionnaire


Thrombotic and cardiovascular events and treatment patterns among patients hospitalized with COVID-19 in Japan: an analysis of a nationwide medical claims database
Authors: Naoki Terasaka 1*, Yukako Matsuo 2, Hirohide Kataoka 2, Yasuhiko Miyata 2, Yoshio Anazawa 2 (rwesheorj A)
Affiliations: 1) Medical Department, Bristol Myers Squibb K.K., Tokyo, Japan 2) Medical Department, Bristol Myers Squibb K.K., Tokyo, Japan
Publications: Cardiology and Therapy
Document Types: , Article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007/s40119-022-00263-9
Condition	Year	Language	Analysis type
, Cardiovascular disease, COVID-19	2022	English	, Database Study


Patients' preferences for attributes of molecular targeting therapies for advanced non-small cell lung cancer with EGFR mutations in Japan - a discrete-choice experiment
Authors: Kazuhiko Nakagawa 1, Yoshinori Tanizawa 2, Zhihong Cai 2, Tomoko Matsui 2, Sotaro Enatsu 2 (rwesheorj A)
Affiliations: 1) Kindai University, Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan 2) Eli Lilly Japan K.K., Japan Drug Development and Medical Affairs, Kobe, Japan
Publications: Japanese Journal of Cancer and Chemotherapy
Document Types: , Article
Countries: , Japan
Abstract: https://www.pieronline.jp/content/article/0385-0684/49120/1329
Condition	Year	Language	Analysis type
, Oncology	2022	Japanese	, Patient questionnaire


Budget impact analysis of next-generation sequencing versus sequential single-gene testing in Japanese patients with advanced non-small-cell lung cancer
Authors: Hiroyuki Matsuda 1, Toru Ogawa 2*, Yasunari Sadatsuki 3, Toshiaki Tsujino 3, Shingo Wada 1, Seok-Won Kim 1, Yutaka Hatanaka 4 (rwesheorj 1)
Affiliations: 1) Real World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan 2) Market Access Oncology, Bayer Yakuhin, Ltd, Osaka, Japan 3) Medical Affairs & Pharmacovigilance, Bayer Yakuhin, Ltd, Osaka, Japan 4) Research Division of Genome Companion Diagnostics, Hokkaido University Hospital, Hokkaido, Japan
Publications: Respiratory Investigation
Document Types: , Article
Countries: , Japan
Abstract: https://www.sciencedirect.com/science/article/pii/S2212534522001435?via%3Dihub
Condition	Year	Language	Analysis type
, Oncology	2022	English	, Budget impact, Database Study


Characteristics of Japanese patients with non-dialysis-dependent chronic kidney disease initiating treatment for anemia: a retrospective real-world database study
Authors: Yoshimasa Kokado 1*, Manabu Ishii 1, Kiichiro Ueta 1, Hiroyuki Yamamoto 2, Hiraku Kumamaru 3, Masaaki Isshiki 4, Sven Demiya 4, Hiroaki Miyata 2 (rwesheorj 4)
Affiliations: 1) Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan 2) Department of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan 3) Department of Healthcare Quality Assessment, Graduate School of Medicine, University of Tokyo, Tokyo, Japan 4) Real World Data Consulting, IQVIA Solutions Japan KK, Tokyo, Japan
Publications: Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2022.2125256
Condition	Year	Language	Analysis type
, Nephrology	2022	English	, Database Study


Physician awareness and understanding of primary immunodeficiency disorders: a web-based study in Japan
Authors: Kohsuke Imai 1, Akinori Oh 2, Ayumi Morishita 3, Yoichi Inoue 2* (rwesheorj 3)
Affiliations: 1) Department of Pediatrics, National Defense Medical College, Tokorozawa, Japan 2) Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan 3) IQVIA Solutions Japan K.K, Tokyo, Japan
Publications: Immunological Medicine
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/25785826.2022.2137966
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2022	English	, Survey research


Impact of refractory and unexplained chronic cough on disease burden: a qualitative study
Authors: Naoya Ueda 1, Anzu Yakushiji 2, Jonathan Schelfhout 3, Shigeru Tokita 1, Takekazu Kubo 1* (rwesheorj 2)
Affiliations: 1) MSD Co., Ltd., Medical Affairs 2) IQVIA Solutions Japan K.K., Tokyo, Japan 3) Merck & Co Inc, Kenilworth, New Jersey, USA
Publications: The 62nd Annual Meeting of the Japanese Respiratory Society
Document Types: , Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.jrs.or.jp/jrs62/index.html
Condition	Year	Language	Analysis type
, Respiratory disease	2022	Japanese	, Patient questionnaire


Real picture of patients with Charcot-Marie-Tooth disease in Japan: IQVIA Claims Database
Authors: Yuki Kado 1, Yuya Tamai 1, Seok-Won Kim 1, Sven Demiya 1 (rwesheorj 1)
Affiliations: 1) Real World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: ISPOR
Document Types: , Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(22)01125-1/fulltext
Condition	Year	Language	Analysis type
, Neurological disorders	2022	English	, Database Study


Prevalence of depression in Japan and the US populations before and during the COVID-19 pandemic: a retrospective observational study using real-world data
Authors: Demiya S 1, Takeno S 1, Kim SW 2, Lee WS 3, Sakai Y 1 (rwesheorj 1-3)
Affiliations: 1) IQVIA Solutions Japan, Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, 13, Japan 3) IQVIA Solutions Japan, Tokyo, 12, Japan
Publications: ISPOR Europe
Document Types: , Conference, Poster, Presentation
Countries: , Japan, USA
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2022-3564/119994
Condition	Year	Language	Analysis type
, Mental health	2022	English	, Database Study, Retrospective database analysis


Characteristics, treatment patterns, and healthcare costs of advanced/metastatic biliary tract cancer patients in Japan
Authors: CC Chen 1, X Wang 1, Seok-Won Kim 2*, Shingo Wada 2, J Garside 3, ES Reese 4 (rwesheorj 2)
Affiliations: 1) IQVIA, Plymouth Meeting, PA, USA 2) IQVIA, Tokyo, Japan 3) GlaxoSmithKline, London, UK 4) EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA
Publications: Japanese Society of Medical Oncology Annual Meeting
Document Types: , Conference, Oral presentation
Countries: , Japan
Abstract: https://www.c-linkage.co.jp/jsmo2022/en/index.html
Condition	Year	Language	Analysis type
, Oncology	2022	English	, Database Study


Healthcare resource utilization and quality of life in patients with sarcoidosis-associated pulmonary hypertension
Authors: Allan Lawrie 1 2, Neil Hamilton 3, Steven Wood 2 4, Fernando Exposto 5, Ruvimbo Muzwidzwa 5, Louise Raiteri 5, AmÃ©lie Beaudet 6, Audrey Muller 6, Rafael Sauter 6, Nadia Pillai 6, David G Kiely
Affiliations: National Heart and Lung Institute, Imperial College London London UK. 2Insigneo Institute for In-Silico Medicine University of Sheffield Sheffield UK. 3Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital Sheffield UK. 4Scientific Computing, Sheffield Teaching Hospitals NHS Foundation Trust Royal Hallamshire Hospital Sheffield UK. 5IQVIA London UK. 6Actelion Pharmaceuticals Ltd. Allschwil Switzerland. 7Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK.
Publications: Pulm Circ. 2022 Oct; 12(4): e12136. Published online 2022 Sep 30. doi: 10.1002/pul2.12136
Document Types: , Article
Countries: , England
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525996/
Condition	Year	Language	Analysis type
, Cardiovascular disease	2022	English	, Observational study, Retrospective cohort analysis


Budget impact analysis of JiviÂ® (damoctocog alfa pegol, BAY 94-9027) in severe Hemophilia A in Japan
Authors: Teruhisa Fujii 1, Yuko Kidoguchi 2, Noriko Takahashi 2, Eric Yu 3, Dilinuer Ainiwaer 3, Aidan Byrne 4 (rwesheorj 3)
Affiliations: 1) Division of Blood Transfusion, Hiroshima University Hospital, Hiroshima, Japan 2) Market Access, Bayer Yakuhin, Ltd., Tokyo, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan 4) IQVIA UK, London, UK
Publications: Journal of Medical Economics
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/13696998.2021.1875788
Condition	Year	Language	Analysis type
, Health economics	2021	English	, Budget impact


Highâ€‘Expenditure Disease in the EUâ€‘28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?
Authors: Wolfgang Greiner, Keyur Patel, Christina-Jane Crossman-Barnes, Troels Vingtoft Rye-Andersen, Christian Hvid, Tom Vandebrouck
Affiliations: Department for Health Economics, Bielefeld University, Bielefeld, Germany; IQVIA Ltd, HEOR, London, UK; Novo Nordisk Region Europe Pharmaceuticals A/S, Copenhagen, Denmark; Novo Nordisk Region Europe Pharmaceuticals A/S, Brussels, Belgium
Publications: PharmacoEconomics-Open. 2021 Jan; doi.org/10.1007/s41669-020-00253-4
Document Types: , Article
Countries: , Europe
Abstract: https://link.springer.com/epdf/10.1007/s41669-020-00253-4?sharing_token=k4IP2sUMn4HrAsHs0WBqlPe4RwlQNchNByi7wbcMAY4Tirkz8MqaNXdxznG7LjXgeeOE1lL_TUFtfOXdhNB_IQ05wAS6SyWtTgC3QV4GkZ1V3rKbHAI_lwyKV2fZ5OfrjVrTPTsYaJr4E7ZctQaMI_Yhmg_dNtoFcG1705dWSU4%3D
Condition	Year	Language	Analysis type
, Diabetes, Health economics, Oncology	2021	English	, Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Quality of life, Retrospective database analysis, Review


Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands
Authors: Hanne van Ballegooijen 1, Lucas Goossens 2, Ralph H Bruin 3, RenÃ©e Michels 3, Marieke Krol 3
Affiliations: 1IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. hanne.vanballegooijen@iqvia.com. 2Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands. 3IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands.
Publications: 1 IQVIA, Herikerbergweg 314, 1101 CT Amsterdam, The Netherlands. 2 Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands BMC Health Services Research (2021) 21:227 PMID: 33712010 PMCID: PMC7953179 DOI: 10.1186/s12913-021-06240-7
Document Types: , Article
Countries: , Netherlands
Abstract: https://pubmed.ncbi.nlm.nih.gov/33712010/
Condition	Year	Language	Analysis type
, Health economics, Health status & patient reported outcomes, Immunology and Vaccination	2021	English	, Observational study, Patient questionnaire, Population Based Study, Public Health, Quality of life, Survey research


Predicting Hospitalization Due to COPD Exacerbations in Swedish Primary Care Patients Using Machine Learning â€“ Based on the ARCTIC Study
Authors: BjÃ¶rn StÃ¤llberg 1, Karin Lisspers 1, Kjell Larsson 2, Christer Janson 3, Mario MÃ¼ller 4, Mateusz Åuczko 5, Bine KjÃ¸ller Bjerregaard 6, Gerald Bacher 7, BjÃ¶rn Holzhauer 7, Pankaj Goyal 7, Gunnar Johansson 1
Affiliations: 1Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. 2Integrative Toxicology, Karolinska Institutet, Stockholm, Sweden. 3Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden. 4Department of Data Science and Advanced Analytics, IQVIA, Frankfurt Am Main, Germany. 5Department of Data Science and Advanced Analytics, IQVIA, Warsaw, Poland. 6Department of Real World Evidence Solutions, IQVIA, Copenhagen, Denmark. 7Department of Clinical Development and Analytics, Novartis Pharma AG, Basel, Switzerland.
Publications: Journal: Int J Chron Obstruct Pulmon Dis. 2021 Mar 16;16:677-688. doi: 10.2147/COPD.S293099. eCollection 2021. Conference: IPCRG, Dublin, Ireland, Weekly series of Clinical Practice Webinars - Various Saturdays from 16th May to 27th June 2020 PMID: 33758504 PMCID: PMC7981164 DOI: 10.2147/COPD.S293099
Document Types: , Article
Countries: , Sweden
Abstract: https://pubmed.ncbi.nlm.nih.gov/33758504/
Condition	Year	Language	Analysis type
, Respiratory disease	2021	English	, Epidemiological study, Population Based Study


Real-world treatment and health care resource use among severe asthma patients in Japan
Authors: Yasuo To 1, Yurie Taguchi 2, Tatsuya Shimazaki 2, Kazuhiko Arima 2, Eric Yu 3, Sven Demiya 3, Takashi Iwanaga 4 (rwesheorj 3)
Affiliations: 1) Department of Pulmonary Medicine, International University of Health and Welfare, School of Medicine, 1-4-3 Mita, Minato-ku, Tokyo 108-8329, Japan 2) Sanofi K.K., 3-20-2 Nishi Shinjuku, Shinjuku-ku, Tokyo 163-1488, Japan 3) IQVIA Solutions Japan K.K., Keikyu Dai-7 Building 4-10-8, Takanawa Minato-ku, Tokyo 108-0074, Japan 4) Kindai University, 377-2 Ohno Higashi, Osakasayama City, Osaka 589-8511, Japan
Publications: Respiratory Investigation
Document Types: , Article
Countries: , Japan
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S2212534521000423?via%3Dihub
Condition	Year	Language	Analysis type
, Clinical practice	2021	English	, Database Study


Leveraging unstructured data to identify hereditary angioedema patients in electronic medical records
Authors: Emily S Brouwer 1 , Emily W Bratton 2 , Aimee M Near 2 , Lynn Sanders 1 , Christina D Mack 2
Affiliations: 1 Takeda Pharmaceutical Company Limited, 300 Shire Way, Lexington, MA, USA. 2 IQVIA, Durham, NC, USA.
Publications: Allergy Asthma Clin Immunol . 2021 Apr 20;17(1):41. doi: 10.1186/s13223-021-00541-6.
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/33879228/
Condition	Year	Language	Analysis type
, Rare disease	2021	English	, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis


Epidemiology of Concussion in the National Football League, 2015-2019
Authors: Christina D Mack 1, Gary Solomon 2 3, Tracey Covassin 4, Nicholas Theodore 5, Javier CÃ¡rdenas 6, Allen Sills 2 3
Affiliations: 1 IQVIA, Durham, NC, USA. 2 Department of Neurological Surgery and Vanderbilt Sports Concussion Center, Vanderbilt University School of Medicine, Nashville, Tennessee 3 National Football League Player Health and Safety Department, New York, New York 4 Department of Kinesiology, Michigan State University, East Lansing, Michigan 5 Department of Neurological Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 6 Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona
Publications: Sports Health . 2021 Apr 19;19417381211011446. doi: 10.1177/19417381211011446.
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/33872087/#:~:text=Results%3A%20A%20total%201302%20concussions,80%25%20occurred%20in%20NFL%20games.
Condition	Year	Language	Analysis type
, Injuries	2021	English	, Epidemiological study, Observational study, Retrospective database analysis


SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason
Authors: Christina D. Mack; John DiFiori; Caroline G. Tai; Kristin Y. Shiue; Yonatan H. Grad; Deverick J. Anderson; David D. Ho; Leroy Sims; Christopher LeMay; Jimmie Mancell; Lisa L Maragakis
Affiliations: 1 IQVIA, Durham, NC, USA (Mack, Tai, Shiue) 2 Hospital for Special Surgery (DiFiori) 3 National Basketball Association, New York, New York (DiFiori, Sims, LeMay) 4 Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Grad) 5 Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina (Anderson) 6 Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, New York (Ho) 7 Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee(Mancell) 8 Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland (Maragakis)
Publications: JAMA Intern Med. Published online April 22, 2021. doi:10.1001/jamainternmed.2021.2114
Document Types: , Article
Countries: , USA
Abstract: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2779287
Condition	Year	Language	Analysis type
, Respiratory disease	2021	English	, Epidemiological study, Observational study, Retrospective database analysis


How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools
Authors: Elvira D'Andrea, Lydia Vinals, Elisabetta Patorno, Jessica M. Franklin, Dimitri Bennett , Joan A. Largent, Daniela C. Moga, Hongbo Yuan, Xuerong Wen, Andrew R. Zullo, Thomas P. A. Debray, Grammati Sarri
Affiliations: D'Andrea: Harvard; Largent: IQVIA
Publications: http://orcid.org/0000-0002-5263-3964PubMed articles
Document Types: , Article
Countries: , Europe, USA
Abstract: https://bmjopen.bmj.com/content/11/3/e043961
Condition	Year	Language	Analysis type
, Methodology	2021	English	, Literature Review


Long-Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity.
Authors: Alberto Esquenazi 1, Ganesh Bavikatte 2, Daniel S Bandari 3, Wolfgang H Jost 4 5, Michael C Munin 6, Simon Fuk Tan Tang 7, Joan Largent 8, Aubrey Manack Adams 9, Aleksej Zuzek 9, Gerard E Francisco 10
Affiliations: 1MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA. 2The Walton Centre, Liverpool, UK. 3Multiple Sclerosis Center of California, Laguna Hills, CA, USA. 4Department of Neurology, University of Freiburg, Freiburg im Breisgau, Germany. 5Parkinson-Klinik Ortenau, Wolfach, Germany. 6Department of Physical Medicine and Rehabilitation, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 7Department of Physical Medicine and Rehabilitation, Lotung Poh-Ai Hospital, Yilan, Taiwan. 8IQVIA Real-World Evidence Solutions, Cambridge, MA, USA. 9Allergan, An AbbVie company, Irvine, CA, USA. 10University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX, USA.
Publications: PMID: 33151636 DOI: 10.1002/pmrj.12517
Document Types: , Article
Countries:
Abstract: https://pubmed.ncbi.nlm.nih.gov/33151636/
Condition	Year	Language	Analysis type
, Neurological disorders	2021	English	, Epidemiological study, Observational study


Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making
Authors: Grammati Sarri 1, Elisabetta Patorno 2, Hongbo Yuan 3, Jianfei Jeff Guo 4, Dimitri Bennett 5, Xuerong Wen 6, Andrew R Zullo 7, Joan Largent 8, Mary Panaccio 9, Mugdha Gokhale 10, Daniela Claudia Moga 11, M Sanni Ali 12 13 14, Thomas P A Debray 15 16
Affiliations: 1Real World Evidence Sciences, Visible Analytics Ltd, Oxford, UK grammati.sarri@visibleanalytics.co.uk. 2Division of Pharmacoepidemiology and Pharmacoeconomics, Dept. of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 3Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, Ontario, Canada. 4Department of Pharmacy Practice & Administrative Sciences, University of Cincinnati College of Pharmacy, Cincinnati, Ohio, USA. 5Takeda, Cambridge, Massachusetts, USA. 6Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA. 7Health Services, Policy, and Practice, Brown University, Providence, Rhode Island, USA. 8Real-World Solutions, IQVIA, California, Colorado, USA. 9Epidemiology and Outcomes Research, Research Outcomes Innovations LLC, New York City, New York, USA. 10GlaxoSmithKline USA, Philadelphia, Pennsylvania, USA. 11University of Kentucky, Department of Pharmacy Practice and Science, Lexington, Kentucky, USA. 12NDORMS, Center for Statistics in Medicine, University of Oxford, Oxford, UK. 13Department of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. 14Department of Public Heath, Environments and Society, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. 15Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands. 16Smart Data Analysis and Statistics, Utrecht, The Netherlands.
Publications: PMID: 33298465 DOI: 10.1136/bmjebm-2020-111493
Document Types: , Article
Countries: , Europe, USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/33298465/
Condition	Year	Language	Analysis type
, Methodology	2021	English	, Literature Review


The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease
Authors: Lars Holger Ehlers 1, Mark Lamotte 2, Sofia Monteiro 3, Susanne Sandgaard 4, Pia Holmgaard 4, Evan C Frary 4, Niels Ejskjaer 5 6 7
Affiliations: 1Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. 2IQVIA Real World Solutions, Zaventem, Belgium. 3IQVIA Real World Solutions, London, UK. 4Boehringer Ingelheim Danmark A/S, KÃ¸benhavn Ã˜, Hovedstaden, Denmark. 5Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. n.ejskjaer@rn.dk. 6Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark. n.ejskjaer@rn.dk. 7Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark. n.ejskjaer@rn.dk.
Publications: Diabetes Therapy https://doi.org/10.1007/s13300-021-01040-y IQVIA HEOR Zaventem Brussels PMID: 33856655 PMCID: PMC8099952 DOI: 10.1007/s13300-021-01040-y
Document Types:
Countries: , Denmark
Abstract: https://pubmed.ncbi.nlm.nih.gov/33856655/
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2021	English	, Clinical setting: Primary care, Cost effectiveness


Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal
Authors: Nuno Marques 1, Laetitia Gerlier 2, Mafalda Ramos 3, Helder Pereira 4, SÃ©rgia Rocha 5, Ana Catarina Fonseca 6, Ana AndrÃ© 7, Ricardo Melo 8, Eduard Sidelnikov 9
Affiliations: 1Department of Cardiology, Centro Hospitalar e UniversitÃ¡rio do Algarve, Faro, Portugal. 2IQVIA, Zaventem, Belgium. 3IQVIA, Zaventem, Belgium. Electronic address: mafalda.ramos@iqvia.com. 4Department of Cardiology, Hospital Garcia de Orta, Almada, Portugal. 5Department of Cardiology, Hospital de Braga, Braga, Portugal. 6Department of Neurology, Hospital de Santa Maria, Universidade de Lisboa, Lisboa, Portugal. 7Department of Neurology, Centro Hospitalar e UniversitÃ¡rio do Algarve, Faro, Portugal. 8Amgen SA, Portugal. 9Amgen (Europe) GmbH, Rotkreuz, Switzerland.
Publications: PMID: 33581948 DOI: 10.1016/j.repc.2020.05.019 IQVIA HEOR Zaventem Brussels Revista Portuguesa de Cardiologia Volume 40, Issue 2, February 2021, Pages 109-115.
Document Types: , Article
Countries: , Portugal
Abstract: https://pubmed.ncbi.nlm.nih.gov/33581948/
Condition	Year	Language	Analysis type
, Cardiovascular disease, Health economics	2021	English	, Burden of illness, Clinical setting: Primary care, Prospective study


Cost-effectiveness analysis of empagliflozin compared with glimepiride in patients with Type 2 diabetes in China
Authors: Ahmed Salem 1, Peng Men 2 3, Mafalda Ramos 4, Yan-Jun Zhang 5, Anastasia Ustyugova 6, Mark Lamotte 7
Affiliations: 1IQVIA, Real World Solutions, Zaventem 1930, Belgium. 2Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China. 3Institute for Drug Evaluation, Peking University Health Science Center, Beijing 100191, China. 4IQVIA, Global HEOR, Porto Salvo 2740-266, Portugal. 5Boehringer Ingelheim, Health Economics & Outcomes Research, Government Affairs & Market Access, Shanghai 200040, China. 6Boehringer Ingelheim, CardioMetabolism Respiratory, Ingelheim am Rhein 55216, Germany. 7IQVIA, Global HEOR, Zaventem 1930, Belgium.
Publications: Journal of Comparative Effectiveness Research 2021 https://doi.org/10.2217/cer-2020-0284. PMID: 33576249 DOI: 10.2217/cer-2020-0284
Document Types: , Article
Countries: , China
Abstract: https://pubmed.ncbi.nlm.nih.gov/33576249/
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2021	English	, Clinical setting: Primary care, Cost effectiveness


Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China
Authors: Ahmed Salem # 1, Heng Zhong # 2, Mafalda Ramos 1, Mark Lamotte 1, Hao Hu 3
Affiliations: 1Real World Evidence, IQVIA, Zaventem, Belgium. 2R&D China, AstraZeneca R&D, Shanghai, China. 3Institute of Chinese Medical Sciences, University of Macau, Macau, China haohu@um.edu.mo. #Contributed equally.
Publications: BMJ Open 2021;11:e043664. doi:10.1136/bmjopen-2020-043664 e043664. doi:10.1136/bmjopen-2020-043664 PMID: 33910947 PMCID: PMC8094343 DOI: 10.1136/bmjopen-2020-043664
Document Types: , Article
Countries: , Belgium, China
Abstract: https://pubmed.ncbi.nlm.nih.gov/33910947/
Condition	Year	Language	Analysis type
, Health economics, Respiratory disease	2021	English	, Clinical setting: Primary care, Cost effectiveness


A novel decision model to predict the impact of weight management interventions: The Core Obesity Model.
Authors: Sandra Lopes 1, Henrik H Meincke 1, Mark Lamotte 2, Anamaria-Vera Olivieri 3, Michael E J Lean 4
Affiliations: 1Novo Nordisk A/S SÃ¸borg Denmark. 2IQVIA Zaventem Belgium. 3IQVIA Basel Switzerland. 4Human Nutrition School of Medicine, Dentistry and Nursing Royal Infirmary University of Glasgow Glasgow UK.
Publications: Obesity Science & Practice 2021. https://doi.org/10.1002/osp4.495
Document Types: , Article
Countries: , Belgium, Switzerland
Abstract: https://pubmed.ncbi.nlm.nih.gov/34123394
Condition	Year	Language	Analysis type
, Health economics, Obesity	2021	English	, Clinical setting: Primary care, Cost effectiveness


Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany
Authors: Rui Cai 1, Laetitia Gerlier 2, Martin Eichner 3 4, Markus Schwehm 5, Sankarasubramanian Rajaram 6, Joaquin Mould-Quevedo 7, Mark Lamotte 2
Affiliations: 1IQVIA Real World Solutions, Amsterdam, The Netherlands. 2IQVIA (Global HEOR), Zaventem, Belgium. 3Epimos GmbH, Dusslingen, Germany. 4Institute for Clinical Epidemiology and Applied Biometry, University of TÃ¼bingen, TÃ¼bingen, Germany. 5ExploSYS GmbH, Leinfelden-Echterdingen, Germany. 6Seqirus Vaccines Ltd, Maidenhead, UK. 7Seqirus Vaccines, Summit, NJ, USA
Publications: Journal of Medical Economics 2021. https://doi.org/10.1080/13696998.2021.1908000
Document Types: , Article
Countries: , Germany
Abstract: https://pubmed.ncbi.nlm.nih.gov/33761803/
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2021	English	, Clinical setting: Primary care, Cost effectiveness


Type 2 diabetes and cancer: an umbrella review of observational and Mendelian randomisation studies
Authors: Jonathan Pearson-Stuttard 1, Nikos Papadimitriou 2 3, Georgios Markozannes 2, Sofia Cividini 4, Artemisia Kakourou 2, Dipender Gill 5, Evangelos C Rizos 6 7, Grace Monori 5, Heather A Ward 5, Maria Kyrgiou 8 9, Marc J Gunter 3, Konstantinos K Tsilidis 2 5
Affiliations: 1Department of Epidemiology and Biostatistics, MRC-PHE Center for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom. j.pearson-stuttard@imperial.ac.uk. 2Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece. 3Nutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France. 4Department of Health Data Science, University of Liverpool, Liverpool, United Kingdom. 5Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. 6Department of Internal Medicine, University Hospital of Ioannina, Ioannina, Greece. 7School of Medicine, European University of Cyprus, Nicosia, Cyprus. 8Department of Gut, Metabolism and Reproduction, and Surgery and Cancer, IRDB, Imperial College London, London, United Kingdom. 9West London Gynecological Cancer Center, Imperial NHS Trust, London, United Kingdom. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. IQVIA.
Publications: PMID: 33737302 DOI: 10.1158/1055-9965.EPI-20-1245
Document Types: , Article
Countries:
Abstract: https://cebp.aacrjournals.org/content/cebp/early/2021/03/18/1055-9965.EPI-20-1245.full.pdf
Condition	Year	Language	Analysis type
, Diabetes	2021	English	, Epidemiological study, Literature Review, Meta analysis


Developing a short-term prediction model for asthma exacerbations from Swedish primary care patientsâ€™ data using machine learning - based on the ARCTIC study Respiratory Medicine
Authors: Karin Lisspers a,*, BjÂ¨orn StÂ¨allberg a, Kjell Larsson b, Christer Janson c, Mario MÃ¼ller d, Mateusz Åuczko e, Bine KjÃ¸ller Bjerregaard f, Gerald Bacher g, BjÂ¨orn Holzhauer g, Pankaj Goyal g, Gunnar Johansson a
Affiliations: a Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden b Integrative Toxicology, Karolinska Institutet, Stockholm, Sweden c Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden d IQVIA, Frankfurt am Main, Germany e IQVIA, Warsaw, Poland f IQVIA, Copenhagen, Denmark g Novartis Pharma AG, Basel, Switzerland
Publications:
Document Types:
Countries: , Sweden
Abstract: https://authors.elsevier.com/c/1d9cV_Lj95hJLT
Condition	Year	Language	Analysis type
, Respiratory disease	2021	English	, Clinical setting: Primary care, clinical setting: Secondary care, Predictive analytics


Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
Authors: Colombo GL, Heiman F, Peduto I
Affiliations: Colombo GL: CEFAT - Department of Drug Sciences, University of Pavia, Pavia, Italy. Peduto I, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publications: Ther Clin Risk Manag. 2021 Apr 21;17:345-356. doi: 10.2147/TCRM.S301005
Document Types: , Article
Countries: , Italy
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072261/pdf/tcrm-17-345.pdf
Condition	Year	Language	Analysis type
, Health economics, Overactive bladder	2021	English	, Clinical setting: Primary care, Cost of illness


Characterisation of Pulmonary Arterial Hypertension (PAH) Patients Initiating a New PAH Specific Therapy in the Context of Age: Insights from EXPOSURE
Authors: P. Escribano (1), S. Gaine (2), P. Biedermann (3), A. Muller (3), M. Valge (4), T. Lange (5), S. SÃ¶derberg (6)
Affiliations: 1 Pulmonary Hypertension Unit, Cardiology Department, CIBERCV, Hospital 12 de Octubre, Madrid, Spain 2 National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland 3 Actelion Pharmaceuticals Ltd, Allschwil, Switzerland 4 StatFinn Estonia OÃœ, Tartu, Estonia (now IQVIA) 5 University Medical Center Regensburg, Regensburg, Germany 6 Department of Public Health and Clinical Medicine, Cardiology and Heart Centre, UmeÃ¥ University, UmeÃ¥, Sweden
Publications: JO - The Journal of Heart and Lung Transplantation VL - 40 IS - 4, Supplement SP - S109 PY - 2021 DA - 2021/04/01/ SN - 1053-2498
Document Types: , Abstract
Countries: , Canada, Europe
Abstract: https://www.jhltonline.org/article/S1053-2498(21)00365-X/fulltext#articleInformation
Condition	Year	Language	Analysis type
, Cardiovascular disease	2021	English	, Epidemiological study, Observational study


Protocol of the Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research (CHARIOT): Prospective Readiness cOhort (PRO) SubStudy
Authors: Udeh-Momoh CT, Watermeyer T, Price G, de Jager Loots CA, Reglinska-Matveyev N, Ropacki M, Ketter N, Fogle M, Raghavan N, Arrighi M, Brashear R, Di J, Baker S, Giannakopoulou P, Robb C, Bassil D, Cohn M, McLellan-Young H, Crispin J, Lakey K, Lisa C, Chowdary Seemulamoodi Y, Kafetsouli D, Perera D, Car J, Majeed A, Ward H, Ritchie K, Perneczky R, Kivipelto M, Scott D, Bracoud L, Saad Z, Novak G, Ritchie CW, Middleton L
Affiliations: Imperial College London
Publications: BMJ Open
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/34168021/
Condition	Year	Language	Analysis type
, Neurological disorders	2021	English	, Epidemiological study, Observational study


Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case-Control Study
Authors: Farah Toron 1, Maureen P Neary 2, Timothy W Smith 3, David Gruben 4, William Romero 5, Amy Cha 3, Keyur Patel 1, Simona Z Vasileva 6, Mahreen Ameen 7
Affiliations: 1Health Economics and Outcomes Research, Real World Solutions, IQVIA, 210 Pentonville Road, London, N1 9JY, UK. 2Inflammation & Immunology, Pfizer Inc, Collegeville, Pennsylvania, USA. 3Inflammation & Immunology, Pfizer Inc, New York, New York, USA. 4Global Biometrics and Data Management (Statistics), Pfizer Inc, Groton, Connecticut, USA. 5Inflammation & Immunology, Pfizer Ltd, Surrey, UK. 6Health Economics and Outcomes Research, Real World Solutions, IQVIA, 210 Pentonville Road, London, N1 9JY, UK. simona.vasileva@iqvia.com. 7Royal Free London National Health Services Foundation Trust, London, UK.
Publications: PMID: 33846907 PMCID: PMC8163940 DOI: 10.1007/s13555-021-00519-7
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/33846907/
Condition	Year	Language	Analysis type
, Dermatology, Drug Utlization Study, Methodology	2021	English	, direct to patient research, direct-to-patient research, Economic evaluation, Population Based Study, Retrospective database analysis


Cost-effectiveness analysis of the treatment strategies with or without opioid medications in surgery-eligible patients with osteoarthritis in Japan
Authors: Tomoyuki Takura 1, Akira Yuasa 2, Naohiro Yonemoto 2, Sven Demiya 3, Hiroyuki Matsuda 3, Nozomi Ebata 4, Koichi Fujii 4, Muneaki Ishijima 5 (rwesheorj 3)
Affiliations: 1) Department of Healthcare Economics and Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 2) Health and Value, Pfizer Japan Inc., Shinjuku Bunka Quint Building, 3-22-7, Yoyogi, Shibuya-ku, Tokyo, 151-8589, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan 4) Medical Affairs, Pfizer Japan Inc, Tokyo, Japan 5) Department of Medicine for Orthopaedics and Motor Organ, Juntendo University Graduate School of Medicine, Tokyo, Japan
Publications: PharmacoEconomics - Open
Document Types: , Article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007/s41669-021-00292-5
Condition	Year	Language	Analysis type
, Health economics	2021	English	, Cost effectiveness, Literature Review


Healthcare resource utilization and economic burden of antifungal management in patients with hematologic malignancy in Japan: a retrospective database study
Authors: Rie Ueno 1, Shinichi Nishimura 1, Go Fujimoto 1, Dilinuer Ainiwaer 2 (rwesheorj 2)
Affiliations: 1) MSD K.K, Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2021.1927691
Condition	Year	Language	Analysis type
, Infectious disease	2021	English	, Database Study


An exploratory assessment of the applicability of direct-to-consumer genetic testing to translational research in Japan
Authors: Masahiro Inoue 1, Shota Arichi 1, Tsuyoshi Hachiya 1, Anna Ohtera 2, Seok-Won Kim 2, Eric Yu 2, Masatoshi Nishimura 3, Kazuhito Shiosakai 3, Takeshi Ohira 3 (rwesheorj 2)
Affiliations: 1) HealthData Lab, Yahoo! Japan Corporation, Kioi Tower, Tokyo Garden Terrace Kioicho, 1-3, Kioi-cho, Chiyoda-ku, Tokyo, 102-8282, Japan 2) Real World Evidence Solutions, IQVIA Solutions Japan K.K, Takanawa 4-10-18, Minato-ku, Tokyo, 108-0074, Japan 3) Daiichi Sankyo Co. Ltd, Tokyo, Japan
Publications: BMC Research Notes
Document Types: , Article
Countries: , Japan
Abstract: https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-021-05696-4
Condition	Year	Language	Analysis type
, Database Validity and methodology	2021	English	, Methodology, Patient questionnaire, Real World Evidence, Survey research


Patient preferences for growth hormone treatment in Japanese children
Authors: Toshiaki Tanaka 1, Takahiro Sato 2, Akira Yuasa 3, Takeshi Akiyama 4, Adeeb Tawseef 4 (rwesheorj 4)
Affiliations: 1) Tanaka Growth Clinic, Tokyo, Japan 2) Medical Affairs, Rare Disease, Pfizer Japan Inc, Tokyo, Japan 3) Corporate Affairs, Health and Value, Pfizer Japan Inc, Tokyo, Japan 4) IQVIA Solutions Japan K.K., RWE & HEOR, Tokyo, Japan
Publications: Pediatrics International
Document Types: , Article
Countries: , Japan
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1111/ped.14760
Condition	Year	Language	Analysis type
, Endocrinology	2021	English	, Patient questionnaire, Survey research


COVID-19 patients analysis utilizing Japan and US claims databases
Authors: Seok-Won Kim 1, T Ishii 2, Shujiro Takeno 2, Yuki Kado 2, Yuya Tamai 2, Takeshi Akiyama 2, Eric Yu 2, Sven Demiya 2 (rwesheorj 1-2)
Affiliations: 1,2) IQVIA Solutions Japan, Minato-ku, Tokyo, Japan
Publications: ISPOR 2021 Conference
Document Types: , Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2021-3340/111047
Condition	Year	Language	Analysis type
, COVID-19	2021	English	, Database Study


COVID-19 patient severities in Japanese EMR
Authors: Masafumi Okada 1, Shingo Wada 1, Masaaki Isshiki 2, Sadako Utsunomiya 2, Takeshi Akiyama 1, Kenji Hamada 1, Sven Demiya 1 (rwesheorj 1)
Affiliations: 1,2) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan
Publications: ISPOR 2021 Conference
Document Types: , Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2021-3340/111009
Condition	Year	Language	Analysis type
, COVID-19	2021	English	, Database Study


A review of the sampling methodology used in studies evaluating the effectiveness of risk minimisation measures in Europe.
Authors: Jouaville LS, Paul T, Almas MF
Affiliations: IQVIA
Publications: Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1143-1152. doi: 10.1002/pds.5301.
Document Types: , Article
Countries: , Europe
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/pds.5301
Condition	Year	Language	Analysis type
, Guidelines, Methodology, Risk Management & REMS	2021	English	, Literature Review


Identification of potentially undiagnosed patients with nontuberculous mycobacterial lung disease using machine learning applied to primary care data in the UK
Authors: Orla M Doyle 1 2, Roald van der Laan 3 2, Marko Obradovic 4 2, Peter McMahon 5, Flora Daniels 6, Ashley Pitcher 7, Michael R Loebinger 8
Affiliations: Predictive Analytics, Real World Analytical Solutions, IQVIA, London, UK. 2These authors contributed equally. 3Insmed Utrecht, Utrecht, The Netherlands. 4Insmed Utrecht, Utrecht, The Netherlands marko.obradovic@insmed.com. 5Real-World Insights, IQVIA, London, UK. 6Real-World Insights, IQVIA, Basel, Switzerland. 7Real-World Insights, IQVIA, Copenhagen, Denmark. 8Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK.
Publications: PMID: 32430411 DOI: 10.1183/13993003.00045-2020
Document Types: , Article
Countries: , Switzerland, UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/32430411/
Condition	Year	Language	Analysis type
, Database Validity and methodology, Pain	2021	English	, Population Based Study, Real World Evidence, Retrospective database analysis


Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults â€“ A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study)
Authors: Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas
Affiliations: University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States
Publications:
Document Types: , Article
Countries: , Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA
Abstract: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab491/6381446
Condition	Year	Language	Analysis type
, Infectious disease	2021	English	, Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study


Interferon beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-based Drug Utilisation Study in Finland and Sweden
Authors: Meritxell SabidÃ³1, Kiliana Suzart-Woischnik2, Nydjie Grimes3, Lisa M Prach4, Liwei Zhao5, Katja M Hakkarainen5
Affiliations: 1Merck Healthcare KGaA; 2Bayer AG; 3Biogen Netherlands B.V.; 4Novartis Pharma AG; 5Global Database Studies, IQVIA
Publications: ECTRIMS 2021, Digital, 13-15 October 2021
Document Types: , Abstract
Countries: , Finland, Sweden
Abstract: https://ectrims2021.abstractserver.com/program/#/details/presentations/466
Condition	Year	Language	Analysis type
, Drug Utlization Study, Neurological disorders	2021	English	, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis


Interferon beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-based Drug Utilisation Study in Finland and Sweden
Authors: Meritxell SabidÃ³1, Kiliana Suzart-Woischnik2, Nydjie Grimes3, Lisa M Prach4, Liwei Zhao5, Katja M Hakkarainen5
Affiliations: 1Merck Healthcare KGaA; 2Bayer AG; 3Biogen Netherlands B.V.; 4Novartis Pharma AG; 5Global Database Studies, IQVIA
Publications: ECTRIMS 2021, Digital, 13-15 October 2021
Document Types: , Poster
Countries: , Finland, Sweden
Abstract: http://medpub-poster.merckgroup.com/ECTRIMS2021_INFORM_Study_Design.pdf
Condition	Year	Language	Analysis type
, Drug Utlization Study, Neurological disorders	2021	English	, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis


Understanding the COVID Impact on Healthcare System in Canada
Authors: Juejing Ling, Scott Shi, Marc Lapierre, HuijuanYang, Brad Millson
Affiliations: Juejing Ling IQVIA, Scott Shi IQVIA, Marc Lapierre IQVIA, HuijuanYang IQVIA, Brad Millson IQVIA
Publications: 2021 CADTH Symposium Confrence, November 2, 3 and 4, 2021
Document Types: , Poster
Countries: , Canada
Condition	Year	Language	Analysis type
, COVID-19	2021	English	, Clinical setting: Primary care, Economic evaluation


Prescribing patterns among in-person vs virtual primary care visits pre-and post-COVID-19 in Ontario, Canada
Authors: Muratov S, Neish D, Ellis K, Wang I, Yang H, Bhattacharjee P, Barot P, Kukaswadia A
Affiliations: Muratov S, Neish D, Ellis K, Wang I, Yang H, Bhattacharjee P, Barot P, Kukaswadia A - all IQVIA authors
Publications: CAPT 2021 Confrence, October 25-27, 2021
Document Types: , Poster
Countries: , Canada
Condition	Year	Language	Analysis type
, COVID-19	2021	English	, Clinical setting: Primary care, Public Health, Survey research


Impact of lurasidone and other antipsychotics on body weight: real-world, retrospective, comparative study of 15,323 adults with schizophrenia
Authors: Pochiero I, Calisti F, Comandini A, Del Vecchio A, Costamagna I, Rosignoli MT, Cattaneo A, Nunna S, Peduto I, Heiman F, Chang H, Chen C, Correll C
Affiliations: Pochiero I: Angelini Regulatory, Research & Development, Angelini Pharma S.p.A., Rome, Italy; Peduto I and Heiman F: IQVIA Solutions Italy Srl, RWS
Publications: Int J Gen Med. 2021 Jul 31;14:4081-4094. doi: 10.2147/IJGM.S320611. PMID: 34366678; PMCID: PMC8336993.
Document Types: , Article
Countries: , Italy, USA
Abstract: https://www.dovepress.com/impact-of-lurasidone-and-other-antipsychotics-on-body-weight-real-worl-peer-reviewed-fulltext-article-IJGM
Condition	Year	Language	Analysis type
, Mental health, Metabolic Disorders	2021	English	, Clinical setting: Primary care, Epidemiological study, Retrospective database analysis


Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany
Authors: Kasper S, Bonelli A, Cattaneo A, Comandini A, Di Dato G, Heiman F, Pegoraro V, Palao D, Roca M, Volz HP
Affiliations: Kasper S: Center for Brain Research, Medical University of Vienna, Austria; Pegoraro V, Heiman F: IQVIA Solutions Italy S.r.l., RWS
Publications: Int J Psychiatry Clin Pract. 2021 Sep 20:1-10. doi: 10.1080/13651501.2021.1972120. Epub ahead of print. PMID: 34543170.
Document Types: , Article
Countries: , Germany
Abstract: https://www.tandfonline.com/doi/full/10.1080/13651501.2021.1972120
Condition	Year	Language	Analysis type
, Mental health	2021	English	, Clinical setting: Primary care, Epidemiological study, Retrospective database analysis


Analisi di impatto sul budget sanitario italiano di gilteritinib per il trattamento della leucemia mieloide acuta FLT3+ recidivante o refrattaria
Authors: Fiorentino F, La Malfa P, Di Rienzo P
Affiliations: Fiorentino F: IQVIA Solutions Italy Srl, RWS
Publications: GIHTAD (2021) 14:4
Document Types: , Article
Countries: , Italy
Abstract: https://springerhealthcare.it/GIHTAD/2021/07/05/analisi-di-impatto-sul-budget-sanitario-italiano-di-gilteritinib-%E2%80%A8per-il-trattamento-della-leucemia-mieloide-acuta-flt3-recidivante-%E2%80%A8o-refrattaria/
Condition	Year	Language	Analysis type
, Health economics, Oncology	2021	Italian	, Budget impact, clinical setting: Secondary care


First Italian guidelines for the economic evaluation of health technologies: how do they compare to NICE standards?
Authors: Fiorentino F, Urbinati D
Affiliations: Fiorentino F: IQVIA Solutions Italy Srl, RWS
Publications: GIHTAD (2021) 14:5
Document Types: , Letter
Countries: , Italy
Abstract: https://springerhealthcare.it/GIHTAD/2021/07/16/first-italian-guidelines-for-the-economic-evaluation-of-health-technologies-how-do-they-compare-to-nice-standards/
Condition	Year	Language	Analysis type
, Health policy	2021	English	, Public Health


Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
Authors: Mennini FS, Gori M, Vlachaki I, Fiorentino F, La Malfa P, Urbinati D, Andreoni M
Affiliations: Mennini FS: EEHTA CEIS, Faculty of Economics, University of Rome "Tor Vergata", Rome, Italy; Fiorentino F, La Malfa P, Urbinati D: IQVIA Solutions Italy Srl, RWS
Publications: Health Econ Rev. 2021 Oct 30;11(1):42. doi: 10.1186/s13561-021-00341-z. PMID: 34716794; PMCID: PMC8557067.
Document Types: , Article
Countries: , Italy
Abstract: https://healtheconomicsreview.biomedcentral.com/articles/10.1186/s13561-021-00341-z
Condition	Year	Language	Analysis type
, Respiratory disease	2021	English	, clinical setting: Secondary care, Cost effectiveness


An Italian individual-level data study investigating on the association between air pollution exposure and Covid-19 severity in primary-care setting
Authors: Pegoraro V, Heiman F, Levante A, Urbinati D, Peduto I
Affiliations: Pegoraro V, Heiman F, Levante A, Urbinati D, Peduto I: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publications: BMC Public Health. 2021 May 12;21(1):902. doi: 10.1186/s12889-021-10949-9
Document Types: , Article
Countries: , Italy
Abstract: https://bmcpublichealth.biomedcentral.com/track/pdf/10.1186/s12889-021-10949-9.pdf
Condition	Year	Language	Analysis type
, Infectious disease, Public Health	2021	English	, Clinical setting: Primary care, Epidemiological study, Public Health


The Burden of Short-Acting Î² 2-Agonist Use in Asthma: Is There an Italian Case? An Update from SABINA Program
Authors: Di Marco F, D'Amato M, Lombardo FP, Micheletto C, Heiman F, Pegoraro V, Boarino S, Manna F, Mastromauro F, Spennato S, Papi A
Affiliations: Di Marco F: Department of Health Sciences, University of Milan, Respiratory Unit, ASST Papa Giovanni XXIII, Bergamo, Italy. Pegoraro V, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publications: Adv Ther. 2021 May 27. doi: 10.1007/s12325-021-01772-0
Document Types: , Article
Countries: , Italy
Abstract: https://link.springer.com/content/pdf/10.1007/s12325-021-01772-0.pdf
Condition	Year	Language	Analysis type
, Respiratory disease	2021	English	, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis


Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
Authors: Colombo GL, Heiman F, Peduto I
Affiliations: Colombo GL: CEFAT - Department of Drug Sciences, University of Pavia, Pavia, Italy. Peduto I, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publications: Ther Clin Risk Manag. 2021 Apr 21;17:345-356. doi: 10.2147/TCRM.S301005
Document Types: , Article
Countries: , Italy
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072261/pdf/tcrm-17-345.pdf
Condition	Year	Language	Analysis type
, Health economics, Orthopedics	2021	English	, Clinical setting: Primary care, Cost of illness, Retrospective database analysis


Office-based Approach to Urinary Tract Infections in 50 000 Patients: Results From the REWIND Study
Authors: Cai T, Palagin I, Brunelli R, Cipelli R, Pellini E, Truzzi JC, Van Bruwaene S
Affiliations: Cai T: Department of Urology, Santa Chiara Regional Hospital, Trento, Italy. Cipelli: Obs Studies Consultat, IQVIA, RWS, Milan, Italy.
Publications:
Document Types: , Article
Countries: , Belgium, Brazil, Italy, Russian Federation
Abstract: https://www.sciencedirect.com/science/article/pii/S0924857920301230?via%3Dihub
Condition	Year	Language	Analysis type
, Miscellaneous	2021	English	, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis


Real-World Profiling of Non-Small Cell Lung Cancer Patients in Japan
Authors: Elaine Chang Takahashi 1, Shiho Wakase 2, Masayuki Ito 1, Todd D Taylor 3 (rwesheorj 3)
Affiliations: 1) Novartis Pharma K.K., Minato-ku, Japan 2) Novartis Pharma K.K., Tokyo, Japan 3) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan
Publications: ISPOR Europe 2021
Document Types: , Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2021-3407/111943
Condition	Year	Language	Analysis type
, Oncology	2021	English	, Database Study, Real World Evidence


Prevalence of prescription opioid use during pregnancy in eight US health plans during 2001-2014
Authors: Pocobelli G, Dublin S, Bobb JF, Albertson-Junkans L, Andrade S, Cheetham TC, Salgado G, Griffin MR, Raebel MA, Smith D, Li DK, Pawloski PA, Toh S, Taylor LG, Hua W, Horn P, Trinidad JP, Boudreau DM
Affiliations: "L Taylor: EPI OR, RWS, IQVIA; 1Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA. 2Meyers Primary Care Institute, Worcester, Massachusetts, USA. 3Kaiser Permanente Southern California, Department of Research & Evaluation, Pasadena, CA, Chapman University, School of Pharmacy, Irvine, CA, USA. 4Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 5Institute for Health Research, Kaiser Permanente Colorado, Colorado, USA. 6Kaiser Permanente Center for Health Research, Portland, Oregon, USA. 7Kaiser Foundation Research Institute, Oakland, California, USA. 8Health Partners Institute, Bloomington, Minnesota, USA. 9Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA. 10Food and Drug Administration, Silver Spring, Maryland, USA."
Publications: Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1541-1550. doi: 10.1002/pds.5312.
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/34169607/
Condition	Year	Language	Analysis type
, Drug Utlization Study, Womens Health	2021	English	, Epidemiological study, Population Based Study


Validation of an ICD-10-based algorithm to identify stillbirth in the Sentinel System
Authors: Andrade SE, Shinde M, Moore Simas TA, Bird ST, Bohn J, Haynes K, Taylor LG, Lauring JR, Longley E, McMahill-Walraven CN, Trinacty CM, Saphirak C, Delude C, DeLuccia S, Zhang T, Cole DV, DiNunzio N, Gertz A, Fazio-Eynullayeva E, Stojanovic D
Affiliations: "1The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, University of Massachusetts Medical School, Worcester, Massachusetts, USA. 2Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA. 3Department of Obstetrics and Gynecology, University of Massachusetts Medical School/UMass Memorial Health Care, Worcester, Massachusetts, USA. 4Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. / L Taylor - IQVIA - RWS 5Department of Scientific Affairs, HealthCore, Inc., Wilmington, Delaware, USA. 6Community Health Care Family Medicine Residency, Tacoma, Washington, USA. 7CVS Health Clinical Trial Services, Part of the CVS Health Family of Companies, Blue Bell, Pennsylvania, USA. 8Kaiser Permanente Center for Integrated Health Care Research Hawaii and Office of Public Health Studies, University of Hawai'i Manoa, Honolulu, Hawaii, USA."
Publications: "Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1175-1183. doi: 10.1002/pds.5300. Epub 2021 Jun 11. PMID: 34089206"
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/34089206/
Condition	Year	Language	Analysis type
, Database Validity and methodology, Womens Health	2021	English	, Epidemiological study, Retrospective database analysis


Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
Authors: Jonathan Gladstone 1, Sameer Chhibber 2, Jagdeep Minhas 3, Calum S Neish 3, G Sarah Power 3, Zhiyi Lan 3, Driss Rochdi 4, Jessica Lanthier-Martel 4, Natacha Bastien 4
Affiliations: 1Neurology, Cleveland Clinic Canada, Toronto, Ontario, Canada. 2Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 3Real-world Solutions, IQVIA, Kirkland, QuÃ©bec, Canada. 4Neuroscience, Novartis Pharmaceuticals Canada Inc., Dorval, QuÃ©bec, Canada.
Publications: PMID: 34807454 DOI: 10.1111/head.14218
Document Types: , Article, Book chapter
Countries: , Canada
Abstract: https://pubmed.ncbi.nlm.nih.gov/34807454/
Condition	Year	Language	Analysis type
, Miscellaneous	2021	English	, direct to patient research, Retrospective cohort analysis


Descriptive study on burden and communication of fatigue among castration-resistant prostate cancer patients in Japan
Authors: Taro Iguchi 1, Yusuke Nakamura 2, Takeshi Akiyama 3, Krishant Chand 3, Eric Yu 3 (rwesheorj 3)
Affiliations: 1) Department of Urology, Kanazawa Medical University 2) Market and Regional Access, Bayer Yakuhin, Ltd 3) Real World Evidence Solutions, IQVIA Solutions Japan K.K.
Publications: Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2021.2006534
Condition	Year	Language	Analysis type
, Oncology	2021	English	, Burden of illness, Observational study, Patient questionnaire, Population Based Study, Real World Evidence, Survey research


Incorporating patient generated health data into pharmacoepidemiological research. Pharmacoepidemiology and Drug Safety.
Authors: Alison Bourke 1, William G Dixon 2, Andrew Roddam 3, Kueiyu Joshua Lin 4, Gillian C Hall 5, Jeffrey R Curtis 6, Sabine N van der Veer 7, Montse Soriano-GabarrÃ³ 8, Juliane K Mills 9, Jacqueline M Major 10, Thomas Verstraeten 11, Matthew J Francis 12, Dorothee B Bartels 13
Affiliations: 1Real World Solutions, IQVIA, London, UK. 2Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK. 3Data & Computational Sciences, GSK, London, UK. 4Brigham and Women's & Department of Medicine, Boston, Massachusetts, USA. 5Gillian Hall Epidemiology Ltd, London, UK. 6Division of Clinical Immunology & Rheumatology, The University of Birmingham, Birmingham, Alabama, USA. 7Centre for Health Informatics, Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK. 8Bayer AG, Berlin, Germany. 9PRA Health Sciences, Raleigh, North Carolina, USA. 10Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. 11P95 Pharmacovigilance and Epidemiology, Leuven, Belgium. 12The Procter & Gamble Company, Cincinnati, Ohio, USA. 13UCB Pharma, Anderlecht, Belgium.
Publications: Pharmacoepidemiol Drug Saf . 2020 Dec;29(12):1540-1549. doi: 10.1002/pds.5169. Epub 2020 Nov 13.
Document Types: , Article
Countries: , Belgium, Germany, UK, USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/33146896/
Condition	Year	Language	Analysis type
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods	2021	English	, Patient questionnaire, Review


Implementation and Evolution of Mitigation Measures, Testing, and Contact Tracing in the National Football League, August 9-November 21, 2020
Authors: Christina D Mack, Erin B Wasserman, Cria G Perrine, Adam MacNeil, Deverick J Anderson, Emily Myers, Sabrina Smith, L Clifford McDonald, Michael Osterholm, Gary S Solomon, Thom Mayer, Allen Sills, NFL COVID-19 Advisory and Operational Team
Affiliations: NFL COVID-19 Advisory and Operational Team: Dawn Aponte 1, Michele Best 2, Paul Blalock 1, Meghan C Carroll 1, M Anthony Casolaro 3, Molly Delaney 1, Daniel Eichner 4, Larry Ferazani 1, Jacob Frank 1, Christopher J Hostler 5, Tiffany Koch 6, John Lynch 7, Jimmie Mancell 8, Damion Martins 9, John Mellody 1, Jeff Miller 1, Navdeep Singh 10, Eric Sugarman 11, Leah Triola 1, Patti Walton 12 1National Football League. 2University of Maryland Capital Region Health. 3Washington Football Team. 4Sports Medicine Research and Testing Laboratory. 5Department of Medicine, Duke Center for Antimicrobial Stewardship and Infection Prevention. 6IQVIA Real-World Solutions. 7Department of Medicine, University of Washington. 8Department of Medicine, University of Tennessee Health Science Center. 9Atlantic Sports Health, Morristown Medical Center. 10Eden Medical Center. 11Minnesota Vikings. 12Williamson Medical Center.
Publications: MMWR Morb Mortal Wkly Rep . 2021 Jan 29;70(4):130-135. doi: 10.15585/mmwr.mm7004e2.
Document Types: , Article
Countries:
Abstract: https://pubmed.ncbi.nlm.nih.gov/33507889/
Condition	Year	Language	Analysis type
, Infectious disease	2021	English	, Survey research


Implementation and Evolution of Mitigation Measures, Testing, and Contact Tracing in the National Football League, August 9-November 21, 2020
Authors: Christina D Mack, Erin B Wasserman, Cria G Perrine, Adam MacNeil, Deverick J Anderson, Emily Myers, Sabrina Smith, L Clifford McDonald, Michael Osterholm, Gary S Solomon, Thom Mayer, Allen Sills, NFL COVID-19 Advisory and Operational Team
Affiliations: NFL COVID-19 Advisory and Operational Team: Dawn Aponte 1, Michele Best 2, Paul Blalock 1, Meghan C Carroll 1, M Anthony Casolaro 3, Molly Delaney 1, Daniel Eichner 4, Larry Ferazani 1, Jacob Frank 1, Christopher J Hostler 5, Tiffany Koch 6, John Lynch 7, Jimmie Mancell 8, Damion Martins 9, John Mellody 1, Jeff Miller 1, Navdeep Singh 10, Eric Sugarman 11, Leah Triola 1, Patti Walton 12 1National Football League. 2University of Maryland Capital Region Health. 3Washington Football Team. 4Sports Medicine Research and Testing Laboratory. 5Department of Medicine, Duke Center for Antimicrobial Stewardship and Infection Prevention. 6IQVIA Real-World Solutions. 7Department of Medicine, University of Washington. 8Department of Medicine, University of Tennessee Health Science Center. 9Atlantic Sports Health, Morristown Medical Center. 10Eden Medical Center. 11Minnesota Vikings. 12Williamson Medical Center.
Publications:
Document Types:
Countries:
Abstract: https://pubmed.ncbi.nlm.nih.gov/33507889/ AND https://www.cdc.gov/mmwr/volumes/70/wr/mm7004e2.htm
Condition	Year	Language	Analysis type
	2021	English


Modernizing Oncology Approvals
Authors: Christina Mack
Affiliations: CAEG
Publications: PharmaVoice. 2021 Mar
Document Types: , Article
Countries: , USA
Abstract: https://www.pharmavoice.com/news/2021-03-modernizing-oncology-approvals/612107/
Condition	Year	Language	Analysis type
, Oncology	2021	English	, clinical setting: Secondary care


Real-world evidence to support regulatory decision making: New or expanded medical product indications
Authors: Franklin JM, Liaw KL, Iyasu S, Critchlow CW, Dreyer NA.
Affiliations: 1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 2Center for Observational and Real-world Evidence, Merck & Co., Inc, Kenilworth, New Jersey, USA. 3Research & Development Strategy and Operations, Amgen, Thousand Oaks, California, USA. 4Real World Solutions, IQVIA, Cambridge, Massachusetts, USA.
Publications: Pharmacoepidemiol Drug Saf . 2021 Jun;30(6):685-693. doi: 10.1002/pds.5222. Epub 2021 Mar 18.
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/33675248/
Condition	Year	Language	Analysis type
, Guidelines, Regulatory	2021	English	, Real World Data, Real World Evidence


Breaking barriers: studying fracture healing in the BONES program.
Authors: Christina D Mack 1, Alessandra Pavesio 2, Kim Kelly 2, Debra E Irwin 3, Greg Maislin 4, John Jones 2, Tawana Wester 2, Robert Zura 5
Affiliations: 1IQVIA Real-World Solutions, Durham, NC. 2Research & Development, Bioventus, Durham, NC. 3IBM Watson Health, Wynnewood, PA. 4Biomedical Statistical Consulting, Wynnewood, PA; and. 5Department of Orthopaedics, Louisiana State University Health Sciences Center, New Orleans, LA.
Publications: J Orthop Trauma . 2021 Mar 1;35(Suppl 1):S22-S27. doi: 10.1097/BOT.0000000000002035.
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/33587543/
Condition	Year	Language	Analysis type
, Orthopedics	2021	English	, Clinical setting: Primary care, Epidemiological study, Observational study


Comparison of ICD-9-CM to ICD-10-CM Crosswalks Derived by Physician and Clinical Coder vs. Automated Methods
Authors: Jason C Simeone, Xinyue Liu, Tarun Bhagnani, Matthew W Reynolds, Jenna Collins, Edward A Bortnichak
Affiliations: CAEG
Publications: Perspective Health Information Management 2021 Mar 15;18(Spring):1e.
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/34035786/
Condition	Year	Language	Analysis type
, Methodology	2021	English


Bridging the Gap Between RCTs and RWE Through Endpoint Selection
Authors: Robert J LoCasale 1, Chris L Pashos 2, Ben Gutierrez 3, Nancy A Dreyer 4, Toby Collins 5, Alan Calleja 5, Michael J Seewald 6, Jonathan M Plumb 7, Johan Liwing 8, Maurille Feudjo Tepie 9, Sajan Khosla 10
Affiliations: 1Real World Evidence, Sanofi, Bridgewater, NJ, USA. 2AbbVie, Chicago, IL, USA. 3GSK, Philadelphia, PA, USA. 4IQVIA, Real-World Solutions, Cambridge, MA, USA. 5IQVIA, Real-World Solutions, London, UK. 6Novartis Pharma AG/Pharma Medical Affairs, Basel, Switzerland. 7Ferring Pharmaceuticals SA, St Prex, Switzerland. 8CellProtect Nordic Pharmaceuticals, Stockholm, Sweden. 9Center for Observational Research, Amgen, Cambridge, UK. 10Real-World Evidence Center of Excellence, AstraZeneca, Cambridge, UK. sajan.khosla@astrazeneca.com.
Publications: Ther Innov Regul Sci . 2021 Jan;55(1):90-96. doi: 10.1007/s43441-020-00193-5. Epub 2020 Jul 6.
Document Types: , Article
Countries: , USA
Abstract: https://doi.org/10.1007/s43441-020-00193-5
Condition	Year	Language	Analysis type
, Regulatory	2021	English	, Real World Data, Real World Evidence


When Can We Trust Real-World Data To Evaluate New Medical Treatments?
Authors: Gregory E Simon 1, Andrew B Bindman 2, Nancy A Dreyer 3, Richard Platt 4, Jonathan H Watanabe 5, Michael Horberg 6, Adrian Hernandez 7, Robert M Califf 8
Affiliations: 1Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA. 2Kaiser Foundation Health Plan and Hospitals, Redwood City, California, USA. 3IQVIA Real World Solutions, Durham, North Carolina, USA. 4Harvard Pilgrim Health Care Institute and Harvard Medical School, Hartford, Connecticut, USA. 5University of California Irvine School of Pharmacy and Pharmaceutical Sciences, Irvine, California, USA. 6Kaiser Permanente Mid-Atlantic Permanente Research Institute and Mid-Atlantic Permanente Medical Group, Rockville, Maryland, USA. 7Duke Clinical Research Institute, Durham, North Carolina, USA. 8Verily Life Sciences and Google Health, South San Francisco, California, USA.
Publications: Clinical Pharmacology & Therapeutics 2022; 111(1):24-29, 2022/1
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/33932030/
Condition	Year	Language	Analysis type
, Regulatory	2021	English	, Real World Data


When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?
Authors: Jessica M Franklin 1 2, Richard Platt 3, Nancy A Dreyer 4, Alex John London 5, Gregory E Simon 6, Jonathan H Watanabe 7, Michael Horberg 8, Adrian Hernandez 9, Robert M Califf 10
Affiliations: 1Optum Epidemiology, Boston, Massachusetts, USA. 2Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 3Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA. 4IQVIA Real World Solutions, Cambridge, Massachusetts, USA. 5Philosophy Department & Center for Ethics and Policy, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA. 6Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA. 7School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, Irvine, California, USA. 8Kaiser Permanente Mid-Atlantic Permanente Research Institute and Mid-Atlantic Permanente Medical Group, Bethesda, Maryland, USA. 9Duke Clinical Research Institute, Durham, North Carolina, USA. 10Verily Life Sciences and Google Health, Cambridge, Massachusetts, USA.
Publications: Clinical Pharmacology & Therapeutics. 2021 Apr 7.
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/33826756/
Condition	Year	Language	Analysis type
, Methodology	2021	English	, Real World Data


Uncontrolled Extensions of Clinical Trials and the Use of External Controlsâ€“scoping opportunities and methods.
Authors: Ching-Yu Wang 1, Jesse A Berlin 2, Barry Gertz 3, Kourtney Davis 4, Jie Li 5, Nancy A Dreyer 6, Wei Zhou 7, John D Seeger 8, Nancy Santanello 9, Almut G Winterstein 1
Affiliations: 1Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety, University of Florida, Gainesville, Florida, USA. 2Epidemiology, Johnson & Johnson, Titusville, New Jersey, USA. 3Blackstone Life Sciences, Cambridge, Massachusetts, USA. 4Global Epidemiology, Janssen R&D, Titusville, New Jersey, USA. 5US Food and Drug Administration, Silver Spring, Maryland, USA. 6Real-World Solutions, IQVIA, Cambridge, Massachusetts, USA. 7Merck & Co., Inc., Kenilworth, New Jersey, USA. 8Optum, Boston, Massachusetts, USA. 9Pharmacoepidemiology Consultant, New Hope, Pennsylvania, USA.
Publications: Clinical Pharmacology & Therapeutics. 2021 Jun 24.
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/34165790/
Condition	Year	Language	Analysis type
, Methodology	2021	English	, Real World Data


Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS)
Authors: Stanislas Pol 1, Fayssoil Fouad 2, Magali Lemaitre 2, Ingrid Rodriguez 3, Olivier Lada 3, Pascaline Rabiega 2, Elias Benabadji 3, FranÃ§oise Roudot-Thoraval 4
Affiliations: 1UniversitÃ© de Paris, dÃ©partement d'hÃ©patologie et d'addictologie, 75014 Cochin (AP-HP), Paris, France. 2IQVIA, 92400 Courbevoie, France. 3Gilead Sciences, 92100 Boulogne Billancourt, France. 4Service d'hÃ©patologie, Henri-Mondor (AP-HP), 94010, CrÃ©teil, France.
Publications: Lancet Reg Health Eur . 2021 Dec 11;13:100281. doi: 10.1016/j.lanepe.2021.100281. eCollection 2022 Feb.
Document Types: , Abstract
Countries: , France
Abstract: https://pubmed.ncbi.nlm.nih.gov/34950924/
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Infectious disease	2021	English	, Observational study, Population Based Study, Predictive analytics


Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018
Authors: C Demont 1, N Petrica 2, I Bardoulat 2, S Duret 2, L Watier 3, A Chosidow 4, M Lorrot 4, A Kieffer 5, M Lemaitre 2
Affiliations: 1Sanofi Pasteur, 14 Espace Henry VallÃ©e, 69007, Lyon, France. Clarisse.Demont@sanofi.com. 2IQVIA, 92400, Courbevoie, France. 3UniversitÃ© Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France. 4Department of Pediatrics, Armand Trousseau Hospital (AP-HP), 75012, Paris, France. 5Sanofi Pasteur, 14 Espace Henry VallÃ©e, 69007, Lyon, France.
Publications: BMC Infect Dis . 2021 Aug 2;21(1):730. doi: 10.1186/s12879-021-06399-8.
Document Types: , Abstract
Countries: , France
Abstract: https://pubmed.ncbi.nlm.nih.gov/34340679/
Condition	Year	Language	Analysis type
, Infectious disease, Respiratory disease	2021	English	, Observational study, Population Based Study


Monitoring outpatient antibiotic utilization using reimbursement and retail sales data: a population-based comparison in France, 2012-17
Authors: Nhung T H Trinh 1 2, Martin Chalumeau 1 3, Tim A Bruckner 4, Corinne Levy 5 6, Antoine Bessou 2, Dejan Milic 2, Robert Cohen 5 7, Magali Lemaitre 2, JÃ©rÃ©mie F Cohen 1 3
Affiliations: 1UniversitÃ© de Paris, Epidemiology and Statistics Research Center-CRESS, INSERM, Obstetrical, Perinatal and Pediatric Epidemiology research team, F-75004, Paris, France. 2IQVIA, La DÃ©fense, France. 3Department of General Pediatrics and Pediatric Infectious Diseases, AP-HP, HÃ´pital Necker-Enfants malades, UniversitÃ© de Paris, Paris, France. 4Program in Public Health, University of California, Irvine, CA, USA. 5Association Clinique et ThÃ©rapeutique Infantile du Val-de-Marne (ACTIV), Saint-Maur-des-FossÃ©s, France. 6Clinical Research Centre, Centre Hospitalier Intercommunal de CrÃ©teil, CrÃ©teil, France. 7UniversitÃ© Paris Est, IMRB-GRC GEMINI, CrÃ©teil, France.
Publications: J Antimicrob Chemother . 2021 Aug 12;76(9):2446-2452. doi: 10.1093/jac/dkab185.
Document Types: , Article
Countries: , France
Abstract: https://pubmed.ncbi.nlm.nih.gov/34120188/
Condition	Year	Language	Analysis type
, Drug Utlization Study	2021	English	, Population Based Study


Ã‰tude EPILYMIA â€“ Ã‰tude rÃ©trospective combinant trois sources de donnÃ©es pour lâ€™estimation de lâ€™incidence de la borrÃ©liose de Lyme en France entre 2015 et 2019
Authors: AntoineBessou1 StÃ©phanieDuret1 MagaliLemaÃ®tre1 CharlesNuttens2
Affiliations: 1 IQVIA France, Courbevoie, France 2 Pfizer SAS France, Paris, France
Publications: https://doi.org/10.1016/j.respe.2021.05.024
Document Types: , Article
Countries: , France
Abstract: sciencedirect.com/science/article/abs/pii/S0398762021002595
Condition	Year	Language	Analysis type
, Infectious disease	2021	French	, Population Based Study


Refracture and mortality following hospitalization for severe osteoporotic fractures: The Fractos Study
Authors: Christian Roux 1, Thierry Thomas 2, Julien Paccou 3, Geoffray Bizouard 4, Anne Crochard 5, Emese Toth 5, Magali Lemaitre 4, FrÃ©dÃ©rique Maurel 4, Laure Perrin 5, Florence Tubach 6
Affiliations: 1 Department of Rheumatology Cochin Hospital, Assistance Publique - HÃ´pitaux de Paris Centre, Institut National de la SantÃ© et de la Recherche MÃ©dicale (INSERM) UnitÃ©s Mixtes de Recherche (UMR) 1153, UniversitÃ© de Paris Paris France. 2 Department of Rheumatology HÃ´pital Nord, Centre Hospitalier Universitaire (CHU) Saint-Etienne, INSERM U1059, Lyon University Saint-Etienne France. 3 Department of Rheumatology Lille University, CHU Lille, Marrow Adiposity and Bone Laboratory (MABlab) ULR 4490 Lille France. 4 IQVIA Courbevoie France. 5 UCB Pharma Colombes France. 6 Department of Public Health, Pharmacoepidemiology Center (Cephepi) Sorbonne University, INSERM, Institut Pierre Louis d'EpidÃ©miologie et de SantÃ© Publique, AP-HP Sorbonne University, PitiÃ©-SalpÃªtriÃ¨re Hospital, CIC-1422 Paris France.
Publications: JBMR Plus . 2021 May 14;5(7):e10507. doi: 10.1002/jbm4.10507. eCollection 2021 Jul.
Document Types: , Abstract
Countries: , France
Condition	Year	Language	Analysis type
, Orthopedics	2021	English	, Population Based Study


Ã‰pidÃ©miologie et mortalitÃ© de la pneumopathie interstitielle diffuse de forme progressive (hors fibrose pulmonaire idiopathique): donnÃ©es du SystÃ¨me National des DonnÃ©es de SantÃ©â€“Ã‰tude PROGRESS
Authors: M.Nasser, P.Rabiega, L.Boussel, S.Si Mohamed, V.Barbet, S.Marque, J.Massol, F.Thivolet-Bejui, L.Chalabreysse, D.Maucort Boulch, E.Hachulla, S.Jouneau, K.Le La, V.Cottin
Affiliations: 1 Hospices civils de Lyon, Lyon, France 2 IQVIA-RWS, La DÃ©fense, France 3 AIXIAL, Paris, France 4 CHU, Lille, France 5 CHU, Rennes, France 6 Boehringer Ingelheim France, Paris, France
Publications: https://doi.org/10.1016/j.rmra.2020.11.023
Document Types: , Article
Countries: , France
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1877120320302196
Condition	Year	Language	Analysis type
, Respiratory disease	2021	French	, Methodology, Population Based Study


Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study).
Authors: Mouhamad Nasser, Sophie Larrieu, Salim Si-Mohamed, KaÃ¯s Ahmad, Loic Boussel, Marie Brevet, Lara Chalabreysse, CÃ©line Fabre, SÃ©bastien Marque, Didier Revel, FranÃ§oise Thivolet-Bejui, Julie Traclet, Sabrina Zeghmar, Delphine Maucort-Boulch, Vincent Cottin
Affiliations: 1 Dept of Respiratory Medicine, National Coordinating Reference Centre for Rare Pulmonary Diseases, OrphaLung, Louis Pradel Hospital, University Hospital of Lyon, Lyon, France 2 Claude Bernard University Lyon 1, UMR754 INRAE, IVPC, Lyon, France 3 IQVIA, La DÃ©fense, France 4 Dept of Radiology, University Hospital of Lyon, Lyon, France 5 Dept of Pathology, University Hospital of Lyon, Lyon, France 6 CYPATH, Villeurbanne, France 7 Dept of Biostatistics, University Hospital of Lyon, Lyon, France
Publications: Eur Respir J . 2021 Feb 11;57(2):2002718. doi: 10.1183/13993003.02718-2020.
Document Types: , Abstract
Countries: , France
Abstract: https://pubmed.ncbi.nlm.nih.gov/32943410/
Condition	Year	Language	Analysis type
, Respiratory disease	2021	English	, Observational study, Population Based Study


Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)
Authors: Mouhamad Nasser, Sophie Larrieu, Loic Boussel, Salim Si-Mohamed, Fabienne Bazin, SÃ©bastien Marque, Jacques Massol, FranÃ§oise Thivolet-Bejui, Lara Chalabreysse, Delphine Maucort-Boulch, Eric Hachulla, StÃ©phane Jouneau, Katell Le Lay & Vincent Cottin
Affiliations: 1 HÃ´pital Louis Pradel, Centre National de RÃ©fÃ©rence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Lyon, OrphaLung, RespiFil, ERN-LUNG, Claude Bernard University Lyon 1, 28 Avenue du Doyen Lepine, 69677, Lyon Cedex, France. 2 UMR754, INRAE, UniversitÃ© Claude Bernard Lyon 1, Lyon, France. 3 IQVIA, RWS - La DÃ©fense, Paris, France. 4 DÃ©partement de Radiologie, Hospices Civils de Lyon, Lyon, France. 5 CNRS, Inserm, CREATIS UMR 5220, UniversitÃ© de Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, Lyon, France. 6 AIXIAL, Boulogne-Billancourt, France. 7 DÃ©partement d'anatomo-pathologie, Hospices Civils de Lyon, Lyon, France. 8 UniversitÃ© de Lyon, 69000, Lyon, France. 9 UniversitÃ© de Lyon 1, 69100, Villeurbanne, France. 10 Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, PÃ´le SantÃ© Publique, 69003, Lyon, France. 11 CNRS, UMR 5558, Ã‰quipe Biostatistique-SantÃ©, Laboratoire de BiomÃ©trie et Biologie Ã‰volutive, 69100, Villeurbanne, France. 12 Service de MÃ©decine Interne et Immunologie Clinique, HÃ´pital Claude Huriez, Centre National de RÃ©fÃ©rence des maladies autoâ€‘immunes systÃ©miques rare du Nord et Nordâ€‘Ouest de France (CeRAINO), CHU de Lille, Lille, France. 13 Centre Hospitalier Universitaire de Rennes, Centre de CompÃ©tences pour les Maladies Pulmonaires Rares, Inserm, EHESP, IRSET (Institut de recherche en santÃ©, environnement et travail), RespiFil, OrphaLung, Univ Rennes, Rennes, France. 14 Boehringer Ingelheim France SAS, Paris, France. 15 HÃ´pital Louis Pradel, Centre National de RÃ©fÃ©rence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Lyon, OrphaLung, RespiFil, ERN-LUNG, Claude Bernard University Lyon 1, 28 Avenue du Doyen Lepine, 69677, Lyon Cedex, France. vincent.cottin@chu-lyon.fr. 16 UMR754, INRAE, UniversitÃ© Claude Bernard Lyon 1, Lyon, France. vincent.cottin@chu-lyon.fr.
Publications: Respir Res . 2021 May 24;22(1):162. doi: 10.1186/s12931-021-01749-1.
Document Types: , Abstract
Countries: , France
Abstract: https://pubmed.ncbi.nlm.nih.gov/34030695/
Condition	Year	Language	Analysis type
, Respiratory disease	2021	English	, Methodology, Observational study


Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France
Authors: Vincent Cottin 1, Sophie Larrieu 2, Loic Boussel 3 4, Salim Si-Mohamed 3 4, Fabienne Bazin 2, SÃ©bastien Marque 2, Jacques Massol 5, FranÃ§oise Thivolet-Bejui 6, Lara Chalabreysse 6, Delphine Maucort-Boulch 7 8 9 10, StÃ©phane Jouneau 11, Eric Hachulla 12, Julien Chollet 13, Mouhamad Nasser 1
Affiliations: 1 HÃ´pital Louis Pradel, Centre Coordonnateur National de RÃ©fÃ©rence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, UMR754 INRAE and UniversitÃ© Claude Bernard Lyon 1, Member of ERN-LUNG, RespiFil, OrphaLung, Lyon, France. 2 IQVIA - RWS La DÃ©fense, Courbevoie, France. 3 DÃ©partement de Radiologie, Hospices Civils de Lyon, Lyon, France. 4 UniversitÃ© Lyon, INSA-Lyon, UniversitÃ© Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS Inserm, CREATIS UMR 5220, Lyon, France. 5 AIXIAL - Paris, Paris, France. 6 DÃ©partement d'anatomo-pathologie, Hospices Civils de Lyon, Lyon, France. 7 Hospices Civils de Lyon, PÃ´le SantÃ© Publique, Service de Biostatistique et Bioinformatique, Lyon, France. 8 UniversitÃ© de Lyon, Lyon, France. 9 UniversitÃ© Lyon 1, Villeurbanne, France. 10 CNRS, UMR 5558, Laboratoire de BiomÃ©trie et Biologie Ã‰volutive, Ã‰quipe Biostatistique-SantÃ©, Villeurbanne, France. 11 Centre Hospitalier Universitaire de Rennes, Centre de CompÃ©tences pour les Maladies Pulmonaires Rares, Univ Rennes, Inserm, EHESP, IRSET (Institut de recherche en santÃ©, environnement et travail), RespiFil, OrphaLung, Rennes, France. 12 HÃ´pital Claude Huriez, Centre National de RÃ©fÃ©rence des maladies auto-immunes systÃ©miques rares (CeRAINO), CHU de Lille, Lille, France. 13 Boehringer Ingelheim France SAS, Paris, France.
Publications: Front Med (Lausanne) . 2021 Aug 30;8:699532. doi: 10.3389/fmed.2021.699532.
Document Types: , Abstract
Countries: , France
Abstract: https://pubmed.ncbi.nlm.nih.gov/34552943/
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Respiratory disease	2021	English	, Observational study, Population Based Study


Impact des nouveaux traitements (AAD) de lâ€™hÃ©patite C dans la population gÃ©nÃ©rale et les populations Ã risque : Ã©tude rÃ©alisÃ©e en France Ã partir des donnÃ©es du SNDS sur la pÃ©riode 2015-2019
Authors: PascalineRabiÃ©ga1, StanislasPol2, FayssoilFouad1, IngridRodriguez3, OlivierLada3, MagaliLemaitre1, EliasBenabadji3, FranÃ§oiseRoudot-Thoraval4
Affiliations: 1 IQVIA, Courbevoie, France 2 Cochin (AP-HP), Paris, France 3 Gilead Sciences, Boulogne Billancourt, France 4 Henri-Mondor (AP-HP), CrÃ©teil, France
Publications: https://doi.org/10.1016/j.respe.2021.05.010
Document Types: , Article
Countries: , France
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S0398762021002455
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Infectious disease	2021	French	, Methodology, Population Based Study


Access to palivizumab among children at high risk of respiratory syncytial virus complications in English hospitals
Authors: Ania Zylbersztejn 1, Ofran Almossawi 1, Nikesh Gudka 2, Daniel Tompsett 1, Bianca De Stavola 1, Joseph F Standing 3, Rosalind Smyth 3, Pia Hardelid 1
Affiliations: 1Population, Policy & Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK. 2Great Ormond Street Hospital, London, UK. 3Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.
Publications: Br J Clin Pharmacol . 2022 Mar;88(3):1246-1257. doi: 10.1111/bcp.15069. Epub 2021 Oct 7.
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Infectious disease, Pediatrics, Respiratory disease	2021	English	, Clinical setting: Primary care, Cost analysis, Database Study, direct to patient research, Population Based Study


Effectiveness and safety of empagliflozin in routine care in Europe and East Asia: results from the empagliflozin comparative effectiveness and safety (EMPRISE) study
Authors: A. Karasik1 , S. Lanzinger2 , E. Chia-Hui Tan3 , D. Yabe4 , D. Jung Kim5 , W. H-H Sheu6 , C. MelzerCohen1 , R.W. Holl2 , K. Ha5 , T. NystrÃ¶m7 , L. Niskanen8 , M. Linnemann Jensen9 , M.H. Kyaw10, J. NÃºÃ±ez11, EMPRISE EU and East Asia Study Group;
Affiliations: Maccabi Research & Innovation Center, Tel Aviv University, Tel Aviv, Israel, 2 Inst. for Epidemiology & Medical Biometry, Uni. of Ulm, Ulm, Germany, 3National Research Inst. of Chinese Medicine, Taipei, Taiwan, 4Dept. of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu, Japan, 5Dept. of Endocrinology & Metabolism, Ajou Uni. School of Medicine, Suwon, Republic of Korea, 6Taipei Veterans General Hospital, Taipei, Taiwan, 7Dept. of Clinical Science & Education, SÃ¶dersjukhuset, Karolinska Institutet, Solna, Sweden, 8Department of Medicine, PÃ¤ijÃ¤t-HÃ¤me Central Hospital, Lahti, Finland, 9 IQVIA, Copenhagen, Denmark, 10Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, USA, 11Dept. of Cardiology, Hospital ClÃnico Universitario de Valencia, Valencia, Spain
Publications: https://doi.org/10.2337/DB21-127-LB Virtual EASD 2021, 57 Annual Meeting, 27 September - 10 October 2021
Document Types: , Abstract
Countries: , Finland, Germany, Israel, Japan, South Korea, Spain, Sweden, Taiwan
Abstract: https://easddistribute.m-anage.com/from.storage?image=gOIMdpw6-DbPpKIQZ5HFcJGqJ2quHgbqFewkkUQkLblXdwzJ9kfmAYikI6R6NFu_GLAQJwEZKsC1PXU8ndyryA2
Condition	Year	Language	Analysis type
, Cardiovascular disease, Diabetes	2021	English	, Database Study, Methodology, Population Based Study


Cardiovascular Effectiveness of Empagliflozin Compared to DPP-4i in Routine Care in East Asia: Results from the EMPRISE study
Authors: Dae Jung Kim, Wayne H.-H. Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Elise Chia-Hui Tan, Yusuke Taneda, Vanessa Lei, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H. Kyaw, Yutaka Seino, EMPRISE East Asia Study Group, Boehringer Ingelheim International GmbH, Ingelheim, Germany, StatFinn - EPID Research an IQVIA Company, Espoo, Finland
Affiliations: 1 Ajou University, Suwon, South Korea; 2 Taichung Veterans General Hospital, Taichung, Taiwan; 3 Gachon University Gil Medical Center, Incheon, South Korea; 4 Kansai Electric Power Medical Research Institute, Kobe, Japan; 5 Gifu University Graduate School of Medicine, Gifu, Japan; 6 National Research Institute of Chinese Medicine, Taipei, Taiwan; 7 Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan; 8 Boehringer Ingelheim Taiwan Ltd., Taipei, Taiwan; 9 IQVIA, Espoo, Finland; 10 Boehringer Ingelheim International GmbH, Ingelheim, Germany; 11 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 12 Kansai Electric Power Hospital, Osaka, Japan
Publications: J Am Coll Cardiol. 2021 May, 77 (18_Supplement_1) 542. https://doi.org/10.1016/S0735-1097(21)01901-X
Document Types: , Abstract, Presentation
Countries: , Japan, South Korea, Taiwan
Abstract: https://www.jacc.org/doi/epdf/10.1016/S0735-1097%2821%2901901-X
Condition	Year	Language	Analysis type
, Cardiovascular disease, Diabetes	2021	English	, Database Study, Methodology, Observational study


Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk ofcardiovascular and renal disease among type 2 diabetes patients in routinecare in europe and israel: EMPRISE study results
Authors: T Nystroem1;AKarasik2; J Nunez3; S Lanzinger4; C Melzer-Cohen2; R W Holl4;P Casajust5; E Toresson Grip6; M Carrasco7; J Foersch8; K Karlsdotter9;M Tuovinen10; R Klement11;MHKyaw12; L Niskanen
Affiliations: Karolinska Institutet,Department of Clinical Science and Education, SÃ¶dersjukhuset, Solna, Sweden;2Tel Aviv University, Maccabi Research and Innovation Center, Tel Aviv, Israel;3University of Valencia, Department of Cardiology, Hospital ClÃnico Universitariode Valencia, INCLIVA, CIBER Cardiovascular, Valencia, Spain;4University of Ulm,Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm, Germany;5Trial FormSupport, Real-World Evidence, Barcelona, Spain;6Swedish Institute for HealthEconomics Quantify Research, Stockholm, Sweden;7Boehringer Ingelheim EspaÃ±aS.A., Barcelona, Spain;8Boehringer Ingelheim Pharma GmbH & Co. Kg, HP CountryMedical Affairs, Ingelheim Am Rhein, Germany;9Boehringer Ingelheim AB, Stock-holm, Sweden;10Boehringer Ingelheim KY, Secondment Boehringer Ingelheim UKHEOR Team, Helsinki, Finland;11IQVIA, Global Database Studies, Tartu, Estonia;12Boehringer Ingelheim Pharmaceutical Inc., Connecticut, United States of America;13University of Eastern Finland, Kuopio, Finland;
Publications: European Journal of Heart Failure (2021)23(Suppl. S2) 2â€“322doi:10.1002/ejhf.2297
Document Types: , Abstract, Article
Countries: , Finland, Germany, Israel, Spain, Sweden
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2297
Condition	Year	Language	Analysis type
, Cardiovascular disease, Diabetes	2021	English	, Database Study, Meta analysis, Methodology, Population Based Study


Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk ofcardiovascular and renal disease among type 2 diabetes patients in routinecare in europe and israel: EMPRISE study results
Authors: T Nystroem1;AKarasik2; J Nunez3; S Lanzinger4; C Melzer-Cohen2; R W Holl4;P Casajust5; E Toresson Grip6; M Carrasco7; J Foersch8; K Karlsdotter9;M Tuovinen10; R Klement11;MHKyaw12; L Niskanen
Affiliations: Karolinska Institutet,Department of Clinical Science and Education, SÃ¶dersjukhuset, Solna, Sweden;2Tel Aviv University, Maccabi Research and Innovation Center, Tel Aviv, Israel;3University of Valencia, Department of Cardiology, Hospital ClÃnico Universitariode Valencia, INCLIVA, CIBER Cardiovascular, Valencia, Spain;4University of Ulm,Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm, Germany;5Trial FormSupport, Real-World Evidence, Barcelona, Spain;6Swedish Institute for HealthEconomics Quantify Research, Stockholm, Sweden;7Boehringer Ingelheim EspaÃ±aS.A., Barcelona, Spain;8Boehringer Ingelheim Pharma GmbH & Co. Kg, HP CountryMedical Affairs, Ingelheim Am Rhein, Germany;9Boehringer Ingelheim AB, Stock-holm, Sweden;10Boehringer Ingelheim KY, Secondment Boehringer Ingelheim UKHEOR Team, Helsinki, Finland;11IQVIA, Global Database Studies, Tartu, Estonia;12Boehringer Ingelheim Pharmaceutical Inc., Connecticut, United States of America;13University of Eastern Finland, Kuopio, Finland;
Publications:
Document Types:
Countries:
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2297
Condition	Year	Language	Analysis type
	2021	English


A review of the sampling methodology used in studies evaluating the effectiveness of risk minimisation measures in Europe
Authors: Laurence Sophie Jouaville 1, Tulika Paul 2, Mariana Ferreira Almas
Affiliations: QVIA Real World Solutions, La Defense, France. 2IQVIA Real World Solutions, Gurugram, Haryana, India. 3IQVIA Real World Solutions, Porto Salvo, Portugal.
Publications: Pharmacoepidemiol Drug Saf . 2021 Sep;30(9):1143-1152. doi: 10.1002/pds.5301. Epub 2021 Jun 24.
Document Types: , Article
Countries:
Abstract: https://pubmed.ncbi.nlm.nih.gov/34092001/
Condition	Year	Language	Analysis type
, Methodology, Risk Management & REMS	2021	English	, Database Study


Burden of pulmonary arterial hypertension in England: retrospective HES database analysis
Authors: Fernando Exposto 1, Ruben Hermans 2, Ã…sa Nordgren 2, Luke Taylor 2, Sanam Sikander Rehman 2, Robert Ogley 2, Evan Davies 3, Amina Yesufu-Udechuku 4, AmÃ©lie Beaudet
Affiliations: IQVIA, 210 Pentonville Road, London, N1 9JY, UK. 2IQVIA, London, UK. 3Actelion Pharmaceuticals Ltd, Allschwil, Basel-Landschaft, Switzerland. 4Actelion Pharmaceuticals UK Ltd, High Wycombe, UK.
Publications: Ther Adv Respir Dis. 2021 Jan-Dec; 15: 1753466621995040. Published online 2021 Feb 23. doi: 10.1177/1753466621995040
Document Types: , Article
Countries: , Switzerland, UK
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905485/
Condition	Year	Language	Analysis type
, Cardiovascular disease, Respiratory disease	2021	English	, Burden of illness


The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan
Authors: Tomotaka Sobue 1 2, Haruhisa Fukuda 3, Tetsuya Matsumoto 4, Bennett Lee 5, Shuhei Ito 5*, Satoshi Iwata 6 (rwesheorj A)
Affiliations: 1) Division of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan 2) Keio University School of Medicine, Tokyo, Japan 3) Department of Health Care Administration and Management, Kyushu University, Fukuoka, Japan 4) Department of Infectious Diseases, International University of Health and Welfare, Narita, Japan 5) Vaccine Medical Affairs, Pfizer Japan Inc., Tokyo, Japan 6) Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan
Publications: PLOS One
Document Types: , Article
Countries: , Japan
Abstract: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0256379
Condition	Year	Language	Analysis type
, COVID-19, Immunology and Vaccination	2021	English	, Database Study, Literature Review


Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee
Authors: Robert Flynn1,2,*, Karin Hedenmalm1, Tarita Murray-Thomas3, Alexandra Pacurariu1, Peter Arlett1, Hilary Shepherd3, Puja Myles3, Xavier Kurz1
Affiliations: 1 Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands 2 Medicines Monitoring Unit (MEMO), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom 3 Clinical Practice Research Datalink (CPRD), MHRA, London, United Kingdom
Publications: First published: 18 January 2020 https://doi.org/10.1002/cpt.1775
Document Types: , Abstract, Article
Countries: , France, Germany, UK
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.1775
Condition	Year	Language	Analysis type
, Database Validity and methodology, Drug safety, Health policy	2020	English	, Retrospective database analysis


Interventional or Non-Interventional? Analyzing the Differences Between Clinical Studies Using Medicines in the European Union
Authors: Tiago Silva, MSc; Alexandra Parnell, MSc; Christopher Bamford, PhD; Catherine Paulen, PharmD; Simona Francisconi, MSc; Jaclyn Bosco, PhD, MPH; Louise Parmenter, PhD, MSc
Affiliations:
Publications: Clinical Researcher February 2020; Volume 34, Issue 2
Document Types: , Article, Online article
Countries: , Europe
Abstract: https://acrpnet.org/2020/02/11/interventional-or-non-interventional-analyzing-the-differences-between-clinical-studies-using-medicines-in-the-european-union/
Condition	Year	Language	Analysis type
, Clinical practice	2020	English	, Population Based Study, Retrospective database analysis


Modernizing Regulatory Evidence with Trials and Real-World Studies
Authors: Nancy A. Dreyer PhD, MPH, FISPE, Marni Hall PhD, MPH & Jennifer B. Christian PharmD, MPH, PhD, FISPE
Affiliations: IQVIA Real World Solutions, 201 Broadway, 5th Floor, Cambridge, MA, 02139, USA Nancy A. Dreyer PhD, MPH, FISPE IQVIA Real-World Solutions, Rockville, MD, USA Marni Hall PhD, MPH IQVIA Real World Solutions, Research Triangle Park, NC, USA Jennifer B. Christian PharmD, MPH, PhD, FISPE
Publications: Ther Innov Regul Sci (2020). https://doi.org/10.1007/s43441-020-00131-5
Document Types: , Article
Countries: , USA
Abstract: https://link.springer.com/article/10.1007%2Fs43441-020-00131-5
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Retrospective database analysis


Use of Low Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitors (PCSK9i) Initiation
Authors: Rymer JA, Mues KE, Monda KL, Bratton EW, Wirtz HS, Okerson T, Overman RA, Brookhart MA, Muntner P, Wang TY
Affiliations: From the Duke Clinical Research InstituteDurham NC (J.A.R., T.Y.W.); Center for Observational ResearchAmgen IncThousand Oaks CA (K.E.M., K.L.M., H.S.W., T.O.); IQVIA, Realâ€World Evidence SolutionsDurham NC (E.W.B.); NoviSci, IncDurham NC (R.A.O., M.A.B.); University of North Carolina at Chapel HillChapel Hill NC (M.A.B.); Department of EpidemiologyUniversity of Alabama at BirminghamAL (P.M.).
Publications: Originally published24 Apr 2020https://doi.org/10.1161/JAHA.119.014347Journal of the American Heart Association. ;0:e014347
Document Types: , Article
Countries: , USA
Abstract: https://www.ahajournals.org/doi/10.1161/JAHA.119.014347
Condition	Year	Language	Analysis type
, Cardiovascular disease, Medication compliance	2020	English	, Epidemiological study


The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Authors: GÃ³mez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, PÃ©rez G3, Saah A3, Alemany L8
Affiliations: 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publications: IPVC, Barcelona, Spain, 23-27 March 2020
Document Types: , Oral presentation
Countries: , China, France, Germany, Italy, Japan, Portugal, Spain
Condition	Year	Language	Analysis type
, Infectious disease, Oncology	2020	English	, Burden of illness, Observational study, Retrospective Field Study


Clinical management of serious infections attributable to carbapenem-resistant Gram-negative pathogens in Spanish hospitals
Authors: Ferrer R1, Calvo-Montes J2, Maseda E3, Salavert M4, Bou G5, DÃaz-RegaÃ±Ã³n J6, LÃ³pez D6, Lozano V6, GÃ³mez-Ulloa D7, Fenoll R7, SÃ¡nchez E7, McCann E8
Affiliations: 1 Vall d'Hebron University Hospital, Barcelona, Spain 2 MarquÃ©s de Valdecilla University Hospital, Santander, Spain 3 La Paz University Hospital, Madrid, Spain 4 La Fe University and Polytechnic Hospital, Valencia, Spain 5 La CoruÃ±a University Hospital, La CoruÃ±a, Spain, Spain 6 Merck Sharp & Dohme Corp., Madrid, Spain 7 IQVIA, Barcelona, Spain 8 Merck & Co., Inc., Kenilworth, NJ, US
Publications: ECCMID, Paris, France, 18-21 April 2020
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Infectious disease	2020	English	, Observational study, Retrospective Field Study


Real-world treatment patterns observed in patients with carbapenem-resistant Gram-negative infections in Italian hospitals
Authors: Durante Mangoni E1, Mastroianni C2, Viale P3, Bassetti M4, Citton R5, Fenoll R6, Roset M6, McCann E7
Affiliations: 1 University of Campania â€˜L. Vanvitelliâ€™, Monaldi Hospital, Naples, Italy 2 Policlinico Umberto I, Rome, Italy 3 AOU Policlinico S. Orsola-Malpighi, Bologna, Italy 4 University of Genova and Ospedale Policlinico San Martino, Genova, Italy 5 RC Merck Sharp & Dohme, Rome, Italy 6 IQVIA, Barcelona, Spain 7 Merck & Co., Inc., Kenilworth, NJ, US
Publications: ECCMID, Paris, France, 18-21 April 2020
Document Types: , Oral presentation
Countries: , Italy
Condition	Year	Language	Analysis type
, Infectious disease	2020	English	, Observational study, Retrospective Field Study


Real-world treatment of patients diagnosed with serious infections due to carbapenem-resistant Gram-negative pathogens in Greek hospitals
Authors: Georgopoulos D1, Safarika A2, Ischaki E3, Filiou E4, Mantzarlis K5, Athanasopoulos D6, Fenoll R7, SÃ¡nchez E7, McCann E8
Affiliations: 1 University Hospital of Crete, Crete, Greece 2 National and Kapodistrian University of Athens, Athens, Greece 3 General Hospital of Athens Evaggelismos, Athens, Greece 4 National and Kapodistrian University of Athens, Medical School, General Hospital for Chest Diseases 'I Sotiriaâ€™ , Athens, Greece 5 University Hospital of Larissa, Larissa, Greece 6 Merck Sharp & Dohme Corp., Athens, Greece 7 IQVIA, Barcelona, Spain 8 Merck & Co., Inc., Kenilworth, NJ, US
Publications: ECCMID, Paris, France, 18-21 April 2020
Document Types: , Oral presentation
Countries: , Greece
Condition	Year	Language	Analysis type
, Infectious disease	2020	English	, Observational study, Retrospective Field Study


Resource utilisation associated with infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals
Authors: Durante Mangoni E1, Georgopoulos D2, FernÃ¡ndez-MartÃnez M3, Mastroianni C4, Viale P5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Perivoliotis E11 ,Bou Arevalo G12, Koutsoukou A13, Mantzarlis K14, Lozano V15, GÃ³mez-Ulloa D16, Roset M16, McCann E17
Affiliations: 1 â€˜L. Vanvitelliâ€™ University, Monaldi Hospital, Naples, Italy 2 University Hospital of Crete, Crete, Greece 3 MarquÃ©s de Valdecilla University Hospital, Santander, Spain 4 Policlinico Umberto I, Rome, Italy 5 Policlinico S. Orsola-Malpighi, Bologna, Italy 6 University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y PolitÃ©cnico de La Fe, ValÃ¨ncia, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La CoruÃ±a, La CoruÃ±a, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiriaâ€™ , Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US
Publications: ECCMID, Paris, France, 18-21 April 2020
Document Types: , Oral presentation
Countries: , Greece, Italy, Spain
Condition	Year	Language	Analysis type
, Infectious disease	2020	English	, Observational study, Retrospective Field Study


Outcomes and predictors of outcomes of serious infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals
Authors: Georgopoulos D1, Durante Mangoni E2, Mastroianni C3, Viale P4, ArnÃ¡iz de las Revillas F5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Malachias S11, Bou Arevalo G12, Kyriakoudi A13, Tsolaki V14, Lopez D15, GÃ³mez-Ulloa D16, Lara N16, McCann E17
Affiliations: 1 University Hospital of Crete, Crete, Greece 2 â€˜L. Vanvitelliâ€™, Monaldi Hospital, Naples, Italy 3 Policlinico Umberto I, Rome, Italy 4 Policlinico S. Orsola-Malpighi, Bologna, Italy 5 MarquÃ©s de Valdecilla University Hospital, Santander, Spain 6University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y PolitÃ©cnico de La Fe, ValÃ¨ncia, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La CoruÃ±a, La CoruÃ±a, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiriaâ€™, Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US
Publications: ECCMID, Paris, France, 18-21 April 2020
Document Types: , Oral presentation
Countries: , Greece, Italy, Spain
Condition	Year	Language	Analysis type
, Infectious disease	2020	English	, Observational study, Retrospective Field Study


Real-world clinical outcomes for third-line standard of care regimens in deficient mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC) in France
Authors: Cohen R1, Thierry A1, Roset M2, Amonkar M3, Patel R3, Lara N2, Kothari S3, Tougeron D4
Affiliations: 1 Sorbonne UniversitÃ©, medical oncology department, AP-HP, hÃ´pital Saint-Antoine, F-75012 Paris, France 2 IQVIA, Barcelona, Spain 3 Merck & Co, Inc., Kenilworth, NJ, US 4 Gastroenterology Department, Poitiers University Hospital and University of Poitiers, Poitiers, France
Publications: ESMO GI, Barcelona, Spain 1-4 July 2020
Document Types: , Poster
Countries: , France
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Observational study, Population Based Study, Retrospective Field Study


Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer
Authors: Gomez-Ulloa D1, Amonkar M2, Kothari S3, Cheung WY4, Chau I5, Zalcberg J6, Lara N1, Falcone A7
Affiliations: 1 IQVIA, Barcelona, Spain 2 Merck & Co., Inc., North Wales, PA, US 3 Merck & Co., Inc., Kenilworth, NJ, US 4 British Columbia Cancer Agency, Vancouver, BC, Canada 5 Royal Marsden Hospital, London, UK 6 Alfred Health, Melbourne, Australia 7 University of Pisa, Pisa, Italy
Publications: BMC Gastroenterology BMC Gastroenterology volume 20, Article number: 133 (2020)
Document Types: , Article
Countries: , Australia, Canada, Italy, UK
Abstract: https://doi.org/10.1186/s12876-020-01232-z
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Retrospective cohort analysis


Nivolumab-treated non-small cell lung cancer patients in the United Kingdom
Authors: Carroll R1, Tanna N1, Ghosh S2, Sanchez E3, Stawiarska Z4, Gemmen E5
Affiliations: 1 Bristol-Myers Squibb, Uxbridge, UK 2 IQVIA, Gurugram, India 3 IQVIA, Barcelona, Spain 4 IQVIA, Warsaw, Poland 5 IQVIA, Rockville, MD, US
Publications: BMC Gastroenterology
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Observational study, Population Based Study, Retrospective Field Study


Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials: a report on the Ninth Mount Hood Diabetes Challenge
Authors: Si L, Willis MS, Asseburg C, Tew M, Clarke PM, Lamotte M, Ramos M, Hui S, Shi L, Zhang P, McEwan P, Ye W, Herman WH, Isaman DJ, Kuo S, Schramm W, Sailer F, Brennan A, Pollard D, Smolen HJ, Leal J, Gray A, Patel R, Feenstra T, Palmer AJ
Affiliations: IQVIA, Zaventem, Belgium and IQVIA, Lisbon, Portugal
Publications: Value in Health
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Diabetes	2020	English	, Cost effectiveness


Contrasting three type 2 diabetes cardiovascular risk equations for east asia with ukpds82 using the IQVIA core diabetes model
Authors: Ramos M1, Monteiro S2, Olivieri AV3, Lamotte M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 IQVIA, London, UK 3 IQVIA, Basel, Switzerland
Publications: ISPOR US 2020 Orlando, Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB56
Document Types: , Article
Countries: , Asia Pacific
Condition	Year	Language	Analysis type
, Diabetes	2020	English	, Population Based Study


Impact of using different types of hba1c progression in the IQVIA core diabetes model
Authors: Ramos M1, Monteiro S2, Lamotte M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 IQVIA, London, UK
Publications: ISPOR US 2020 Orlando Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB52
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Diabetes	2020	English	, Population Based Study


Does including acute pancreatitis as a complication have an impact on cost-effectiveness analyses using the IQVIA core diabetes model?
Authors: Monteiro S1, Ramos M2, Lamotte M2
Affiliations: 1 IQVIA, London, UK 2 IQVIA, Zaventem, Belgium
Publications: ISPOR US 2020 Orlando Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB52
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Diabetes	2020	English	, Population Based Study


The prevalence of polypharmacy and the use of potentially inappropriate medications (PIMs): a cross-national study in five European countries - Preliminary Results
Authors: Bennie M1, Elseviers M2, Schubert I3, Poluzzi E4, MacBride S5, Sermet C6, Jouaville Abrouk LS7, Menon S7, Trehony J7, Nasuti P7, Taxis K8
Affiliations: 1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde / Information Services Division, NHS National Services Scotland, UK 2 Clinical Pharmacology, Ghent University, Belgium Centre for Innovation and Care, University of Antwerp, Belgium 3 PMV Research Group, Faculty of Medicine and University Hospital of Cologne, University for Cologne, Germany 4 University of Bologna, Italy 5 NHS Greater Glasgow and Clyde, Scotland 6 IRDES, Institut de Recherche en Economie de la SantÃ©, France 7 IQVIA Real World Solutions, London, UK / France 8 University of Groningen, PharmacoTherapy, Epidemiology and Economics, Groningen, The Netherlands
Publications: European Drug Utilisation Resarch Group (EuroDURG) Conference 2020, Szeged, Hungary, 4-7 March 2020
Document Types: , Poster
Countries: , Belgium, France, Germany, Italy, UK
Condition	Year	Language	Analysis type
, Clinical practice, Public Health	2020	English	, Population Based Study, Public Health, Retrospective database analysis


Cross-sectional survey in patients with type 1 and type 2 diabetes to understand mealtime insulin unmet needs in Japan: The MINUTES-J study
Authors: Hitoshi Ishii 1, Suzuki Shuichi 2, Paul Williams 3, Sven Demiya 4, Toshihiko Aranishi 2, Tamas Treuer 5 (rwesheorj 4)
Affiliations: 1) Department of Diabetology, Nara Medical University, Nara, Japan 2) Eli Lilly Japan, K.K., Kobe, Japan 3) RWE Patient-Centered Endpoints Center of Excellence, IQVIA, Paris, France 4) IQVIA Solutions K.K., Tokyo Japan 5) Eli Lilly and Company, Budapest, Hungary
Publications: Diabetes Research and Clinical Practice
Document Types: , Article
Countries: , Japan
Abstract: https://www.sciencedirect.com/science/article/pii/S0168822719314494?via%3Dihub
Condition	Year	Language	Analysis type
, Diabetes	2020	English	, Patient questionnaire


Annualized Hospitalization Rate With Natalizumab vs Fingolimod in Second-Line Treatment for RRMS in the Public Healthcare System in Brazil: A Claim Database Approach
Authors: Guilherme Silva Julian 1, Ricardo PapalÃ©o Rosim 2, Estela Cristina Carneseca 3, JÃ©ssica Rigolon 2
Affiliations: 1 IQVIA Brasil, SÃ£o Paulo-SP, Brazil. 2 Biogen Brasil, SÃ£o Paulo-SP, Brazil. 3 Proestat Consultoria EstatÃstica, RibeirÃ£o Preto-SP, Brazil.
Publications: PMID: 32119696 PMCID: PMC7051079 DOI: 10.1371/journal.pone.0229768
Document Types: , Article
Countries: , Brazil
Abstract: https://pubmed.ncbi.nlm.nih.gov/32119696/
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Retrospective database analysis


Cost of Macrovascular Complications in People With Diabetes From a Public Healthcare Perspective: A Retrospective Database Study in Brazil
Authors: Guilherme Silva Julian 1, Daniel Campos 1, Julie Broe Honore 2, FlÃ¡via Sauer Tobaruella 3, Jung Hyun Yoon 3, Nino HallÃ©n 2
Affiliations: 1 IQVIA Brasil, SÃ£o Paulo, Brazil. 2 Novo Nordisk A/S, SÃ¸borg, Denmark. 3 Novo Nordisk FarmacÃªutica Do Brasil Ltda, SÃ£o Paulo, Brazil.
Publications: PMID: 32372710 DOI: 10.1080/13696998.2020.1764966
Document Types: , Article
Countries: , Brazil
Abstract: https://www.tandfonline.com/doi/full/10.1080/13696998.2020.1764966
Condition	Year	Language	Analysis type
, Diabetes	2020	English	, Observational study, Retrospective database analysis


Concomitant use of drugs known to cause interactions with oral antiplateletsâ€”polypharmacy in acute coronary syndrome outpatients in Finland
Authors: Tuire Prami, Houssem Khanfir, PÃ¥l Hasvold, Eeva Reissell, Juhani Airaksinen, Ville KytÃ¶
Affiliations: Ville KytÃ¶: Heart Center, Turku University Hospital
Publications: European Journal of Clinical Pharmacology (2020) 76:257â€“265
Document Types: , Article
Countries: , Finland
Abstract: https://link.springer.com/article/10.1007/s00228-019-02777-z
Condition	Year	Language	Analysis type
, Cardiovascular disease	2020	English	, Population Based Study, Retrospective database analysis


Predictors of ironâ€‘deficiency anemia in primary care older adults: a realâ€‘world European multiâ€‘country longitudinal study
Authors: Vetrano DL, Zucchelli A, Marconi E, Levi M, Pegoraro V, Cataldo N, Heiman F, Cricelli C, Lapi F
Affiliations: Vetrano DL: Department of Geriatrics, Catholic University of Rome and IRCCS Fondazione Policlinico â€œA. Gemelliâ€, Rome, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy
Publications: Aging Clin Exp Res (2020). https://doi.org/10.1007/s40520-019-01454-6
Document Types: , Article
Countries: , Belgium, Germany, Italy, Spain
Abstract: https://link.springer.com/article/10.1007/s40520-019-01454-6
Condition	Year	Language	Analysis type
, Hematology	2020	English	, Epidemiological study, Retrospective database analysis


What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis
Authors: Lavorini F, Bianco A, Blasi F, Braido F, Corsico AG, Di Marco F, Gentile A, Paggiaro PL, Pegoraro V, Pelaia G, Rogliani P, Santus P, Scichilone N, Soldi A, Canonica GW
Affiliations: Lavorini F: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy.
Publications: Respir Med. 2020;166:105937. doi:10.1016/j.rmed.2020.105937
Document Types: , Article
Countries: , Italy
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S0954611120300779
Condition	Year	Language	Analysis type
, Respiratory disease	2020	English	, Retrospective database analysis, Survey research


High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study
Authors: Gerard E.Franciscoa; Daniel S.Bandari; Ganesh Bavikattec; Wolfgang H.Jost; Emily McCusker; Joan Largent; Alekse Zuzek; Alberto Esquenazi
Affiliations: a The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX, USA b Multiple Sclerosis Center of California & Research Group, Newport Beach, CA, USA c The Walton Centre, Liverpool, UK d University of Freiburg, Department of Neurology, Freiburg im Breisgau, Germany e Parkinson-Klinik Ortenau, Wolfach, Germany f Allergan, an AbbVie Company, Irvine, CA, USA g IQVIA Real-World Evidence Solutions, Cambridge, MA, USA h MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA
Publications: PM R . 2020 Jan 17. doi: 10.1002/pmrj.12328. PMID: 31953896 DOI: 10.1002/pmrj.12328
Document Types: , Article
Countries: , Asia Pacific, Europe, USA
Abstract: https://www.sciencedirect.com/science/article/pii/S2590171020300187?via%3Dihub
Condition	Year	Language	Analysis type
, Drug Utlization Study, Medication compliance	2020	English	, Methodology, Observational study


Predicting hospitalization of Swedish patients due to COPD exacerbation with machine learning
Authors: Karin Lisspers, Uppsala University Christer Janson, Uppsala University Gunnar Johansson, Uppsala University Kjell Larsson, Karolinska Institutet BjÃ¶rn StÃ¤llberg, Uppsala University Mario Mueller, IQVIA Mateusz Luczko, IQVIA Bine Kjoeller Bjerregaard, IQVIA Stuart Fell, IQVIA Gerald Bacher, Novartis Bjorn Holzhauer, Novartis Pankaj Goyal, Novartis Pharma AG
Affiliations: Uppsala University, IQVIA Denmark, IQVIA Germany, IQVIA Poland
Publications: IPCRG, International Primary Care Respiratory Group Conference 2020
Document Types: , Oral presentation
Countries: , Sweden
Abstract: https://www.ipcrg.org/11516
Condition	Year	Language	Analysis type
, Respiratory disease	2020	English


Ã‰valuation de la population Ã risque dâ€™hyperkaliÃ©mie
Authors: Gilles Berrut1 Anne-Sophie Boureau1 Laure de Decker1 Olivier Hanon2
Affiliations: 1 PÃ´le hospitalo-universitaire de gÃ©rontologie clinique, CHU Nantes, France 2 HÃ´pitaux universitaires Paris Centre, Service de gÃ©riatrie, HÃ´pital Broca, UniversitÃ© Paris-Descartes, Paris, France
Publications: 10.1684/pnv.2020.0873
Document Types: , Article
Countries:
Abstract: https://www.jle.com/fr/revues/gpn/e-docs/evaluation_de_la_population_a_risque_dhyperkaliemie__317258/article.phtml
Condition	Year	Language	Analysis type
, Cardiovascular disease, Hematology	2020	French	, Retrospective database analysis


IQVIA hospital information system DATA secondary use for outcome identification to assess the validity of definitions
Authors: Masaya H 1, Kenji Hamada 1, Masafumi Okada 1, Dilinuer Ainiwaer 1, Masaaki I 1, Takeshi Akiyama 1 (rwesheorj 1)
Affiliations: 1) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: ISPOR Asia Pacific
Document Types: , Abstract, Conference, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/asia2020-3264/104325
Condition	Year	Language	Analysis type
, Database Validity and methodology	2020	English	, De-identification / anonymisation


Descriptive study on perceptions and communication of fatigue among castration resistant prostate cancer (CRPC) patients in Japan
Authors: Taro Iguchi 1, Y Nakamura 2, Takeshi Akiyama 3, Krishant Chand 3, Eric Yu 3 (rwesheorj 3)
Affiliations: 1) Osaka City University Graduate School of Medicine Urology and Pathology 2) Bayer Yakuhin Co., Ltd. Market Access Headquarters 3) IQVIA Solutions Japan Co., Ltd. Real World Evidence Solutions
Publications: Japanese Urological Association 2020 Annual Meeting
Document Types: , Abstract, Conference, Presentation
Countries: , Japan
Abstract: http://www.congre.co.jp/jua2020/program/files/program_1223.pdf
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Patient questionnaire, Survey research


A systematic literature review of the disease and economic burden of multidrug resistance gram negative infections (MRGN) in Japan
Authors: T Hara 1, H Ikeoka 1, Adeeb Tawseef 2, Ryo Mitsuo 2 (rwesheorj 2)
Affiliations: 1) Shionogi & Co., Ltd., Osaka, Japan 2) IQVIA Solutions Japan KK, Tokyo, Japan
Publications: ISPOR Asia Pacific 2020 Conference
Document Types: , Abstract
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/asia2020-3264/103814
Condition	Year	Language	Analysis type
, Drug Utlization Study	2020	English	, Burden of illness, Literature Review


Retrospective study for comorbidities in ACTIVE population using Japanese health insurance claims database
Authors: Seok-Won Kim 1, Ayumi Morishita 1, Takeshi Akiyama 1 (rwesheorj 1)
Affiliations: 1) Real World Evidence Solutions, IQVIA Solutions Japan K.K.
Publications: ISPOR Asia Pacific 2020 Conference
Document Types: , Abstract
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/asia2020-3264/104345
Condition	Year	Language	Analysis type
, Database Validity and methodology	2020	English	, Database Study


Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Authors: Masakazu Yamada 1, Tadashi Nakano 2, Hiroyuki Matsuda 3, Seok-Won Kim 3, Yasutaka Takagi 4 (rwesheorj 3)
Affiliations: 1) Department of Ophthalmology, Kyorin University School of Medicine, Mitaka, Japan 2) Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan 3) Real World Evidence Solutions, IQVIA solutions Japan, Tokyo, Japan 4) Japan Medical Affairs Group, Santen Pharmaceutical Co., Ltd, Osaka, Japan
Publications: Journal of Medical Economics
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/13696998.2020.1804392
Condition	Year	Language	Analysis type
, Health economics	2020	English	, Budget impact, Cost effectiveness


Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan
Authors: Toyomi Kamesaki 1, Jun-Ichi Nishimura 2, Hideho Wada 3, Eric Yu 4, Elisa Tsao 5, Jaime Morales 5, Yuzuru Kanakura 2 6 (rwesheorj 4)
Affiliations: 1) Division of Support in Community Medicine, Center for Community Medicine, Regional Medical Center, Center for Regional Medical Care, Jichi Medical University, 3311 - 1 Yakushiji Shimotsuke-shi, Tochigi, Japan 2) Osaka University, Osaka, Japan 3) Kawasaki Medical School, Kurashiki, Japan 4) IQVIA Solutions K.K., Tokyo, Japan 5) Sanofi, Waltham, MA, USA 6) Sumitomo Hospital, Osaka, Japan
Publications: International Journal of Hematology
Document Types: , Article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007%2Fs12185-020-02899-6
Condition	Year	Language	Analysis type
, Rare Diseases	2020	English	, Retrospective database analysis


Evaluation of the optimal position for vedolizumab in the Japanese treatment paradigm for ulcerative colitis using Markov modeling
Authors: Akihito Uda 1, Yuki Eto 1, Yuxin Li 2, Hiroyuki Matsuda 3, Sven Demiya 3, Tomoyuki Watanabe 1, Mihoko Ota 1, Ryuichi Iwakiri 1, Ataru Igarashi 4 5 (rwesheorj 3)
Affiliations: 1) Japan Medical Office, Takeda Pharmaceutical Co. Ltd., Tokyo, Japan 2) IQVIA Solutions UK Ltd., London, UK 3) IQVIA Solutions Japan KK, Tokyo, Japan 4) Unit of Public Health and Preventive Medicine, School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan 5) Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, Japan
Publications: Crohn's & Colitis 360
Document Types: , Article
Countries: , Japan
Abstract: https://academic.oup.com/crohnscolitis360/article/2/2/otaa017/5809344
Condition	Year	Language	Analysis type
, Health economics	2020	English	, Budget impact, Cost effectiveness, Economic evaluation


An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in Germany
Authors: Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4
Affiliations: 1 Eli Lilly and Company, Indianapolis, US 2 Eli Lilly and Company, HaaPACS GmbH, Schriesheim, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Real World Solutions, Barcelona, Spain
Publications: Postgraduate Medicine
Document Types: , Article
Countries: , Germany
Abstract: https://www.endocrine-abstracts.org/ea/0063/ea0063p207
Condition	Year	Language	Analysis type
, Diabetes	2020	English	, Compliance


Who owns patient data? The answer is not that simple
Authors: Alison Bourke, Georgina Bourke
Affiliations: Scientific Director, Centre of Advanced Evidence Generation, IQVIA, and Past President of the International Society for Pharmacoepidemiology. Designer and Strategist at Projects by IF, a technology studio that focuses on the ethical and practical uses of data and AI.
Publications: BJMOpinion August 6, 2020
Document Types: , Article
Countries: , UK, USA
Abstract: https://blogs.bmj.com/bmj/2020/08/06/who-owns-patient-data-the-answer-is-not-that-simple/
Condition	Year	Language	Analysis type
, COVID-19, Health policy	2020	English	, Market impact


Infections in patients with multiple sclerosis: A national cohort study in Sweden
Authors: Anna Castelo-Branco, Flaminia Chiesa, Simona Conte, Camilla Bengtsson , Sally Lee, Neil Minton, Steve Niemcryk, Anders Lindholm, Mats Rosenlund, Fredrik Piehl, Scott Montgomery
Affiliations: 1.Real-world Insights, IQVIA Nordics, Solna, Sweden 2. Celgene Corporation, Summit, NJ, USA
Publications: Mult Scler Relat Disord. 2020;45:102420. [published online ahead of print, 2020 Jul 23].
Document Types: , Abstract
Countries: , Sweden
Abstract: https://pubmed.ncbi.nlm.nih.gov/32736217/
Condition	Year	Language	Analysis type
, Infectious disease, Neurological disorders, Patient Registries & Real-World Study Methods	2020	English	, Epidemiological study


Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden
Authors: Anna Castelo-Branco, Flaminia Chiesa, Camilla E Bengtsson , Sally Lee, Neil N Minton, Steve Niemcryk, Anders Lindholm, Mats Rosenlund, Fredrik Piehl, Scott Montgomery
Affiliations: 1.Real-world Insights, IQVIA Nordics, Solna, Sweden 2. Celgene Corporation, Summit, NJ, USA
Publications: Mult Scler J Exp Transl Clin. 2020 Jul-Sep; 6(3): 2055217320947761. Published online 2020 Aug 14
Document Types: , Article
Countries: , Sweden
Abstract: https://pubmed.ncbi.nlm.nih.gov/32864156/
Condition	Year	Language	Analysis type
, Cardiovascular disease, Neurological disorders, Patient Registries & Real-World Study Methods	2020	English	, Epidemiological study, Observational study, Population Based Study, Retrospective cohort analysis


Replication of randomized clinical trial results using real-world data: paving the way for effectiveness decisions
Authors: Kristin M Sheffield , Nancy A Dreyer , James F Murray, Douglas E Faries & Megan N Klopchin
Affiliations: 1Global Patient Outcomes & Real World Evidence, Eli Lilly & Company, Indianapolis, IN 46225, USA 2IQVIA Real-World & Analytic Solutions, Cambridge, MA 02139, USA 3Real World Analytics, Eli Lilly & Company, Indianapolis, IN 46225, USA
Publications: Published Online:11 Sep 2020https://doi.org/10.2217/cer-2020-0161
Document Types: , Article
Countries: , USA
Abstract: https://www.futuremedicine.com/doi/10.2217/cer-2020-0161
Condition	Year	Language	Analysis type
, Drug safety, Drug Utlization Study, Guidelines, Methodology, Public Health	2020	English	, Methodology, Observational study, Population Based Study


Combatting COVID-19 With Real-World Evidence
Authors: Jennifer B. Christian, PharmD, MPH, PhD , Matthew W. Reynolds, PhD
Affiliations: Jennifer B. Christian, PharmD, MPH, PhD, is vice president of Clinical Evidence & Epidemiology, Real World Solutions, IQVIA Matthew W. Reynolds, PhD, is vice president, Real World Evidence, IQVIA
Publications: AJMC.org (UVPM: 137,786) September 7, 2020 Jennifer B. Christian, PharmD, MPH, PhD , Matthew W. Reynolds, PhD
Document Types: , Article
Countries: , USA
Abstract: https://www.ajmc.com/view/combatting-covid-19-with-real-world-evidence
Condition	Year	Language	Analysis type
, Infectious disease	2020	English	, Burden of illness, direct to patient research, Methodology


Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study
Authors: Yutaka Seino, Dae Jung Kim, Daisuke Yabe, Elise Chia-Hui Tan, Wook-Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement*, Atsutaka Yasui, Wei-Yu, Sunwoo Lee, Moe H Kyaw, Anouk Deruaz-Luyet, Kimberly G Brodovicz,Wayne H-H Sheu, on behalf of the EMPRISE East Asia study group
Affiliations: * Kansai Electric Power Medical Research Institute, Kobe, Japan and Kansai Electric Power Hospital, Osaka, Japan **EPID Research an IQVIA company, Tartu, Estonia
Publications: Endocrinology, Diabetes and Metabolism 2020;00:e00183
Document Types: , Article
Countries: , Japan, South Korea, Taiwan
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/edm2.183
Condition	Year	Language	Analysis type
, Cardiovascular disease, Diabetes	2020	English	, Epidemiological study, Retrospective database analysis


An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in Germany
Authors: Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4
Affiliations: 1 Eli Lilly and Company, Indianapolis, US 2 Eli Lilly and Company, HaaPACS GmbH, Schriesheim, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Real World Solutions, Barcelona, Spain
Publications: Postgraduate Medicine
Document Types: , Article
Countries: , Germany
Abstract: https://www.endocrine-abstracts.org/ea/0063/ea0063p207
Condition	Year	Language	Analysis type
, Diabetes	2020	English	, Compliance


Hospitalizations and outpatient vists (H&OV) in moderate and severe acute graft versus host disease (aGVHD) patients in Finland and Sweden
Authors: ItÃ¤lÃ¤-Remes M1, Viayna E2, Nicklasson M3, KerÃ¤nen M4, ThunstrÃ¶m D5, Pfeiffer M5, Roset M2, Lara N2, Sabatelli L5
Affiliations: 1 Turku University Hospital, Finland 2 IQVIA, Real World Solutions, Barcelona, Spain 3 Sahlgrenska, University Hospital, Gothenburg, Sweden 4 Helsinki University Hospital, Finland 5 Incyte Biosciences International, Morges, Switzerland
Publications: ISPOR 2020 Annual European Congress. 14-18 November 2020. Milan, Italy
Document Types: , Poster
Countries: , Finland, Sweden
Abstract: x
Condition	Year	Language	Analysis type
, Hematology, Transplant	2020	English	, Population Based Study, Retrospective cohort analysis


Patient preferences, treatment satisfaction, and quality of life in newly diagnosed and relapsed/refractory multiple myeloma patients receiving injectable-containing or fully oral therapies: the EASEMENT study
Authors: Neil Rabin1, Rami Kotb2, Athanasios Zomas3, Alonso Fernandez-Nistal3, Rocco Dâ€™Ambrosio3, Nawal Bent-Ennakhil3, Montserrat Roset4, Ombretta Annibali5
Affiliations: 1 University College London Hospitals, London, and North Middlesex University Hospital, UK; 2 CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3 Takeda Pharmaceuticals International AG, Zurich, Switzerland; 4 IQVIA, Barcelona, Spain; 5 UniversitÃ Campus Bio-Medico di Roma, Rome, Italy
Publications: COMy (the 6th World Congress on Controversies in Multiple Myeloma), Virtual congress, 3-4 October 2020
Document Types: , Poster
Countries: , Canada, Italy, UK
Condition	Year	Language	Analysis type
, Hematology, Oncology	2020	English	, Population Based Study


Quantifying the burden of the treatment-resistant depression in Ontario: Shredding light on an inportant mental health issue
Authors: Brad Millson, G Sarah Power, Dr. Roger S. McIntyre
Affiliations: Brad Millson, G Sarah Power, IQVIA RWE team
Publications: CADTH 2020
Document Types: , Article
Countries: , Canada
Abstract: hhttps://www.sciencedirect.com/science/article/pii/S0165032720324903
Condition	Year	Language	Analysis type
, Health status & patient reported outcomes, Mental health	2020	English	, Retrospective cohort analysis


Osteoporosis and fracture risk associated with ICS use among Swedish COPD patients: the ARCTIC study
Authors: Christer Janson, Karin Lisspers, BjÃ¶rn StÃ¤llberg, Gunnar Johansson, Florian S. Gutzwiller, Karen Mezzi, Linda Mindeholm, Bine Kjoeller Bjerregaard, Leif Jorgensen, Kjell Larsson
Affiliations: 1Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden; 2Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden; 3Novartis Pharma AG, Basel, Switzerland; 4Novartis Institutes for Biomedical Research (NIBR), Cambridge, USA and Basel, Switzerland; 5IQVIA Solutions, Copenhagen, Denmark; 6Intergrative Toxicology, National Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
Publications: Eur Respir J 2020; in press (https://doi.org/10.1183/13993003.00515-2020).
Document Types: , Article
Countries: , Sweden
Abstract: https://erj.ersjournals.com/content/early/2020/08/28/13993003.00515-2020
Condition	Year	Language	Analysis type
, Respiratory disease	2020	English	, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis


Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients
Authors: BjÃ¶rn StÃ¤llberg 1âœ‰, Christer Janson2, Karin Lisspers1, Gunnar Johansson1, Florian S. Gutzwiller 3, Karen Mezzi3, Bine Kjoeller Bjerregaard 4, Anne Mette Tranberg Kejs4, Leif Jorgensen4 and Kjell Larsson5
Affiliations: 1Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. 2Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden. 3Novartis Pharma AG, Basel, Switzerland. 4IQVIA Solutions, Copenhagen, Denmark. 5Integrative Toxicology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. ?email: b.stallberg@telia.com
Publications: npj Primary Care Respiratory Medicine (2020) 30:47 ; https://doi.org/10.1038/s41533-020-00207-7
Document Types: , Article
Countries: , Sweden
Condition	Year	Language	Analysis type
, Respiratory disease	2020	English	, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis


Investigation of factors considered by health technology assessment agencies in eight countries
Authors: Akira Yuasa 1 2, Naohiro Yonemoto 1, Sven Demiya 3, Chihiro Foellscher 3, Shunya Ikeda 2 (rwesheorj 3)
Affiliations: 1) Pfizer Japan Inc, Tokyo, Japan 2) Graduate School of Medicine, International University of Health and Welfare, 1-26, Akasaka 4-chome, Minato-ku, Tokyo, 107-8402, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: PharmacoEconomics - Open
Document Types: , Article
Countries: , Japan
Abstract: https://link.springer.com/article/10.1007%2Fs41669-020-00235-6
Condition	Year	Language	Analysis type
, Health economics	2020	English	, Economic evaluation


A Retrospective Observational Cohort study to Assess the Prevalence of Diabetic Kidney Disease Among Type 2 Diabetes Patients in Ontario, Canada
Authors: Wally Rapattoni, David Zante, Ali Tehrani, Varun Myageri, Shane Golden, Brad Millson, Sheldon W. Tobe, Jennifer B. Rose
Affiliations: Ali Tehrai, Varun Myageri, shane Golden, Brad Millson
Publications: ERA - EDRA Virtual Congress June 6-9 2020
Document Types: , Poster
Countries: , Canada
Abstract: https://academic.oup.com/ndt/article/35/Supplement_3/gfaa142.P0775/5853053
Condition	Year	Language	Analysis type
, Diabetes, Public Health	2020	English	, Clinical setting: hospital, Clinical setting: Primary care, Cost analysis, direct-to-patient research, Observational study, Retrospective cohort analysis


Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal
Authors: Max Schlueter, AmÃ©lie Beaudet, Evan Davies, Binu Gurung, Andreas Karabis
Affiliations: IQVIA, 210 Pentonville Road, London, N1 9JY; IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, Netherlands; Department of Statistical Science, University College London, London, WC1E 6BT, UK.
Publications:
Document Types: , Article
Countries:
Abstract: https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-01241-4
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Methodology, Rare Diseases	2020	English	, Literature Review, Review


Comparison of Laboratory and On-Field Performance of American Football Helmets
Authors: Ann M Bailey 1, Timothy L McMurry 2, Joseph M Cormier 3, James R Funk 3, Jeff R Crandall 3, Christina D Mack 4, Barry S Myers 5, Kristy B Arbogast 6
Affiliations: 1 Biomechanics Consulting and Research, LLC, Charlottesville, VA, USA. abailey@bicorellc.com. 2 Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA. 3 Biomechanics Consulting and Research, LLC, Charlottesville, VA, USA. 4 IQVIA, Durham, NC, USA. 5 Department of Biomedical Engineering, Duke University, Durham, NC, USA. 6 Center for Injury Research and Prevention, Children's Hospital of Philadelphia, Pennsylvania, USA.
Publications: PMID: 33025320 DOI: 10.1007/s10439-020-02627-5
Document Types:
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/33025320/
Condition	Year	Language	Analysis type
, Injuries	2020	English	, Clinical setting: Primary care, direct to patient research, Machine Learning/Artificial Intelligence, Observational study, Public Health


Sports Performance and Injury Research: Methodologic Limitations and Recommendations for Future Improvements
Authors: Travis G.MaakM.D.ab Christina D.MackPh.D., MSPHacBrian J.ColeMD, M.B.A.adMackenzie M.HerzogPh.D, M.P.HacJohnDifioriM.D., F.A.M.S.S.M.aPeterMeiselM.S.P.H.a
Affiliations: a National Basketball Association, Research Committee, U.S.A. b Department of Orthopaedics, University of Utah, Salt Lake City, Utah, U.S.A. c IQVIA Real-World Solutions, Research Triangle Park, Durham, North Carolina, U.S.A. d Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, Illinois, U.S.A.
Publications: https://doi.org/10.1016/j.arthro.2020.08.038
Document Types: , Article
Countries: , USA
Abstract: https://www.sciencedirect.com/science/article/pii/S0749806320307398
Condition	Year	Language	Analysis type
, Injuries	2020	English	, Clinical setting: Primary care, Cost of illness, direct-to-patient research, Machine Learning/Artificial Intelligence, Market impact, Methodology


Incidence of Lower Extremity Injury in the National Football League: 2015 to 2018
Authors: Christina D. Mack, PhD, MSPH, â€ , Richard W. Kent, PhDâ€¡, Michael J. Coughlin, MDÂ§, â€–, Kristin Y. Shiue, MPHâ€ , Leigh J. Weiss, PT, DPT, ATCÂ¶, James R. Jastifer, MD#, *, Edward M. Wojtys, MDâ€ â€ , Robert B. Anderson, MDâ€¡â€¡on behalf of the NFL Musculoskeletal Committee
Affiliations: â€ IQVIA Real World Solutions, Research Triangle Park, North Carolina, USA â€¡Center for Applied Biomechanics, University of Virginia, Biomechanics Consulting & Research (Biocore), Charlottesville, Virginia, USA Â§University of California, San Francisco, San Francisco, California, USA â€–Coughlin Foot and Ankle Clinic, Saint Alphonsus Hospital, Boise, Idaho, USA Â¶New York Football Giants, Quest Diagnostics Training Center, East Rutherford, New Jersey, USA #Borgess Orthopedics, Kalamazoo, Michigan, USA **WMU Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, USA â€ â€ MedSport, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan, USA â€¡â€¡Bellin Health Titletown Sports Medicine and Orthopedics, Green Bay, Wisconsin, USA
Publications: https://doi.org/10.1177/0363546520922547
Document Types: , Article
Countries: , USA
Abstract: https://journals.sagepub.com/doi/10.1177/0363546520922547?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&
Condition	Year	Language	Analysis type
, Injuries	2020	English	, Epidemiological study


Clinical Research in the National Football League: The Player Scientific and Medical Research Protocol
Authors: Christina Mack 1, Matthew Matava 2, Kristina Zeidler 1, Allen Sills, Gary Solomon
Affiliations: 1IQVIA Research Triangle Park, NC. 2Department of Orthopedic Surgery, Washington University School of Medicine St. Louis, MO.
Publications: PMID: 32358299 DOI: 10.1249/JSR.0000000000000711
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/32358299/
Condition	Year	Language	Analysis type
, Injuries	2020	English	, Epidemiological study


RWE is the Future of Clinical Research: Time to Get Onboard
Authors: Nancy A. Dreyer,
Affiliations: Chief Scientific Officer and Senior VP, IQVIA Real World Solutions
Publications: PharmaVOICE - March 2020
Document Types: , Article
Countries: , USA
Abstract: https://www.pharmavoice.com/article/2020-03-rwe-research/#:~:text=We've%20been%20talking%20about,tools%20are%20coming%20into%20use.
Condition	Year	Language	Analysis type
, Health economics, Health status & patient reported outcomes	2020	English	, Economic evaluation, Literature Review, Market impact


Comparison of electronic self-reported prescription medication use during pregnancy with the national prescription register in Denmark
Authors: Maja Laursen 1, Christine E Hallgreen 2 3, Nancy Dreyer 4, Alison Bourke 5, Shahrul Mt-Isa 2 6, Stella Blackburn 5
Affiliations: 1The Danish Health Data Authority, Copenhagen, Denmark. 2School of Public Health, Imperial College London, London, UK. 3Copenhagen Center for Regulatory Science, Department of Pharmacy, SUND, University of Copenhagen, Copenhagen, Denmark. 4IQVIA Real-World and Analytic Solutions, Boston, Massachusetts. 5IQVIA Real-World and Analytic Solutions, London, UK. 6Biostatistics and Research Decision Sciences, MSD Research Laboratories, London, UK.
Publications: Pharmacoepidemiol Drug Saf . 2020 Mar;29(3):328-336. doi: 10.1002/pds.4937. Epub 2019 Dec 6.
Document Types: , Article
Countries: , Denmark, UK, USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/31811680/
Condition	Year	Language	Analysis type
, Patient Registries & Real-World Study Methods, Pregnancy	2020	English	, Epidemiological study, Methodology, Patient questionnaire, Real World Data


Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms
Authors: Mehmet Burcu 1, Nancy A Dreyer 2, Jessica M Franklin 3, Michael D Blum 4, Cathy W Critchlow 5, Eleanor M Perfetto 6, Wei Zhou 1
Affiliations: 1Center for Observational and Real-World Evidence, Merck & Co., Inc., West Point, Pennsylvania, United States. 2Real-World Solutions, IQVIA, Cambridge, Massachusetts. 3Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 4Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, U.S. Food and Drug Administration, White Oak, Maryland. 5Center for Observational Research, Amgen Inc., Thousand Oaks, California. 6National Health Council, Washington, District of Columbia, and University of Maryland Baltimore (UMB), Baltimore, Maryland.
Publications: Pharmacoepidemiol Drug Saf . 2020 Oct;29(10):1228-1235. doi: 10.1002/pds.4975. Epub 2020 Mar 11.
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/32162381/
Condition	Year	Language	Analysis type
, Drug safety	2020	English	, Epidemiological study, Real World Data, Real World Evidence


Considerations when evaluating real-world data quality in the context of fitness for purpose
Authors: Matthew W Reynolds 1, Alison Bourke 2, Nancy A Dreyer 3
Affiliations: 1Real World Solutions, IQVIA, Maryland, USA. 2Real World Solutions, IQVIA United Kingdom, UK. 3Real World Solutions, IQVIA, Massachusetts, USA.
Publications: Pharmacoepidemiol Drug Saf . 2020 Oct;29(10):1316-1318. doi: 10.1002/pds.5010. Epub 2020 May 6.
Document Types: , Article
Countries: , UK, USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/32374042/
Condition	Year	Language	Analysis type
, Health status & patient reported outcomes	2020	English	, Real World Data, Real World Evidence


Leveraging Real-World Data for COVID-19 Research: Challenges and Opportunities
Authors: Matthew W. Reynolds, Jennifer B Christian, Christina D Mack, Marni Hall and Nancy A Dreyer
Affiliations: Matthew W. Reynolds, PhD, FISPE Vice President, Real World Evidence, IQVIA Christina Mack, PhD, MSPH Vice President, Epidemiology and Clinical Evidence, IQVIA Adjunct Faculty, UNC-Chapel Hill Marni Hall, PhD, MPH Vice President of Clinical Evidence, IQVIA Nancy Dreyer, PhD, FISPE Chief Scientific Oï¬ƒcer and Senior Vice President, IQVIA Jennifer B. Christian, PharmD, MPH, PhD, FISPE
Publications: Precision Medicine 2020; 6 (2), June
Document Types: , Article
Countries: , USA
Abstract: https://www.thejournalofprecisionmedicine.com/leveraging-real-world-data-for-covid-19-research-challenges-and-opportunities/
Condition	Year	Language	Analysis type
, COVID-19	2020	English	, Data linkage, Observational study, Population Based Study, Real World Data, Real World Evidence


Bridging the Gap Between RCTs and RWE Through Endpoint Selection
Authors: Robert J LoCasale 1, Chris L Pashos 2, Ben Gutierrez 3, Nancy A Dreyer 4, Toby Collins 5, Alan Calleja 5, Michael J Seewald 6, Jonathan M Plumb 7, Johan Liwing 8, Maurille Feudjo Tepie 9, Sajan Khosla 10
Affiliations: 1Real World Evidence, Sanofi, Bridgewater, NJ, USA. 2AbbVie, Chicago, IL, USA. 3GSK, Philadelphia, PA, USA. 4IQVIA, Real-World Solutions, Cambridge, MA, USA. 5IQVIA, Real-World Solutions, London, UK. 6Novartis Pharma AG/Pharma Medical Affairs, Basel, Switzerland. 7Ferring Pharmaceuticals SA, St Prex, Switzerland. 8CellProtect Nordic Pharmaceuticals, Stockholm, Sweden. 9Center for Observational Research, Amgen, Cambridge, UK. 10Real-World Evidence Center of Excellence, AstraZeneca, Cambridge, UK. sajan.khosla@astrazeneca.com.
Publications: Published online 2020 Jul 6. doi: 10.1007/s43441-020-00193-5
Document Types: , Article
Countries: , Sweden, Switzerland, UK, USA
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785541/
Condition	Year	Language	Analysis type
, Health status & patient reported outcomes	2020	English	, Real World Data, Real World Evidence


The Certainty Framework for Assessing Realâ€World Data in Studies of Medical Product Safety and Effectiveness
Authors: Noelle M. Cocoros Peter Arlett Nancy A. Dreyer Chieko Ishiguro Solomon Iyasu Miriam Sturkenboom Wei Zhou Sengwee Toh
Affiliations: 1Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA. 2Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands. 3London School of Hygiene and Tropic Medicine, London, UK. 4Center for Advanced Evidence Generation, IQVIA Real World Solutions, Cambridge, Massachusetts, USA. 5Division of Epidemiology, Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. 6Center for Observational and Real-world Evidence, Merck & Co., Inc., Kenilworth, New Jersey, USA. 7Julius Center, Global Health, University Medical Center Utrecht, Utrecht, The Netherlands.
Publications: https://doi.org/10.1002/cpt.2045
Document Types: , Article
Countries: , Japan, Netherlands, USA
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2045
Condition	Year	Language	Analysis type
, Health status & patient reported outcomes	2020	English	, direct to patient research, Real World Data, Real World Evidence


Methods for external control groups for single arm trials or long-term uncontrolled extensions to randomized clinical trials
Authors: John D Seeger 1, Kourtney J Davis 2, Michelle R Iannacone 3, Wei Zhou 4, Nancy Dreyer 5, Almut G Winterstein 6, Nancy Santanello 7, Barry Gertz 8, Jesse A Berlin 2
Affiliations: 1Life Sciences Epidemiology, Optum, Boston, Massachusetts, USA. 2Global Epidemiology, Johnson & Johnson, Titusville, New Jersey, USA. 3Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA. 4Pharmacoepidemiology, Merck & Co., Inc., Kenilworth, New Jersey, USA. 5Real-World Solutions, IQVIA, Cambridge, Massachusetts, USA. 6University of Florida, Gainesville, Florida, USA. 7Nancy Santanello Research Consultant, Philadelphia, Pennsylvania, USA. 8Blackstone, Cambridge, Massachusetts, USA.
Publications: PMID: 32964514 PMCID: PMC7756307 DOI: 10.1002/pds.5141 Published online 2020 Oct 4. doi: 10.1002/pds.5141
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756307/
Condition	Year	Language	Analysis type
, Guidelines	2020	English	, Epidemiological study, Real World Data, Real World Evidence


High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study
Authors: Gerard E Francisco 1, Daniel S Bandari 2, Ganesh Bavikatte 3, Wolfgang H Jost 4 5, Emily McCusker 6, Joan Largent 7, Aleksej Zuzek 6, Alberto Esquenazi 8
Affiliations: 1The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX, USA. 2Multiple Sclerosis Center of California & Research Group, Newport Beach, CA, USA. 3The Walton Centre, Liverpool, UK. 4University of Freiburg, Department of Neurology, Freiburg im Breisgau, Germany. 5Parkinson-Klinik Ortenau, Wolfach, Germany. 6Allergan, an AbbVie Company, Irvine, CA, USA. 7IQVIA Real-World Evidence Solutions, Cambridge, MA, USA. 8MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA.
Publications: PMID: 32875289 PMCID: PMC7452133 DOI: 10.1016/j.toxcx.2020.100040
Document Types: , Article
Countries: , Europe, USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/32875289/
Condition	Year	Language	Analysis type
, Neurological disorders	2020	English	, Epidemiological study, Observational study


Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician- and Patient-Reported Satisfaction: Long-Term Observational Results from the ASPIRE Study
Authors: Gerard E Francisco 1, Wolfgang H Jost 2, Ganesh Bavikatte 3, Daniel S Bandari 4, Simon F T Tang 5, Michael C Munin 6, Joan Largent 7, Aubrey M Adams 8, Aleksej Zuzek 8, Alberto Esquenazi 9
Affiliations: 1The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX. 2Department of Neurology, University of Freiburg, Freiburg im Breisgau, Germany. 3The Walton Centre, Liverpool, UK. 4Multiple Sclerosis Center of California & Research Group, Newport Beach, CA. 5Department of Physical Medicine and Rehabilitation, Lotung Poh-Ai Hospital, Yilan, Taiwan. 6Department of Physical Medicine and Rehabilitation, University of Pittsburgh School of Medicine, Pittsburgh, PA. 7IQVIA Real-World Evidence Solutions, Cambridge, MA. 8Allergan plc, Irvine, CA. 9MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA.
Publications: PMID: 31953896 PMCID: PMC7687094 DOI: 10.1002/pmrj.12328
Document Types: , Article
Countries: , Asia Pacific, Europe, USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/31953896/
Condition	Year	Language	Analysis type
, Neurological disorders	2020	English	, Epidemiological study, Observational study


Multicenter Prospective Evaluation of Parenteral Nutrition Preparation Time and Resource Utilization: 3-Chamber Bags Compared With Hospital Pharmacy-Compounded Bags
Authors: Sarah V Cogle 1 2, Robert G Martindale 3, Mafalda Ramos 4, Gregory J Roberti 5, Pamela R Roberts 6, Kaci Taylor 7, Gordon S Sacks 1 8
Affiliations: 1Department of Pharmacy Practice, Auburn University, Auburn, Alabama, USA. 2Department of Pharmacy, East Alabama Medical Center, Opelika, Alabama, USA. 3Department of Surgery, Oregon Health and Science University, Portland, Oregon, USA. 4IQVIA, Zaventem, Belgium. 5Department of Pharmacy, Oregon Health and Science University, Portland, Oregon, USA. 6Department of Anesthesiology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, USA. 7Department of Pharmacy, OU Medical Center, Oklahoma City, Oklahoma, USA. 8Medical Affairs, Fresenius Kabi, LLC, Lake Zurich, Illinois, USA.
Publications: Journal of Parenteral and Enteral Nutrition Volume 0 Number 0 November 2020 1â€“7 DOI: 10.1002/jpen.2045 PMID: 33188572 DOI: 10.1002/jpen.2045
Document Types:
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/33188572/
Condition	Year	Language	Analysis type
, Health economics, Neurological disorders	2020	English	, Clinical setting: hospital, Cost effectiveness, Prospective study


Cost-effectiveness of empagliflozin compared with liraglutide based on cardiovascular outcome trials in Type II diabetes
Authors: Mafalda Ramos 1, Anastasia Ustyugova 2, Nikco Hau 3, Mark Lamotte 4
Affiliations: 1IQVIA Global HEOR, Porto Salvo 2740-266, Portugal. 2Boehringer Ingelheim International GmbH, TA CardioMetabolism Respiratory, Binger Str 173, Ingelheim am Rhein 55216, Germany. 3Boehringer Ingelheim Ltd, UK Market Access, Bracknell RG128YS, UK (at the time of the study). 4IQVIA, Global HEOR, Zaventem 1930, Belgium.
Publications: Journal of Comparative Effectiveness Research 2020. https://doi.org/10.2217/cer-2020-0071 PMID: 32573253 DOI: 10.2217/cer-2020-0071
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/32573253/
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2020	English	, Clinical setting: Primary care, Cost effectiveness


Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK
Authors: Mafalda Ramos 1, Michael H Cummings 2, Anastasia Ustyugova 3, Syed I Raza 4, Shamika U de Silva 4, Mark Lamotte 5
Affiliations: 1Global HEOR/Real World Solutions, IQVIA, 2740-266, Porto Salvo, Portugal. 2Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Portsmouth, PO6 3LY, Hampshire, UK. 3Boehringer Ingelheim International GmbH, 55216, Ingelheim Am Rhein, Germany. 4Boehringer Ingelheim Ltd., Bracknell, RG12 8YS, Berkshire, UK. 5Global HEOR/Real World Solutions, IQVIA, 1930, Zaventem, Belgium. Mark.lamotte@iqvia.com.
Publications: Diabetes Therapy 2020; 11(9), 2041-2055; https://doi.org/10.1007/s13300-020-00883-1. PMID: 32700188 PMCID: PMC7434815 DOI: 10.1007/s13300-020-00883-1
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/32700188/
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2020	English	, Clinical setting: Primary care, Cost effectiveness


External Validation of the Core Obesity Model to Assess the Cost Effectiveness of Weight Management Interventions
Authors: Sandra Lopes 1, Pierre Johansen 2, Mark Lamotte 3, Phil McEwan 4, Anamaria-Vera Olivieri 5, Volker Foos 4
Affiliations: 1Novo Nordisk A/S, SÃ¸borg, Denmark. snlb@novonordisk.com. 2Novo Nordisk A/S, SÃ¸borg, Denmark. 3IQVIA, Zaventem, Belgium. 4Health Economics and Outcomes Research Ltd, Cardiff, UK. 5IQVIA, Basel, Switzerland.
Publications: Pharmacoeconomics 2020 https://doi.org/10.1007/s40273-020-00941-3 + Pharmacoeconomics. 2021 Jan;39(1):137-138. doi: 10.1007/s40273-020-00982-8. Epub 2020 Nov 30
Document Types: , Article
Countries: , Belgium, Denmark, Switzerland, UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/32656686/
Condition	Year	Language	Analysis type
, Health economics, Obesity	2020	English	, Clinical setting: Primary care, Cost effectiveness


DOES INCLUDING ACUTE PANCREATITIS AS A COMPLICATION HAVE AN IMPACT ON COST-EFFECTIVENESS ANALYSES USING THE IQVIA CORE DIABETES MODEL?
Authors: Monteiro S, Ramos M, Lamotte M
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: ISPOR US 2020 Orlando. Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB44.
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2020	English	, Clinical setting: Primary care, Cost effectiveness


IMPACT OF USING DIFFERENT TYPES OF HBA1C PROGRESSION IN THE IQVIA CORE DIABETES MODEL.
Authors: Ramos M, Monteiro S, Lamotte M
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: ISPOR US 2020 Orlando Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB52.
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2020	English	, Clinical setting: Primary care, Cost effectiveness


Three Asian Type 2 Diabetes cardiovascular risk equations simulation using the IQVIA Core Diabetes Model
Authors: Ryo Mitsuo 1, Sven Demiya 1, Adeeb Tawseef 1, Raf De Moor 1, M Ramos, M Lamotte (rwesheorj 1)
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: Japan Diabetes Society 2020 Annual Meeting
Document Types: , Poster
Countries: , Asia Pacific, Japan
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2020	English	, Clinical setting: Primary care, Cost effectiveness


CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL.
Authors: Ramos M, Monteiro S, Olivieri AV, Lamotte M.
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: ISPOR US 2020 Orlando. Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB56
Document Types: , Poster
Countries: , Asia Pacific
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2020	English	, Clinical setting: Primary care, Cost effectiveness


Does Including EGFR Along to HBA1C As a Driver of Treatment Switch Changes Outcomes in Cost-Effectiveness Analyses in Type 2 Diabetes?
Authors: Ramos M, Monteiro S, Lamotte M
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 108179.
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2020	English	, Clinical setting: Primary care, Cost effectiveness


Cost-Effectiveness of the CELL-Based Quadrivalent Versus the Standard Egg-Based Quadrivalent Influenza Vaccine in Germany. Results of a Dynamic Transmission Modelling Approach
Authors: Cai R, Gerlier L, Eichner M, Schwehm M, Majaram S, Mould-Quevedo J, Lamotte M.
Affiliations: IQVIA HEOR Zaventem
Publications: ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 105463
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2020	English	, Clinical setting: Primary care, Cost effectiveness


The Cost-Effectiveness of Empagliflozin in Type 2 Diabetes in Denmark, Incorporating Cardiovascular Outcomes
Authors: Ehlers LH, Lamotte M, Monteiro S, Sandgaard S, Holmgaard P, Frary EC, Staehr P, Ejskjaer N.
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 107114
Document Types: , Poster
Countries: , Denmark
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2020	English	, Clinical setting: Primary care, Cost effectiveness


Cost-Effectiveness of the FreeStyle Libre System versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Treatment not Reaching Glycemic Goals in Sweden.
Authors: Jendle J, Eeg-Olofsson K, Svensson AM, Franzen S, Lamotte M, Levrat-Guillen F.
Affiliations: IQVIA HEOR Zaventem Brussels
Publications: American Diabetes Associationâ€™s (ADAâ€™s) 81st Scientific Sessions. Poster presentation number 135-LB
Document Types: , Poster
Countries: , Sweden
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2020	English	, Clinical setting: Primary care, Cost effectiveness


Budget IMPACT Analysis of a Reduced Maintenance Dose of Certolizumab Pegol in Patients with Axial Spondyloarthritis in the United Kingdom
Authors: Kiri S, Arteaga Duarte C, Lamotte M, Gerlier L
Affiliations: IQVIA HEOR Zaventem
Publications: ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 107821
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Rheumatology	2020	English	, clinical setting: Secondary care, Cost effectiveness


Cost-Effectiveness Analysis of Certolizumab Pegol Versus Secukinumab and Ixekizumab in Non-Radiographic Axial Spondyloarthritis in the U.S
Authors: Kiri S, Arteaga Duarte Ca, Lee E, Low R, Tsakeu E, Lamotte M, Gerlier L.
Affiliations: IQVIA HEOR Zaventem
Publications: AMCP Nexus 2020 Virtual October 19.
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Rheumatology	2020	English	, clinical setting: Secondary care, Cost effectiveness


The disease burden of mucormycosis in Japan: results from a systematic literature review and retrospective database study
Authors: Rie Ueno 1, Shinichi Nishimura 1, Go Fujimoto 1, Dilinuer Ainiwaer 2 (rwesheorj 2)
Affiliations: 1) MSD KK, Tokyo, Japan 2) IQVIA Solutions Japan KK, Tokyo, Japan
Publications: Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2020.1846510
Condition	Year	Language	Analysis type
, Infectious disease	2020	English	, Database Study, Literature Review


Investigation of factors considered in the health technology assessment conducted by regulatory authority in eight countries
Authors: Akira Yuasa 1, Naohiro Yonemoto 1, Sven Demiya 2, Chihiro Foellscher 2, Shunya Ikeda 3 (rwesheorj 2)
Affiliations: 1) Pfizer Japan Inc., Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, Japan 3) Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan
Publications: ISPOR 2020 Conference
Document Types: , Abstract
Countries: , Australia, Canada, France, Germany, Italy, Japan, Spain, UK
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2020-3182/101019
Condition	Year	Language	Analysis type
	2020	English


Health technology assessment submissions for cardiovascular interventions in the ASIA-Pacific region
Authors: Ryo Mitsuo 1, Hiroyuki Matsuda 1, Krishant Chand 1, Eric Yu 1, Sven Demiya 1, Raf De Moor 1 (rwesheorj 1)
Affiliations: 1) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan
Publications: ISPOR Asia Pacific 2020 Conference
Document Types: , Abstract
Countries:
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/asia2020-3264/104035
Condition	Year	Language	Analysis type
, Cardiovascular disease	2020	English	, Pricing & Reimbursement


Voice technology - an opportunity to broaden participation in patient reported outcomes research
Authors: Sven Demiya 1, C Neumann 2, Chieh Chu 1, Krishant Chand K1, Eric Yu 1 (rwesheorj 1)
Affiliations: 1) IQVIA Solutions Japan, Tokyo, Japan 2) easyDialog GK, Tokyo, Japan
Publications: ISPOR Asia Pacific 2020 Conference
Document Types: , Abstract
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/asia2020-3264/103782
Condition	Year	Language	Analysis type
	2020	English	, Machine Learning/Artificial Intelligence, Survey research


Development and validation of patient-level prediction models for adverse outcomes following total knee arthroplasty
Authors: Ross D. Williams, Jenna M. Reps, Anthony G. Sena, Edward Burn, Ying He, Daniel R. Morales, David Culliford, Dahai Yu, Victoria Y. Strauss, Talita Duarte-Salles, Albert Prats-Uribe, Antonella Delmestri, James Weaver, William Sproviero, Danielle Robinson, Henry Morgan Stewart, Belay Birlie, Rafael Pinedo-Villanueva, Spyros Kolovos, Luis H. John, Ruth E. Costello, Michel van Speybroeck, Caroline Oâ€™Leary, Evan Minty, Thomas Falconer, Alison Callahan, Stephen Pfohl, Theresa Burkard, Jennifer Lane, Peter R. Rijnbeek, Patrick B. Ryan, Daniel Prieto-Alhambra
Affiliations: 1Erasmus University Medical Centre, Rotterdam 2Janssen Research and Development, Raritan, NJ, USA 3NDORMS, University of Oxford, Oxford, UK 4University of Dundee, UK 5NIHR Applied Research Collaboration Wessex, University of Southampton, UK 6Keele University, Keele, UK 7FundaciÃ³ Institut Universitari per a la recerca a lâ€™AtenciÃ³ PrimÃ ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain 8Department of Psychiatry, University of Oxford, Oxford, UK 9IQVIA, London, UK 10Centre for Epidemiology Versus Arthritis, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK 11Janssen Pharmaceutica, Beerse, Belgium 12Oâ€™Brien Institute of Public Health, Faculty of Medicine, University of Calgary, Alberta, Canada 13Department of Biomedical Informatics, Columbia University Medical Center 14Center for Biomedical Informatics Research, School of Medicine, Stanford University, Stanford, California, USA 15University of Basel, Switzerland
Publications: doi: https://doi.org/10.1101/2020.12.14.20240994
Document Types: , Abstract
Countries: , UK
Abstract: https://www.medrxiv.org/content/10.1101/2020.12.14.20240994v1
Condition	Year	Language	Analysis type
, Database Validity and methodology	2020	English	, clinical setting: Secondary care, Database Study, direct to patient research, Methodology, Observational study


Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK
Authors: Jennifer K Quint 1, Alessandra Venerus 2, Caroline O'Leary 2, Melissa Myland 2, Ulf Holmgren 3, Precil Varghese 4, Claudia Cabrera 3 5
Affiliations: 1Imperial College London, London, UK. 2IQVIA, London, UK. 3Real World Science and Digital, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden. 4Global Medical Affairs, AstraZeneca, Gaithersburg, MD, USA. 5Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Publications: PMID: 33324049 PMCID: PMC7733404 DOI: 10.2147/COPD.S278101
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/33324049/
Condition	Year	Language	Analysis type
, Database Validity and methodology	2020	English	, Observational study, Retrospective database analysis


Persistence and Adherence to ICS/LABA Drugs in UK Patients with Asthma: A Retrospective New-User Cohort Study
Authors: Mounika Parimi 1, Henrik Svedsater 2, Quratul Ann 1, Mugdha Gokhale 3, Christen M Gray 1, David Hinds 3, Mark Nixon 1, Naomi Boxall 1
Affiliations: 1Real World Solutions, IQVIA, London, UK. 2Value Evidence and Outcomes, GlaxoSmithKline Plc., Brentford, Middlesex, UK. henrik.x.svedsater@gsk.com. 3Epidemiology, GlaxoSmithKline Plc., Collegeville, PA, USA.
Publications: PMID: 32361850 PMCID: PMC7467428 DOI: 10.1007/s12325-020-01344-8
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/32361850/
Condition	Year	Language	Analysis type
, Database Validity and methodology	2020	English	, Real World Data, Retrospective database analysis


Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children
Authors: Pegoraro V, Urbinati D, Visser GHA, Di Renzo GC, Zipursky A, Stotler BA, Spitalnik SL
Affiliations: Spitalink SL: Department of Pathology and Cell Biology, Columbia University, New York, NY, United States of America. Pegoraro V: IQVIA Solutions Italy S.r.l., Milan, Italy,
Publications: PLoS ONE 15(7): e0235807. https://doi.org/10.1371/journal.pone.0235807
Document Types: , Article
Countries: , Italy
Abstract: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0235807
Condition	Year	Language	Analysis type
, Public Health, Womens Health	2020	English


A quantitative bias analysis of the confounding effects due to smoking on the association between fluoroquinolones and risk of aortic aneurysm.
Authors: Zhang M, Falconer M, Taylor LG
Affiliations: "1Division of Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. 2Real World Solutions, IQVIAâ„¢, Durham, North California, USA."
Publications: Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):958-961. doi: 10.1002/pds.5019. Epub 2020 May 13.PMID: 32406104
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/32406104/
Condition	Year	Language	Analysis type
, Drug safety, Methodology	2020	English	, Observational study


Validity of diagnosis and procedure codes for identifying neural tube defects in infants
Authors: Cheetham TC, Dublin S, Pocobelli G, Bobb JF, Andrade S, Hechter RC, Portugal C, Munis M, Albertson-Junkans L, Salgado G, Wong L, Maarup TJ, Carroll K, Griffin MR, Raebel MA, Smith D, Li DK, Pawloski PA, Toh S, Taylor L, Hua W, Dinatale M, Ceresa C, Trinidad JP, Boudreau DM
Affiliations: "1Chapman University - School of Pharmacy, Irvine, California, USA. 2Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA. 3Meyers Primary Care Institute & University of Massachusetts Medical School, Worcester, Massachusetts, USA. 4Kaiser Permanente Department of Research & Evaluation, Pasadena, California, USA. 5The Permanente Medical Group, Clinical Genetics, Oakland, California, USA. 6Southern California Permanente Medical Group, Genetics Department, Downey, California, USA. 7Department of Pediatrics, Vanderbilt University Medical School, Nashville, Tennessee, USA. 8Department of Health Policy, Vanderbilt University Medical School, Nashville, Tennessee, USA. 9Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado, USA. 10Kaiser Permanente Northwest, Center for Health Research, Portland, Oregon, USA. 11Division of Research, Kaiser Permanente Northern California, Oakland, California, USA. 12HealthPartners Institute, Bloomington, Minnesota, USA. 13Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Research Institute, Boston, Massachusetts, USA. 14CDER, Food and Drug Administration, Office of Surveillance and Epidemiology, Silver Spring, Maryland, USA. L Taylor: EPI OR, RWS, IQVIA 15Division of Pediatric and Maternal Health, CDER, Food and Drug Administration, Silver Spring, Maryland, USA."
Publications: Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1489-1493. doi: 10.1002/pds.5128. Epub 2020 Sep 15.PMID: 32929845
Document Types: , Article
Countries: , USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/32929845/
Condition	Year	Language	Analysis type
, Pediatrics, Womens Health	2020	English	, Epidemiological study, Retrospective database analysis


Fardeau hospitalier du Virus respiratoire syncitial (VRS) chez lâ€™enfant de moins de 5 ans entre 2010 et 2018 : utilisation des donnÃ©es du PMSI
Authors: N. Petrica a, M. Lemaitre a, I. Bardoulat a, L. Watier b, M. Lorrot c, A. Chosidow c, A. Kieffer d, C. Demont d
Affiliations: a IQVIA, Courbevoie, France b Biostatistique, biomathÃ©matique, pharmacoÃ©pidÃ©miologie et maladies infectieuses (B2PHI), Inserm, UVSQ, Institut Pasteur, UniversitÃ© Paris-Saclay, Insermc, France c DÃ©partement de pÃ©diatrie, HÃ´pital Armand Trousseau (AP-HP), Paris, France d SanofiPasteur Lyon, Marcy-lâ€™Etoile, France
Publications: Doi : 10.1016/j.respe.2020.04.041
Document Types: , Abstract
Countries: , France
Abstract: https://www.em-consulte.com/article/1388418/fardeau-hospitalier-du-virus-respiratoire-syncitia
Condition	Year	Language	Analysis type
, Infectious disease, Respiratory disease	2020	French	, Observational study, Population Based Study


Estimation du fardeau direct et indirect de la grippe en France de la saison 2010/2011 Ã la saison 2017/2018 : analyse Ã©pidÃ©miologique et Ã©conomique Ã partir du Programme de mÃ©dicalisation des systÃ¨mes dâ€™information
Authors: F. Fouad a, A. Bessou a , F. Carrat b, P. CrÃ©pey c, d, M.-C. Levant e, M. Uhart e
Affiliations: a IQVIA, La DÃ©fense, France b Sorbonne UniversitÃ©, Inserm, Institut Pierre Louis dâ€™Ã©pidÃ©miologie et de santÃ© publique ; Assistance publique-HÃ´pitaux de Paris (AP-HP), HÃ´pital Saint-Antoine, UnitÃ© de santÃ© publique, Paris, France c UMR Emergence des pathologies virales, UniversitÃ© Aix-Marseille - IRD 190 - Inserm 1207, Marseille, France d Ecole des hautes Ã©tudes en santÃ© publique, Rennes, France e Sanofi Aventis, France
Publications: Doi : 10.1016/j.respe.2020.01.114
Document Types: , Article
Countries: , France
Abstract: https://www.em-consulte.com/article/1352598/estimation-du-fardeau-direct-et-indirect-de-la-gri
Condition	Year	Language	Analysis type
, Infectious disease, Respiratory disease	2020	French	, Methodology, Population Based Study


A RETROSPECTIVE COHORT STUDY OF THE NATIONAL HEALTHCARE RESOURCE UTILISATION (HCRU) AND COSTS OF TREATING MULTIPLE MYELOMA (MM) IN FRANCE USING THE SYSTÃˆME NATIONAL DES DONNÃ‰ES DE SANTÃ‰ (SNDS) DATABASE
Authors: A. Bessou X. Colin J. De Nascimento W. Sopwith S.A. Ferrante B. Gorsh B. Gutierrez L. Sansbury J. Willson S. Sapra F. Wang
Affiliations: 1 IQVIA, Paris, France 2 GlaxoSmithKline, Rueil Malmaison, 92, France, 3 IQVIA,La Defense Cedex, 75, France, 4 IQVIA, London, UK, 5 Value Evidence and Outcomes, GlaxoSmithKline, Upper Providence, PA, USA, 6 Value Evidence and Outcomes, GlaxoSmithKline, Research Triangle Park, NC, USA, 7 Value Evidence and Outcomes, GlaxoSmithKline, London, UK
Publications: DOI:https://doi.org/10.1016/j.jval.2020.08.250
Document Types: , Abstract
Countries: , France
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(20)32506-7/fulltext
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Observational study, Population Based Study


PrÃ©valence et mortalitÃ© de la pneumopathie interstitielle diffuse associÃ©e Ã la sclÃ©rodermie systÃ©mique (PID-ScS) en France : donnÃ©es du SystÃ¨me National des DonnÃ©es de SantÃ© (SNDS)
Authors: M.Nasser, P.Rabiega, L.Boussel, S.Si-Mohamed, V.Barbet, S.Marque, J.Massol, F.Thivolet-Bejui, L.Chalabreysse, D.Maucort-Boulch, S.Jouneau, E.Hachulla, J.Chollet, V.Cottin
Affiliations: 1 Pneumologie, Hospices Civils de Lyon - HCL, Lyon 2 RWS, IQVIA, Courbevoie 3 Imagerie mÃ©dicale, Hospices Civils de Lyon - HCL, Lyon 4 Consultant, Aixial, Boulogne-Billancourt 5 Anatomie et cytologie pathologiques, Hospices Civils de Lyon - HCL, Lyon 6 Biostatistiques, Hospices Civils de Lyon - HCL, Lyon 7 Pneumologie, CHU de Rennes, Rennes 8 MÃ©decine interne, Centre Hospitalier RÃ©gional Universitaire de Lille, Lille 9 Heor department, Boehringer Ingelheim France, Paris 10 Pneumologie, Hopital Louis Pradel, Bron
Publications: https://doi.org/10.1016/j.rhum.2020.10.078
Document Types: , Article
Countries: , France
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1169833020302726
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Respiratory disease	2020	French	, Methodology, Observational study, Population Based Study


Healthcare Resource Utilization and Associated Costs of Progressive Fibrosing Interstitial LUNG Disease (PF-ILD) and Systemic Sclerosis Associated Interstitial LUNG Disease (SSC-ILD) in France.
Authors: M. Nasser P. RabiÃ©ga L. Boussel S. Si-Mohamed V. Barbet S. Marque J. Massol D. Revel F. Thivolet-Bejui L. Chalabreysse D. Maucort-Boulch S. Jouneau E. Hachulla V. Cottin
Affiliations: 1 University Claude Bernard, Lyon, France, 2 IQVIA, La DÃ©fense, 92, France, 3 Hospices Civils de Lyon, Lyon, France, 4 IQVIA, La DÃ©fense, France, 5 AIXIAL, Paris, France, 6 UniversitÃ© de Rennes 1, CHU Rennes, INSERM, EHESP, Rennes, France, 7 HÃ´pital Claude Huriez, Centre National de RÃ©fÃ©rence des maladies auto-immunes systÃ©miques, CHRU de Lille, Lille, France, 8 National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, University Claude Bernard, Lyon, France
Publications: DOI:https://doi.org/10.1016/j.jval.2020.08.1891
Document Types: , Article
Countries: , France
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(20)34147-4/fulltext
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Respiratory disease	2020	English	, Observational study, Population Based Study


Cohorte de patients prÃ©sentant une pneumopathie interstitielle diffuse fibrosante chronique de phÃ©notype progressif (PID-FP) autre quâ€™une fibrose pulmonaire idiopathique (FPI) et appariement des donnÃ©es au SystÃ¨me national des donnÃ©es de santÃ© : Ã©tude PROGRESS
Authors: S. Larrieu, M. Nasser, S. Si-Mohamed, K. Ahmad, L. Boussel, M. Brevet, L. Chalabreysse, C. Fabre, S. Marque, D. Revel, F. Thivolet-Bejui, J. Traclet, S. Zeghmar, D. Maucort-Boulch, V. Cottin
Affiliations: a IQVIA, La DÃ©fense, France b Hospices Civils de Lyon, Pneumology Department, Lyon, France c Hospices Civils de Lyon, Radiology Department, Bron, France d Centre de recherche en applications et traitement de lâ€™image pour la santÃ© (CREATIS)â€“UniversitÃ© Claude Bernard Lyon 1, Hospices Civils de Lyon, Institut national des sciences appliquÃ©es, Inserm U1044, CNRS : UMR5220, Villeurbanne, France e Hospices Civils de Lyon, Radiology Department, France f Hospices Civils de Lyon, Anatomopathology Department, Lyon, France g Hospices Civils de Lyon, Biostatistics Department, Lyon, France
Publications: Doi : 10.1016/j.respe.2020.04.019
Document Types: , Article
Countries: , France
Abstract: https://www.em-consulte.com/article/1388397/article/cohorte-de-patients-presentant-une-pneumopathie-in
Condition	Year	Language	Analysis type
, Respiratory disease	2020	French	, Observational study, Population Based Study


Prevalence and mortality of systemic sclerosis-associated interstitial lung disease (SSc-ILD) using the French national health insurance system (SNDS) database in France
Authors: Mouhamad Nasser, Sophie Larrieu, Loic Boussel, Salim Si-Mohamed, Fabienne Bazin, SÃ©bastien Marque, Jacques Massol, Didier Revel, Francoise Thivolet-Bejui, Lara Chalabreysse, Delphine Maucort-Boulch, Eric Hachulla, StÃ©phane Jouneau, Vincent Cottin
Affiliations: 1 Hospices Civils de Lyon, Lyon, France 2 IQVIA, Bordeaux, France 3 AIXIAL, Paris, France 4 CHU de Lille, Lyon, France 5 CHU de Rennes, Lyon, France
Publications: European Respiratory Journal 2020 56: 805; DOI: 10.1183/13993003.congress-2020.805
Document Types: , Article
Countries: , France
Abstract: https://erj.ersjournals.com/content/56/suppl_64/805.article-info
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Respiratory disease	2020	English	, Observational study, Population Based Study


Patrones de tratamiento biolÃ³gico en pacientes con enfermedades articulares inflamatorias. Estudio retrospectivo de 4 aÃ±os de seguimiento
Authors: Juan D. CaÃ±ete1, Antonio Naranjo2, Javier Calvo3, Carmen OrdÃ¡s4, BelÃ©n AragÃ³n5, Gonzalo Nocea5, Montse Roset6, Antonio FernÃ¡ndez-Nebro7
Affiliations: 1 Servicio de ReumatologÃa, Hospital ClÃnic e IDIBAPS, Barcelona, EspaÃ±a 2 Departamento de ReumatologÃa, Hospital Dr. NegrÃn, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, EspaÃ±a 3 Departamento de ReumatologÃa, Hospital General Universitario de Valencia, Valencia, EspaÃ±a 4 Departamento de ReumatologÃa, Hospital de CabueÃ±es, GijÃ³n, EspaÃ±a 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, EspaÃ±a 6 Departamento de Health Economics and Outcomes Research, IQVIA, Barcelona, EspaÃ±a 7 Departamento de ReumatologÃa, Instituto de InvestigaciÃ³n BiomÃ©dica (IBIMA), Hospital Regional Universitario de MÃ¡laga, Universidad de MÃ¡laga, MÃ¡laga, EspaÃ±a
Publications: ReumatologÃa ClÃnica, 2019. DOI: 10.1016
Document Types: , Article
Countries: , Spain
Abstract: http://reumatologiaclinica.org/es-patrones-tratamiento-biologico-pacientes-con-avance-S1699258X18302596
Condition	Year	Language	Analysis type
, Drug Utlization Study	2019	Spanish	, Clinical setting: hospital, Observational study


Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden
Authors: Lindmark K, Boman K, Olofsson M, TÃ¶rnblom M, Levine A, Castelo-Branco A, Schlienger R, Wirta SB, StÃ¥lhammar J, WikstrÃ¶m G
Affiliations: Real-World & Analytics Solutions, IQVIA, Solna, Sweden
Publications: Clinical Epidemiology
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: https://www.dovepress.com/articles.php?article_id=44704
Condition	Year	Language	Analysis type
, Cardiovascular disease	2019	English	, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis


Use of postmenopausal hormone therapy and risk of Alzheimer?s disease in Finland: nationwide case-control study
Authors: Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.
Affiliations: EPID Research Oy, Espoo, Finland
Publications: BMJ
Document Types: , Article
Countries: , Finland, Nordic
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402043/
Condition	Year	Language	Analysis type
, Mental health	2019	English	, Epidemiological study, Retrospective database analysis


Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse
Authors: Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS
Affiliations: EPID Research Oy, Espoo, Finland
Publications: Menopause
Document Types: , Article
Countries: , Finland
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29994974
Condition	Year	Language	Analysis type
, Patient Registries & Real-World Study Methods	2019	English	, Population Based Study, Retrospective database analysis


Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy
Authors: Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS
Affiliations: EPID Research Oy, Espoo, Finland
Publications: Int Urogynecol J
Document Types: , Article
Countries: , Finland
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29946829
Condition	Year	Language	Analysis type
, Patient Registries & Real-World Study Methods	2019	English	, Population Based Study, Retrospective database analysis


Registries for Evaluating Patient Outcomes: A Userâ€™s Guide (Prepared by the Outcome DEcIDE Center [Outcome Sciences, Inc., a Quintiles company] under Contract No. 290 2005 00351 TO7.) AHRQ Publication No. 13(14)-EHC111. Rockville, MD: Agency for Healthcare Research and Quality. April 2014. 1st edition, April 2007; 2nd Edition, September, 2010; Third edition, 2014. also available in Korean (Korean National Evidence-based Healthcare Collaborating Agency, published December 2010), and in Chinese (University of Peking, published December 2012). 4th edition, in press, 2019.
Authors: Gliklich R, Dreyer N, Leavy M, eds.
Affiliations:
Publications:
Document Types: , Book
Countries: , USA
Condition	Year	Language	Analysis type
	2019	English


Lessons on Data Collection and Curation from the NFL Injury Surveillance Program. Sports Health, in press.
Authors: Dreyer NA. Mack CD, Anderson RB, Wojtys EM, Hershman EB, Sills A
Affiliations:
Publications: Sports Health 2019; 11(5): 440-445.
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Injuries	2019	English


The Establishment and Refinement of the National Basketball Association Player Injury and Illness Database. Journal of Athletic Training, in press.
Authors: Mack C, Meisel P, Herzog M, Oakkar E, Walden T, Callahan L, Shapre J, Dreyer N, DiFiori J.
Affiliations:
Publications:
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Injuries	2019	English


Adoption of immuno-oncology in NSCLC, a real-world study in EU5.
Authors: Alejandra Martinez De Pinillos, Isabel Ricote Lobera, Cristina Martinez, Caroline Anger, Filippo Guglielmetti, Roberto Jorge Bitton
Affiliations: IQVIA, London, United Kingdom; IQVIA, Madrid, Spain; IQVIA, Milan, Italy; IQVIA, Buenos Aires, Argentina
Publications: Journal of Clinical Oncology 2019 37:15_suppl, e20631-e20631
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e20631
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Retrospective database analysis


Cost-utility model for 2nd generation treatment of chronic HCV in general population: impact of EASL recommendations in 2016 and 2018
Authors: Natàlia Pascual-Argenté (1,2); Carlos Crespo (1,3); Laura Planellas (4); Míriam Solozabal (4), Núria Perulero (4); Jaume Puig-Junoy (1,2)
Affiliations: (1) UPF Barcelona School of Management; (2) Dept. Economía y Empresa – CRES UPF; (3) Universitat de Barcelona; (4) HEOR-RWE, IQVIA Spain
Publications: XXXIX Jornadas de Economía de la Salud. Albacete, 12 al 14 de junio de 2019
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/pdfs/Jornadas_AES_2019-Libro_abstracts.pdf
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Health economics, Infectious disease	2019	Spanish	, Clinical setting: hospital, Cost effectiveness


USO DE DATOS DE PRACTICA REAL PARA ANALIZAR LOS TRATAMIENTOS PRESCRITOS EN LA DIABETES TIPO 2 EN ESPA?A
Authors: Maria Targhetta, Jean Paul Tang, Hector Gutierrez, Nuria Perulero, Daniel Callejo, Miriam Solozabal
Affiliations: IQVIA Spain
Publications: XXXIX Jornadas de Economía de la Salud. Albacete, 12 al 14 de junio de 2019
Document Types: , Oral presentation
Countries: , Spain
Abstract: http://www.aes.es/jornadas/pdfs/Jornadas_AES_2019-Libro_abstracts.pdf
Condition	Year	Language	Analysis type
, Diabetes	2019	Spanish	, Clinical setting: Primary care, Population Based Study, Retrospective database analysis


Access to palivizumab against respiratory syncytial virus among high-risk children in English hospitals
Authors: Zylbersztejn A, Standing J, De Stavola B, Hardelid P
Affiliations: IQVIA
Publications:
Document Types: , Abstract, Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Respiratory disease	2019	English


Access to palivizumab against respiratory syncytial virus among high-risk children in English hospitals
Authors: Zylbersztejn A, Standing J, De Stavola B, Hardelid P
Affiliations:
Publications:
Document Types: , Oral communication
Countries: , UK
Condition	Year	Language	Analysis type
, Respiratory disease	2019	English


GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data.
Authors: Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K
Affiliations: IQVIA, Eli Lilly
Publications: Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088.
Document Types: , Article
Countries: , Belgium, Canada, France, Germany, Italy, Netherlands
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31028689
Condition	Year	Language	Analysis type
, Diabetes	2019	English	, Retrospective database analysis


ONE-YEAR ECONOMIC BURDEN AMONG PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) INITIALLY MANAGED IN THE OUTPATIENT SETTING- A RETROSPECTIVE US COHORT STUDY, 2012-2017
Authors: Divino V, Schranz J, Shah H, Jiang M, DeKoven M, Zilberberg M
Affiliations: IQVIA, Nabriva
Publications: Conference. ISPOR 2019, New Orleans, USA, 18-22 May 2019
Document Types: , Oral presentation
Countries: , USA
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation-paper/intl2019-2608/9913/one-year-economic-burden-among-patients-with-community-acquired-pneumonia-cap-initially-managed-in-the-outpatient-setting-a-retrospective-us-cohort-study-2012-2017
Condition	Year	Language	Analysis type
, Respiratory disease	2019	English	, Burden of illness, Retrospective database analysis


ECONOMIC OUTCOMES OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) HOSPITALIZATIONS IN THE US- A RETROSPECTIVE COHORT STUDY, 2012-2017
Authors: Divino V, Schranz J, Shah H, Jiang M, DeKoven M, Zilberberg M
Affiliations: IQVIA, Nabriva
Publications: Conference. ISPOR 2019, New Orleans, USA, 18-22 May 2019
Document Types: , Poster
Countries: , USA
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2019-1479/89813
Condition	Year	Language	Analysis type
, Respiratory disease	2019	English	, Burden of illness, Retrospective database analysis


Cost per Episode of Care With Collagenase Clostridium histolyticum Versus Fasciectomy for Dupuytren Contracture: A Real-World Claims Database Analysis
Authors: Camper S, Divino V, Hurley D, DeKoven M
Affiliations: Endo; IQVIA
Publications: Journal of Hand Surgery Global Online. 2019; 1(2):57-64.
Document Types: , Article
Countries: , USA
Abstract: https://doi.org/10.1016/j.jhsg.2018.12.005
Condition	Year	Language	Analysis type
, Musculoskeletal disease	2019	English	, Cost analysis, Retrospective database analysis


Return to Function in Adults with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum Versus Fasciectomy
Authors: Divino V, DeKoven M, Hurley D
Affiliations: IQVIA; Endo
Publications: Conference. 74TH ANNUAL MEETING OF THE ASSH. Las Vegas, Nevada, USA, 5-7 September 2019
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Musculoskeletal disease	2019	English	, Retrospective database analysis


REAL WORLD OUTCOMES OF ADJUVANTED TRIVALENT INFLUENZA VACCINE COMPARED TO FLUZONE-HD AND EGG-BASED QUADRIVALENT AND TRIVALENT VACCINES AMONG THE US ELDERLY DURING 2016-2018 FLU SEASONS USING CLAIMS DATA
Authors: Victoria Divino, Joaquin Mould-Quevedo, Miao Jiang, Mitchell DeKoven, Girishanthy Krishnarajah
Affiliations: IQVIA; Seqirus
Publications: Conference. Options X for the Control of Influenza. Singapore, 28 August - 1 September 2019
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Respiratory disease	2019	English	, Retrospective database analysis


HOSPITALIZATION ENCOUNTERS FOLLOWING VACCINATION WITH ADJUVANTED TRIVALENT INFLUENZA VACCINE COMPARED TO FLUZONE-HD AND EGG-BASED QUADRIVALENT AND TRIVALENT VACCINES AMONG THE US ELDERLY USING CLAIMS DATA
Authors: Victoria Divino, Joaquin Mould-Quevedo, Mitchell DeKoven, Miao Jiang, Girishanthy Krishnarajah
Affiliations: IQVIA; Seqirus
Publications: Conference. Options X for the Control of Influenza. Singapore, 28 August - 1 September 2019
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Respiratory disease	2019	English	, Retrospective database analysis


Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe
Authors: Fife D, Waller J, Kaplan S, Hu P, Phillips S, Oliveria SA, Richarz U
Affiliations: Fife: Janssen Research and Development, LLC Waller: Adephi Real World Kaplan: Teva Pharmaceutical Indusries Ltd. Hu: Janssen Global Services Phillips: IQVIA Oliveria, IQVIA Richarz: Janssen Research and Development, LLC
Publications: Clin Drug Investig (2019). https://doi.org/10.1007/s40261-019-00831-3
Document Types: , Article
Countries: , Belgium, France, Germany, Spain, UK
Abstract: https://link.springer.com/article/10.1007/s40261-019-00831-3
Condition	Year	Language	Analysis type
, Drug safety, Drug Utlization Study	2019	English	, Population Based Study, Retrospective database analysis


Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review.
Authors: Brandenburg NA1, Phillips S2, Wells KE3, Woodcroft KJ3, Amend KL4, Enger C4, Oliveria SA2
Affiliations: 1 - Global Drug Safety and Risk Management, Celgene Corporation, Summit, New Jersey, USA. 2 - IQVIA, New York, New York, USA. 3 - Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA. 4 - Department of Epidemiology, Optum, Ann Arbor, Michigan, USA
Publications: Front Oncol. 2016;6:224. Published 2016 Oct 27. doi:10.3389/fonc.2016.00224
Document Types: , Article
Countries: , USA
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.4711
Condition	Year	Language	Analysis type
, Database Validity and methodology, Oncology	2019	English	, Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis


European Multi-Country Drug Utilization Study of Dulaglutide
Authors: Ayad K. Ali1, Karen E. Wells2, Mathieu Rosé3, Massoud Toussi3
Affiliations: 1Eli Lilly and Company, Indianapolis, IN, USA 2IQVIA, Oakland, MI, USA 3IQVIA, Courbevoie, France
Publications: ICPE, Philadelphia, USA, 24-28 August 2019
Document Types: , Abstract
Countries: , France, Germany, Spain, Sweden, UK
Condition	Year	Language	Analysis type
, Diabetes, Drug safety	2019	English	, Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis


A population-based analysis of anti-diabetic medications in four Canadian provinces: secular trends and prescribing patterns
Authors: Secrest MH, Azoulay L, Dahl M, Clemens KK, Durand M, Hu N, Targownik L, Turin TC, Dormuth CR, and Filion KB
Affiliations: IQVIA, Cambridge, MA
Publications: Pharmacoepidemiology & Drug Safety (in press)
Document Types: , Article, In press/to be published
Countries: , Canada
Condition	Year	Language	Analysis type
, Diabetes, Drug Utlization Study	2019	English	, Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis


Multiple imputation for systematically missing confounders within a distributed data drug safety network: a simulation study and real-world example
Authors: Secrest MH, Platt RW, Reynier P, Dormuth CR, Benedetti A, and Filion KB
Affiliations: IQVIA, Cambridge, MA
Publications: Pharmacoepidemiology & Drug Safety (In press)
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Database Validity and methodology	2019	English	, Epidemiological study, Retrospective database analysis


Methods, Results, and Lessons Learned from Two Postmarketing Drug Safety Surveillance Studies Linking State Cancer Registry Data to Large Pharmacy Databases
Authors: Harris D1; Casso D2; Midkiff K1; Anderson A2; Gilsenan A1; Oliveria SA2; Andrews E1; KellierSteele N3
Affiliations: 1RTI Health Solutions, Research Triangle Park, NC, United States 2IQVIA, Plymouth Meeting, PA, United States 3Eli Lilly and Company, Indianapolis, IN, United States
Publications: NAACCR / IACR Combined Annual Conference, Vancouver, Canada, 9-13 June 2019
Document Types: , Abstract
Countries: , USA
Abstract: https://www.naaccr.org/wp-content/uploads/2019/06/NAACCR_IACR_Abstract_Program_Final_.pdf
Condition	Year	Language	Analysis type
, Drug safety	2019	English	, Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis


Osteosarcoma Surveillance Program Estimating the Incidence of Osteosarcoma Among Teriparatide (Forteo) Users by Linking State Cancer Registry Data to Pharmacy Database Data (United States)
Authors: Kellier-Steele N1, Anderson A2, Casso D2, Oliveria SA2, Gilsenan A3, Midkiff K3, Harris D3, Andrews E3
Affiliations: 1Eli Lilly and Company, Indianapolis, USA, 2IQVIA, Durham, USA, 3RTI-HS, Raleigh, USA
Publications: WCO, Paris France, 4-7 April 2019
Document Types: , Abstract
Countries: , USA
Abstract: https://www.wco-iof-esceo.org/sites/wco19/pdf/WCO19-AbstractBook.pdf
Condition	Year	Language	Analysis type
, Drug safety	2019	English	, Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis


Use of maximum medical therapy in primary open-angle glaucoma: a retrospective, electronic medical records-based study from the UK
Authors: Costa VP1, Durus A2, Gondos A3, Bezlyak V2, Wintermantel T3, Sagkriotis A2, Hubatsch D4, Kim YS2
Affiliations: 1: Department of Ophthalmology, University of Campinas, Sao Paulo, Brazil; 2: Novartis Pharma AG, Basel, Switzerland; 3: Real World Insights, IQVIA, Basel, Switzerland; 4: Novartis Pharmaceutical Corporation Inc, Fort Worth, TX, USA
Publications: Wolrd Glaucoma Congress, Melbourne, Australia, 27-30 March 2019
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Ophthalmology	2019	English	, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis


Association between changes in anatomical and functional outcomes and physicians’ decisions to treat patients with licensed anti-VEGFs for neovascular age-related macular degeneration in the UK
Authors: Chakravarthy U1, Kap E2, Pillai N2, Syntosi A3, Sagkriotis A3
Affiliations: 1. Centre for Experimental Medicine, Institute of Clinical Science, Queen's University Belfast, Belfast, UK; 2. IQVIA, Switzerland, Germany; 3. Novartis Pharma AG, Basel, Switzerland
Publications: 19th EURETINA Congress, Paris, France, 5-8 September 2019
Document Types: , Oral presentation
Countries: , UK
Condition	Year	Language	Analysis type
, Ophthalmology	2019	English	, clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis


A REVIEW OF SWEDISH HEALTH TECHNOLOGY ASSESSMENTS BASED ON INDIRECT COMPARISONS OF HOSPITAL DRUGS IN ONCOLOGY
Authors: Rongrong Zhang, Heller Vincent, Maximilian Schlueter, Ashley Pitcher
Affiliations: IQVIA
Publications: ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019
Document Types: , Abstract
Countries: , Sweden
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Clinical setting: Home care, Review


Drug utilization and associated visual acuity in patients treated with anti-VEGFs for neovascular age-related macular degeneration (nAMD) in the UK
Authors: Sagkriotis A1, Bennett N2, Skelly A1, Venkatesan S3, Oyetunde S2
Affiliations: 1. Novartis Pharma AG, Basel, Switzerland; 2. Novartis Pharmaceuticals UK Limited, Surrey, United Kingdom; 3. IQVIA Real World Insights, UK
Publications: 19th EURETINA Congress, Paris, France, 5-8 September 2019
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Ophthalmology	2019	English	, clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis


Long term treatment patterns and visual outcomes of anti-vascular endothelial growth factor agents among people with neovascular age-related macular degeneration in the US
Authors: Skelly A1, Khanani AM2, Griner R3, Bezlyak V1, Clark J4, Sagkriotis A1
Affiliations: 1. Novartis Pharma AG, Basel, Switzerland; 2. Sierra Eye Associates, Reno, Nevada, USA; 3. IQVIA, Cambridge, MA, US; 4. Novartis Pharmaceuticals, East Hanover, NJ, US
Publications: ARVO, Vancouver, Canada, April 28 - May 2 2019
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Ophthalmology	2019	English	, clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis


Clinical effectiveness of switching between ranibizumab and aflibercept in treatment of neovascular AMD: US real-world outcomes
Authors: Dugel PU1, Griner R2, Ferreira A3, Milnes F3, Lotery AJ4
Affiliations: 1. Retinal Consultants of Arizona LTD, Retinal Research Institute LLC, Phoenix, AZ, USA; 2. IQVIA Real World Solutions, USA; 3. Novartis Pharma AG, Basel, Switzerland; 4. Eye Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK
Publications: J Vitreoretin Dis. 2019 3(3):127-134
Document Types: , Article
Countries: , USA
Abstract: https://doi.org/10.1177%2F2474126419836614
Condition	Year	Language	Analysis type
, Ophthalmology	2019	English	, clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis


Treat and extend treatment interval patterns with anti-VEGF therapy in nAMD patients
Authors: Skelly A1, Bezlyak V1, Liew G2, Kap E3, Sagkriotis A1
Affiliations: 1. Novartis Pharma AG, 4002 Basel, Switzerland; 2. Westmead Institute for Medical Research, University of Sydney, Westmead NSW 2145, Australia; 3. IQVIA Commercial GmbH & Co. OHG, 60549 Frankfurt, Germany
Publications:
Document Types: , Article
Countries: , Australia
Abstract: https://doi.org/10.3390/vision3030041
Condition	Year	Language	Analysis type
, Ophthalmology	2019	English	, clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis


Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study
Authors: Shin SJ, You SC, Park YR, Roh J, Kim JH, Haam S, Reich CG, Blacketer C, Son DS, Oh S, Park RW
Affiliations:
Publications: J Med Internet Res. 2019 Mar 26;21(3):e13249. doi: 10.2196/13249
Document Types: , Article
Countries:
Abstract: https://www.jmir.org/2019/3/e13249/
Condition	Year	Language	Analysis type
	2019	English	, Methodology


Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care
Authors: Galaznik A, Reich C, Klebanov G, Khoma Y, Allakhverdiiev E, Hather G, Shou Y
Affiliations:
Publications: Cancer Inform. 2019 Mar 15;18:1176935119835538. doi: 10.1177/1176935119835538. eCollection 2019
Document Types:
Countries:
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30906191
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Methodology


Expanding the role of PETs in the data protection and privacy narrative
Authors: 39. K. El Emam
Affiliations: IQVIA
Publications: Journal of Data Protection and Privacy, 2(3):198-200, 2019.
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
	2019	English	, De-identification / anonymisation


Comparing the benefits of pseudonymisation and anonymisation under the GDPR
Authors: M. Hintze and K. El Emam
Affiliations:
Publications: Journal of Data Protection and Privacy, 2(2):145-158, 2018.
Document Types:
Countries:
Condition	Year	Language	Analysis type
	2019	English	, De-identification / anonymisation


Understanding post discharge management after an acute myocardial infarction in Italy: regional pathways and outcome index
Authors: Mastrorilli G1, Tettamanti A1, Urbinati D1
Affiliations: 1 IQVIA, Milan, Italy
Publications: ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Cardiovascular disease	2019	English


Real-world evidence on patients with relapse/refractory FLT3 mutation-positive acute myeloid leukemia in Italy
Authors: La Malfa P1, Arenga A1, De Santo E1, Urbinati D1
Affiliations: 1 IQVIA, Milan, Italy
Publications: ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Real World Data, Real World Evidence


The impact of out-of-pocket spending on the preparation of generic drugs after the expiry of the market exclusivity
Authors: Cioni L1, Tettamanti A1, Urbinati D1
Affiliations: IQVIA, Milan, Italy
Publications: ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Health policy	2019	English	, Market impact, Public Health


Assessment of the oncological offer among Italian regions: a patient-centered analysis
Authors: Rova A1, Tettamanti A1, Pinto L1, Urbinati D1
Affiliations: 1 IQVIA, Milan, Italy
Publications: ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Health policy	2019	English	, Public Health


European survey on stable angina: real world insights on patients' characteristics, perception of disease, and quality of life
Authors: Heiman F1, Peduto I1, Pegoraro V1, Cipelli R1, Ambrosio G2, Camm AJ3, Collins P4, Dechend R5, Lopez-Sendon J6, Manolis AJ7
Affiliations: 1 IQVIA, Milan, Italy 2 Division of Cardiology, University of Perugia School of Medicine, Perugia, Italy 3 Imperial College London, London, United Kingdom - Cardiology Clinical Academic Group, Molecular & Clinical Sciences Institute, St. George’s University of London, London, United Kingdom 4 National Heart and Lung Institute, Imperial College London, United Kingdom - Royal Brompton Hospital, London, United Kingdom 5 Experimental and Clinical Research Center, A joint cooperation between the Max-Delbruck Center for Molecular Medicine and the Charité Medical Faculty, Berlin, Germany - HELIOS-Clinic, Berlin, Germany 6 Cardiology, Hospital Universitario La Paz, IdiPaz, Madrid, Spain 7 Department of Cardiology, Asklepeion General Hospital, Athens, Greece
Publications: ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Cardiovascular disease	2019	English	, Survey research


Change in treatment paradigm of ALK+ Non-Small Cell Lung Cancer (NSCLC) in the Italian real practice
Authors: Tucci C1, Urbinati D1, De Santo E1, Fico M2, Fioravanti L2, Demma F2
Affiliations: 1 IQVIA, Milan, Italy 2 Takeda, Rome, Italy
Publications: ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Public Health, Real World Data, Real World Evidence


Brentuximab Vedotin for consolidation therapy after ASCT in CD30+ Hodgkin's limphoma: a sustainable pharmaceutical expenditure for the Italian National Health Service
Authors: Peduto I1, Heiman F1, Morelli P2, Fioravanti L2, Demma F2
Affiliations: 1 IQVIA, Milan, Italy 2 Takeda, Rome, Italy
Publications: ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Cost analysis, Economic evaluation


Patients prescribed with opioid treatment in primary care practices: a population-based study in Italy
Authors: Peduto I1, Pegoraro V1, Cipelli R1, Heiman F1
Affiliations: 1 IQVIA, Milan, Italy
Publications: ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Pain	2019	English	, Database Study, Longitudinal study, Observational study, Real World Data, Real World Evidence, Retrospective database analysis


Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries
Authors: Levi M1, Simonetti M2, Marconi E2, Brignoli O3, Cancian M3, Masotti A4, Pegoraro V5, Heiman F5, Cricelli C3, Lapi F2
Affiliations: 1 Local Health Unit Tuscany Centre, Florence, Italy 2 Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy 3 Italian College of General Practitioners and Primary Care, Florence, Italy 4 Department of Transfusion Medicine, Pordenone, Italy 5 IQVIA, Milan, Italy
Publications: Annals of Hematology (2019) 98:1573–1582
Document Types: , Article
Countries: , Belgium, Germany, Italy, Spain
Condition	Year	Language	Analysis type
, Hematology	2019	English	, Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


The Close Link between Anxiety and Cluster Symptoms in Lung Cancer Patients during First-Line Chemotherapy
Authors: Carnio S1, Galetta D2, Pilotto S3, Scotti V4, Cortionovis DL5, Antonuzzo A6, Pisconti S7, Rossi A8, Martelli O9, Cecere FL10, Lunghi A11, Del Conte A12, Montrone M2, Topulli J4, Canova S5, Rapetti SG1, Gianetta M1, Pacchiana MV1, Capelletto E1, Pegoraro V13, Cataldo N13, Bria E3 and Novello S1
Affiliations: 1 Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Orbassano, Italy 2 Clinical Cancer Center “Giovanni Paolo II”, Bari, Italy 3 U.O.C. Oncology, Department of Medicine, University of Verona, Italy 4 Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy 5 Medical Oncology Unit, San Gerardo Hospital, Monza, Italy 6 Division of Medical Oncology Department of Oncology, S. Chiara University Hospital, Pisa, Italy 7 Department of Onco-Ematology Medical Oncology, SG Moscati Hospital, Taranto, Italy 8 Division of Medical Oncology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG) 9 Medical Oncology Unit, San Giovanni Addolorata Hospital, Roma, Italy 10 Medical Oncology 1, Regina Elena National Cancer Institute, Roma, Italy 11 Department of Oncology, Medical Oncology Unit, Careggi University Hospital, Florence, Italy 12 IRCCS - Oncological Reference Center (CRO) - U.O. Oncology, Pordenone-S. Vito, Italy 13 IQVIA, Milan, Italy
Publications: J Cancer Sci Ther 2018, 10:9
Document Types: , Article
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Survey research


Real-world insights on the management of migraine patients: an Italian nationwide study
Authors: Agostoni E1, Barbanti P2, Frediani F3, Trifirò G4, Burgio L5, di Nola L5, Pegoraro V6, Pulimeno S5, Cepparulo M5
Affiliations: 1 Neurology and Stroke Unit, Department of Neurosciences, Niguarda Neuro Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy 2 Headache and Pain Unit, Department of Neurological, Motor and Sensorial Sciences, IRCCS San Raffaele Pisana, Rome, Italy - San Raffaele University, Rome, Italy 3 Headache Center, Neurology and Stroke Unit Division, S. Carlo Borromeo Hospital, ASST Santi Paolo e Carlo, Milan, Italy 4 Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy 5 TEVA Italia Srl, Milan, Italy 6 IQVIA, Milan, Italy
Publications: Curr Med Res Opin. 2019 Mar 29:1-10
Document Types: , Article
Countries: , Italy
Condition	Year	Language	Analysis type
, Neurological disorders, Pain	2019	English	, Database Study, Epidemiological study, Observational study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database
Authors: Marzioni M1, Bassanelli C2, Ripellino C3, Urbinati D3, Alvaro D4
Affiliations: 1 Clinic of Gastroenterology and Hepatology, Università Politecnica delle Marche, Ancona, Italy 2 Intercept Italia srl, Milan, Italy 3 IQVIA, Milan, Italy 4 Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy
Publications: Dig Liver Dis. 2019 May;51(5):724-729
Document Types: , Article
Countries: , Italy
Condition	Year	Language	Analysis type
, Gastrointestinal disorders	2019	English	, Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


The Pharmacoepidemiology of Anti-Depressant Prescribing Trends in Canadian Children from 2012 to 2016
Authors: Aysha Lukmanji1BA&Sc, Tamara Pringsheim2,3MD, Andrew G. Bulloch1,3PhD, David G Stewart1, Parco Chan1, Ali Tehrani1, Scott B. Patten1,3,4MD PhD
Affiliations: 1Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW Calgary, Alberta T2N 4Z6, Canada 2 Department of Clinical Neurosciences 3 Mathison Center for Research & Education, Hotchkiss Brain Institute, University of Calgary 4Cuthbertson & Fischer Chair in Pediatric Mental Health, University of Calgary. 5 IQVIA Canada
Publications: J Child Adolesc Psychopharmacol. 2019 Jul 29. doi: 10.1089/cap.2019.0018
Document Types: , Article
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31355670
Condition	Year	Language	Analysis type
	2019	English


PRODUCTIVITY LOSS IN THE FIRST YEAR AFTER A CARDIOVASCULAR EVENT IN CANADA: A CROSS SECTIONAL STUDY OF WORKING ADULTS
Authors: A. Shekhar Pandey, B.Sc., MD, FRCPC, ABIM, CBNC;1 Milan Gupta, MD, FRCPC, FACC;1 Theodore Wein, MD, FRCPC, FAHA;2 Aren Fischer, MSc;3 Johanna Mancini, BSc, MSc, PhD;3 Eduard Sidelnikov, MD, PhD;4 Raina Rogoza, MSc;5 Louisa Pericleous, MSc, PhD.5
Affiliations: 1Department of Medicine, McMaster University, Hamilton, ON, Canada; 2Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada; 3IQVIA, Mississauga, ON, Canada; 4AMGEN, Europe GmbH, Rotkreuz, Switzerland; 5AMGEN; Mississauga, ON, Canada.
Publications:
Document Types: , Poster
Countries: , Canada
Condition	Year	Language	Analysis type
, Cardiovascular disease	2019	English


Trends in Psychotropic Medication Use for Canadian Children and Youth with ASD from 2010 to 2016: A Pharmacoepidemiologic Study
Authors: McMorris, C.A.1, Patten, S.2, Stewart, D.3, Tehrani, A.3 & Pringsheim, T.2
Affiliations: 1 Werklund School of Education, University of Calgary (Calgary, AB Canada) 2 Cumming School of Medicine, University of Calgary (Calgary, AB Canada)
Publications:
Document Types: , Poster
Countries: , Canada
Condition	Year	Language	Analysis type
, Mental health	2019	English	, Database Study


Prescriptions for Alpha Agonists and Antipsychotics in Children and Youth with Tic Disorders: A Pharmacoepidemiologic Study
Authors: Nicholas Cothros1, Davide Martino1, Carly McMorris2,3, David Stewart4, Ali Tehrani4 & Tamara Pringsheim1,5,6*
Affiliations: 1Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary and Hotchkiss Brain Institute, Foothills Hospital, Calgary, AB, CA, 2Werklund School of Education, Alberta Children’s Hospital Research Institute (ACHRI), University of Calgary, Calgary, AB, CA, 3The Owerko Centre, Child Development Centre (CDC), Calgary, AB, CA, 4IQVIA, Kanata, ON, CA, 5Department of Psychiatry, Cumming School of Medicine, University of Calgary, Foothills Hospital, Calgary, AB, CA, 6Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB, CA
Publications: Tremor Other Hyperkinet Mov (N Y)v.9; 2019
Document Types: , Article
Countries: , Canada
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691607/
Condition	Year	Language	Analysis type
, Mental health	2019	English	, Survey research


LANDSCAPE TRANSFORMATION: pCPA CHANGES AND IMPACT TO MARKET ACCESS IN CANADA – RESULTS FROM AN OBSERVATIONAL CROSS-SECTIONAL STUDY
Authors: Minhas, Jagdeep, M.Biotech1; Iqbal-Khan, Sarah, MBA2; Laforty, Callahan, MSc2; Ling, Juejing, MSc2; Shi, Scott, PharmD2; Millson, Brad, MBS1
Affiliations: 1Health Access and Outcomes, IQVIA, 535 Legget Drive, Kanata, ON, K2K 3B8; 2Health Access and Outcomes, IQVIA, 6700 Century Avenue, Mississauga, ON, L5N 6A4
Publications: CADTH Symposium 2019, Edmonton, AB, April 14-16, 2019
Document Types: , Poster
Countries: , Canada
Condition	Year	Language	Analysis type
	2019	English


Anti-VEGF persistence and switching in nAMD: real world analysis from a Canadian claims database
Authors: Tina Maio-Twofoot 1, Alexandros Sagkriotis 2, Atif Kukaswadia 3, François Lebeau 1, Valerie Gregory 1
Affiliations: 1 Novartis Pharmaceuticals Canada Inc., 2 Novartis Pharma AG; 3 IQVIA
Publications:
Document Types: , Poster
Countries: , Canada
Condition	Year	Language	Analysis type
, Ophthalmology	2019	English	, Longitudinal study, Observational study, Retrospective database analysis


Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
Authors: Sean Wharton1, Aiden Liu2, Arash Pakseresht2, Emil N?rtoft3, Christiane L. Haase3, Johanna Mancini4, G. Sarah Power5, Sarah Vanderlelie1, and Rebecca A. G. Christensen1
Affiliations: 1 Wharton Medical Clinic, Burlington, Canada. Correspondence: Sean Wharton (wharton@whartonmedicalclinic.com) 2 Novo Nordisk Canada Inc., Mississauga, Canada 3 Novo Nordisk A/S, S?borg, Denmark 4 IQVIA, Kirkland, Canada 5 IQVIA, Mississauga, Canada.
Publications: Obesity (Silver Spring). 2019 Jun;27(6):917-924. doi: 10.1002/oby.22462. Epub 2019 May 7.
Document Types: , Article
Countries: , Canada, Nordic
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31062937
Condition	Year	Language	Analysis type
, Obesity	2019	English


Reduction in the Utilization of Prednisone or Methotrexate in Canadian Claims Data Following Initiation of Etanercept in Pediatric Patients with Juvenile Idiopathic Arthritis
Authors: Majed M M Khraishi1, Brad Millson2, John Woolcott3, Lisa Marshall4 and Heather Jones4
Affiliations: 1Memorial University of Newfoundland, St John's, NF, Canada, 2IQVIA, Kanata, ON, Canada, 3Global Outcomes & Evidence, Pfizer, Collegeville, PA, 4Pfizer, Collegeville, PA
Publications: Annals of the Rheumatic Diseases 2018;77:494.
Document Types: , Article
Countries: , Canada
Abstract: https://acrabstracts.org/abstract/reduction-in-the-utilization-of-prednisone-and-or-methotrexate-following-the-initiation-of-etanercept-in-pediatric-patients/
Condition	Year	Language	Analysis type
, Pediatrics, Rheumatology	2019	English	, Longitudinal study, Retrospective database analysis


Real-world utilization of methotrexate or prednisone co-therapy with etanercept among Canadian patients with rheumatoid arthritis: a retrospective cohort study
Authors: Majed Khraishi, Jelena Ivanovic, Yvonne Zhang, Brad Millson, Marie-Josee Brabant, John Woolcott, Heather Jones & Cinzia Curiale
Affiliations:
Publications: Journal of Current Medical Research and Opinion, Accepted author version posted online: 25 Jun 2019, Published online: 10 Jul 2019
Document Types: , Article
Countries: , Canada
Abstract: ?https://doi.org/10.1080/03007995.2019.1636543
Condition	Year	Language	Analysis type
, Rheumatology	2019	English	, Retrospective cohort analysis


Use of subcutaneous and intravenous trastuzumab: real-world experience from three hospitals in Sweden.
Authors: Valachis A, Sundqvist M, Carlsson L, Li B, Chiesa F, Uhde M, Sanglier T
Affiliations: Department of Oncology, Faculty of Medicine & Health, ?rebro University, SE 70182 ?rebro, Sweden (Valachis) AND Real World & Analytic Solutions (RWAS), IQVIA, Stockholm, Sweden (Milica Uhde)
Publications: Future Oncol. 2019 Aug;15(23):2733-2741. doi: 10.2217/fon-2019-0160. Epub 2019 Jul 15.
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31306041
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Clinical setting: hospital, Epidemiological study, Retrospective cohort analysis


Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study.
Authors: Larsson K1, Janson C2, Ställberg B3, Lisspers K3, Olsson P4, Kostikas K5, Gruenberger JB5, Gutzwiller FS5, Uhde M6, Jorgensen L7, Johansson G3.
Affiliations: Work Environment Toxicology, Karolinska Institutet, Stockholm, Sweden (Larsson) and IQVIA Sweden (Uhde)
Publications: Int J Chron Obstruct Pulmon Dis. 2019 May 13;14:995-1008. doi: 10.2147/COPD.S195382. eCollection 2019.
Document Types: , Article
Countries: , Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31190785
Condition	Year	Language	Analysis type
, Respiratory disease	2019	English	, Clinical setting: Primary care, Epidemiological study, Retrospective cohort analysis


Patient characteristics and initiation of mineralocorticoid receptor antagonists in patients with chronic kidney disease in routine clinical practice in the US: a retrospective cohort study
Authors: Blankenburg M1, Fett AK2, Eisenring S3, Haas G2, Gay A4
Affiliations: 1. Bayer AG, Market Access, Berlin, Germany; 2. IQVIA Commercial GmbH & Co OHG, Frankfurt/Main, Germany; 3. IQVIA, Basel, Switzerland; 4. Bayer AG, Medical Affairs, Berlin, Germany
Publications: BMC Nephrology 2019;20:171
Document Types: , Article
Countries: , USA
Abstract: https://doi.org/10.1186/s12882-019-1348-4
Condition	Year	Language	Analysis type
, Nephrology	2019	English	, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis


CLUE: Consequences for life of children with in utero exposure to metformin in Finland
Authors: Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch, Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen
Affiliations: Merck KGaA: Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch IQVIA (SF-EPID): Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen
Publications: The International Diabetes Federation (IDF) Congress 2019
Document Types: , Oral presentation
Countries: , Finland, Nordic
Condition	Year	Language	Analysis type
, Diabetes	2019	English	, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Population Based Study, Public Health, Retrospective cohort analysis, Retrospective database analysis


An Exploratory Analysis of Real-World Endpoints for Assessing Outcomes Among Immunotherapy-Treated Patients with Advanced Non-Small Cell Lung Cancer.
Authors: Stewart M, Norden AD, Dreyer N, Henk HJ, Abernethy AP, Chrischilles E, Kushi L, Mansfield AS, Khozin S, Sharon E, Arunajadai S, Carnahan R, Christian JB, Miksad RA, Sakoda LC, Torres AZ, Valice E, Allen J.
Affiliations:
Publications: JCO Clinical Care Informatics 2019. 3:1-15.
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2019	English


EPIDEMIOLOGY OF ATTENTION DEFICIT HYPERACTIVITY DISORDERS IN SPAIN BASED ON REAL-WORLD DATA
Authors: Ramos-Quiroga JA (1), Targhetta M (2), Gasche D (2), Rubio M (2), Perulero N (3)
Affiliations: 1Hospital Universitari Vall dâ€™Hebron, Barcelona, Spain, 2IQVIA Information, Madrid, Spain; 3IQVIA Information, Barcelona, Spain
Publications: ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Patient Registries & Real-World Study Methods	2019	English	, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis


AnÃ¡lisis de la implementaciÃ³n de los Informes de Posicionamiento TerapÃ©utico en EspaÃ±a
Authors: MÃriam Solozabal, Laura Planellas, Elisabet Viayna, Neus Canal
Affiliations: Health Economics & Outcomes Research. Real-World Insights. IQVIA EspaÃ±a
Publications: Revista EspaÃ±ola de EconomÃa de la Salud. 2019; 14(3):596-605
Document Types: , Article
Countries: , Spain
Abstract: https://www.economiadelasalud.com/Articulo.aspx?i=v14n3d018
Condition	Year	Language	Analysis type
, Health policy, Pricing and reimbursement, Public Health	2019	Spanish	, Clinical setting: hospital, Clinical setting: Primary care, Internet or Interactive voice response system, Pricing & Reimbursement, Public Health


A REAL-WORLD DATA STUDY TO ANALYSE THE PHARMACOLOGICAL TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN SPAIN
Authors: Ramos-Quiroga JA (1), Tang JP (2), Solozabal M (2), De Prado A (2), MiÃ±arro C (2), Callejo-Velasco D (2)
Affiliations: 1Hospital Universitari Vall dâ€™Hebron, Barcelona, Spain, 2IQVIA Information, Madrid, Spain
Publications: ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Patient Registries & Real-World Study Methods	2019	English	, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis


EMPAGLIFLOZIN VS SITAGLITPIN, SAXAGLIPTIN AND LIRAGLUTIDE IN SPAIN. A BUDGET IMPACT MODEL BASED ON THE CORE DIABETES MODEL AND CARDIOVASCULAR OUTCOMES TRIALS
Authors: Carrasco Perez M, Ustyugova A, Rubio M, Callejo-Velasco D, Gasche D, Gonzalez-Rojas Guix N
Affiliations: Boehringer Ingelheim and IQVIA
Publications: ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Diabetes	2019	English	, Budget impact, Clinical setting: Primary care


Ankle Sprains in the National Basketball Association, 2013-14 through 2016-17.
Authors: Herzog MM, Mack CD, Dreyer NA, Wikstrom EA, Padua DA, Kocher MS, DiFiori JP, Marshall SW
Affiliations:
Publications: American Journal of Sports Medicine 2019 Sep;47(11):2651-2658. doi: 10.1177/0363546519864678. Epub 2019 Aug 7
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Injuries	2019	English


Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005-2015 show improved survival over time.
Authors: LindstrÃ¶m V, Hakkarainen KM, MehtÃ¤lÃ¤ J, Klement R, Leval A, JÃ¤rvinen TM
Affiliations: VL: Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland. JM, KMH: StatFinn & EPID Research. AL, TMJ: Janssen-Cilag.
Publications: Eur J Haematol. 2019 Sep;103(3):190-199. doi: 10.1111/ejh.13273.
Document Types: , Article
Countries: , Finland, Nordic
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31210368
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Clinical setting: hospital, Epidemiological study, Observational study, Retrospective cohort analysis


Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005-2015 show improved survival over time.
Authors: LindstrÃ¶m V, Hakkarainen KM, MehtÃ¤lÃ¤ J, Klement R, Leval A, JÃ¤rvinen TM
Affiliations: VL: Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland. JM, KMH: StatFinn & EPID Research. AL, TMJ: Janssen-Cilag.
Publications:
Document Types:
Countries:
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31210368
Condition	Year	Language	Analysis type
	2019	English


Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain.
Authors: Schlueter M, Finn E, DÃaz S, Dilla T, Inciarte-Mundo J, Fakhouri W.
Affiliations: IQVIA, Real World Evidence, London N1 9JY, UK. Lilly Spain, Health Outcomes & RWE, Alcobendas 28108, Spain. Lilly Spain, Medical, Alcobendas 28108, Spain. Lilly, Global Patient Reported Outcomes and Real World Evidence (GPORWE) International, Windlesham, Surrey GU20 6PH, UK.
Publications: Clinicoecon Outcomes Res. 2019 Jun 6;11:395-403
Document Types: , Article
Countries: , Spain
Abstract: https://www.dovepress.com/cost-effectiveness-analysis-of-baricitinib-versus-adalimumab-for-the-t-peer-reviewed-fulltext-article-CEOR
Condition	Year	Language	Analysis type
, Rheumatology	2019	English	, Retrospective cohort analysis


Comparative Efficacy and Tolerability of Lurasidone versus Other Oral Atypical Antipsychotics for the Treatment of Pediatric Schizophrenia: A Network Meta-Analysis
Authors: Arango C, Ng-Mak D, Finn E, Byrne A, Rajagopalan K, Loebel A
Affiliations: Chair Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio MaraÃ±Ã³n, Universidad Complutense, IBERSAM, Madrid, Spain Senior Director, Global Health Economics & Outcomes Research, Sunovion Pharmaceuticals Inc, Marlborough, MA, USA QuintilesIMS, London, United Kingdom Head of Global HEOR, Global Health Economics and Outcomes Research, Sunovion Pharmaceuticals, Marlborough, MA Executive Vice President, Chief Medical Officer, Research & Development, Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USA
Publications: 30th Annual U.S. Psych Congress; 2017 Sept 15-19; New Orleans (USA) European Psychiatric Association; 2018 Mar 3-6; Nice, France. NEI Congress Scientific Poster Session; 2017 Nov 10; Colorado Springs (USA). Lurasidone in Bipolar Depression: Update of SLR and NMA
Document Types: , Poster
Countries: , USA
Abstract: https://www.psychcongress.com/posters/comparative-efficacy-and-tolerability-lurasidone-versus-other-oral-atypical-antipsychotics
Condition	Year	Language	Analysis type
, Mental health, Pediatrics	2019	English	, Meta analysis, Retrospective cohort analysis


EVALUATION OF THE EFFECTIVENESS OF RISK MINIMISATION MEASURES TARGETING PHYSICIANS ON PRESCRIBING PRACTICES OF THIOCOLCHICOSIDE (TCC) CONTAINING MEDICINAL PRODUCTS FOR SYSTEMIC USE
Authors: Laurence Sophie Jouaville, Carole Ehrhardt, Marie-Laure KÃ¼rzinger, Hanka de Voogd, Massoud Toussi
Affiliations: Real World Evidence Solutions, IQVIA, France; Global Pharmacovigilance â€“ Global Safety Sciences - Risk Management, Sanofi; Epidemiology and Benefit Risk Evaluation, Sanofi; Global Clinical Sciences; Vaccines & Anti-Infectives, Mylan, The Netherlands
Publications: Poster presented at: 35th International Conference an Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Pennsylvania Convention Center Philadelphia, Pennsylvania August 24-28, 2019
Document Types: , Poster
Countries: , France, Greece, Italy, Portugal
Abstract: https://www.coodoc.com/pages/p1819-Thiocholchicoside-ICPE-2019
Condition	Year	Language	Analysis type
, Health policy, Musculoskeletal disease	2019	English	, Survey research


A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on DarzalexÂ® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries
Authors: Mathieu RosÃ©, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi
Affiliations: IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK
Publications: Presented at ISPEâ€™s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24â€“28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA.
Document Types: , Poster
Countries: , Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland
Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019
Condition	Year	Language	Analysis type
, Hematology, Oncology	2019	English	, Public Health, Survey research


Every Mother Counts: Target Sample Size Estimates for Pregnancy Exposure Registries
Authors: Bratton EW, Lee KM, Hawkes WG, Landi SN, Hahn KA
Affiliations: IQVIA Durham, NC; NoviSci, Durham, NC
Publications:
Document Types:
Countries:
Condition	Year	Language	Analysis type
, Pregnancy	2019	English	, Population Based Study, Real World Data


Outcome measurement in pregnancy exposure registries: A preliminary review of publicly available resources
Authors: Suzanne N. Landi, Jessica R. Probst , Katherine Lee, , Elsa GarcÃa HernÃ¡ndez , Kristen Hahn
Affiliations: IQVIA, Durham, NC NoviSci Inc., Durham, NC
Publications:
Document Types:
Countries: , Europe, USA
Condition	Year	Language	Analysis type
, Pregnancy	2019	English	, Population Based Study, Review


The clinical and economic burden of cytomegalovirus management post allogeneic hematopoietic stem cell transplantation in Japan - a retrospective database study
Authors: Rie Ueno 1, Shinichi Nishimura 1, Go Fujimoto 1, Yi Piao 2, Katsuto Takenaka 3 (rwesheorj A)
Affiliations: 1) MSD K.K., Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan 3) Department of Hematology, Clinical Immunology and Infectious Diseases, Graduate School of Medicine, Ehime University, Toon, Japan
Publications: Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2019.1649379
Condition	Year	Language	Analysis type
, Hematology	2019	English	, Epidemiological study, Retrospective database analysis


Determining Real-World Dataâ€™s Fitness for Use and the Role of Reliability
Authors: Nirosha Mahendraratnam Christina Silcox Kerra Mercon Adam Kroetsch Morgan Romine Nicholas Harrison Adam Aten Rachel Sherman Gregory Daniel* Mark McClellan
Affiliations: The Robert J. Margolis, MD, Center for Health Policy at Duke University is directed by Mark McClellan, MD, PhD, and brings together expertise from the Washington, DC, policy community, Duke University, and Duke Health to address the most pressing issues in health policy. The mission of Duke-Margolis is to improve health and the value of health care through practical, innovative, and evidence-based policy solutions. Duke-Margolis catalyzes Duke Universityâ€™s leading capabilities, including interdisciplinary academic research and capacity for education and engagement, to inform policy making and implementation for better health and health care. For more information, visit healthpolicy.duke.edu.
Publications: https://healthpolicy.duke.edu/sites/default/files/atoms/files/_determining_real-world_datas_fitness_for_use_and_the_role_of_reliability.pdf
Document Types: , Health authorities guidelines/assessment report, Report
Countries:
Abstract: https://healthpolicy.duke.edu/publications/determining-real-world-dataâ€™s-fitness-use-and-role-reliability
Condition	Year	Language	Analysis type
, Drug Utlization Study, Health policy	2019	English	, Retrospective database analysis


Medication adherence/persistence and demographics of Japanese dyslipidemia patients on statin-ezetimibe as a separate pill combination lipid-lowering therapy- an observational pharmacy claims database study
Authors: Tatsuya Umeda 1, Ai Hayashi 1, Go Fujimoto 1, Yi Piao 2, Nobutomo Matsui 2, Shigeru Tokita 1
Affiliations: 1) Medical Affairs, MSD K.K. 2) Real World Insights, IQVIA Solutions Japan K.K.
Publications: Circulation Journal Circ J. 2019 Jul 25;83(8):1689-1697
Document Types: , Abstract, Article, Poster
Countries: , Japan
Abstract: https://www.jstage.jst.go.jp/article/circj/83/8/83_CJ-18-1344/_article
Condition	Year	Language	Analysis type
, Hematology	2019	English	, Epidemiological study, Retrospective database analysis


When Context Is Hard to Come By: External Comparators and How to Use Them.
Authors: Mack C, Christian J, Brinkley E, Warren EJ, Hall M, Dreyer N
Affiliations: IQVIA Real-World & Analytic Solutions, Durham, NC, USA. IQVIA Real-World & Analytic Solutions, Rockville, MD, USA. IQVIA Real-World & Analytic Solutions, Cambridge, MA, USA
Publications: Ther Innov Regul Sci. 2019 Nov 5:2168479019878672.
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31690113
Condition	Year	Language	Analysis type
, Methodology	2019	English	, Retrospective database analysis


AN EARLY LOOK AT THE SECOND DOSE COMPLETION OF THE RECOMBINANT ZOSTER VACCINE (RZV) IN CANADIAN ADULTS ? A RETROSPECTIVE ANALYSIS
Authors: Ashleigh McGirr1, Tara Bourgoin2, Michael Wortzman1, Brad Millson2, Shelly McNeil3
Affiliations: 1GSK, Mississauga, Canada, 2IQVIA, Ot tawa, Canada, 3Canadian Center for Vaccinology, IWK Heal th Centre and Nova Scotia Health Authority, Dalhousie University
Publications: The CIRN Annual Meeting, 20 & 21 November 2019 - Toronto, Canada
Document Types: , Poster
Countries: , Canada
Abstract: https://gsk.envisionpharma.com/dv_gsk_bio/
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2019	English	, Retrospective database analysis


A budget impact analysis of anti-inhibitor coagulant complex use in pediatric hemophilia A patients with inhibitors across kingdom of Saudi Arabia
Authors: Al Jedai A1, AL-Mudaiheem H1, Al daamah S2, Al kasim F3, Wasri A4, Shaheen N5, Dawood E6, El-Hamaidi I7, Mohamed O8
Affiliations: 1Ministry of Health, Riyadh, NJ, USA, 2Ministry of Health, Damam, Saudi Arabia, 3Ministry of Health, Riyadh, Saudi Arabia, 4Ministry of National Guards, Jeddah, Saudi Arabia, 5King Faisal Specialized Hospitals, Damam, Saudi Arabia, 6Ministry of Health, Mekkah, Saudi Arabia, 7Ministry of National Guards, Riyadh, Saudi Arabia, 8IQVIA, Dubai, DU, United Arab Emirates
Publications: 2019-11, ISPOR Europe 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Saudi Arabia
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3122/96011
Condition	Year	Language	Analysis type
, Hematology, Rare disease	2019	English	, Budget impact


Cost of inflammatory bowel disease management in the kingdom of Saudi Arabia
Authors: Al Jedai A1, AL-Mudaiheem H1, Haines A2, Mosli M3, Albogami M4, Al-jaroudi F5, Alsaqa'aby M6, Awad N7, Mohamed O8
Affiliations: 1Ministry of Health, Riyadh, NJ, USA, 2Toronto University, Toronto, ON, Canada, 3King Abdulaziz University, Jeddah, Saudi Arabia, 4Ministry of Health, Damam, Saudi Arabia, 5King Fahad Specialist Hospital, Damam, Saudi Arabia, 6King Faisal Specialized Hospital and Research Center, Riyadh, Saudi Arabia, 7IQVIA, Dubai, United Arab Emirates, 8IQVIA, Dubai, DU, United Arab Emirates
Publications: 2019-11, ISPOR Europe 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Saudi Arabia
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3122/97718
Condition	Year	Language	Analysis type
, Gastrointestinal disorders	2019	English	, Budget impact, Literature Review


Extracting UMLS Concepts from Medical Text Using General and Domain-Specific Deep Learning Models
Authors: Kathleen C. Fraser1, Isar Nejadgholi1, Berry De Bruijn1, Muqun Li2, Astha LaPlante2 , Khaldoun Zine El Abidine2
Affiliations: 1National Research Council Canada 2Privacy Analytics Inc., Ottawa, Canada
Publications: [v1] Thu, 3 Oct 2019 01:51:17 UTC
Document Types: , Article
Countries: , USA
Abstract: https://arxiv.org/abs/1910.01274
Condition	Year	Language	Analysis type
, Miscellaneous	2019	English	, Methodology, Observational study, Public Health


Economic evaluation of cladribine tablets in relapsing multiple sclerosis (RMS) patients with high disease activity (HAD) in lebanon
Authors: Metni M1, Yamout B2, Koussa S3, Khamis C3, Fleifel L4, Sharifi S4, Mohamed O5
Affiliations: 1National Social Security Fund, Beirut, NJ, Lebanon, 2American University if Beirut, Beirut, NJ, Lebanon, 3Geitaoui hospital, Beirut, Lebanon, 4Merck Serono Middle East FZ-Ltd, an affiliate of Merck KGaA, Dubai, 07, United Arab Emirates, 5IQVIA, Dubai, NJ, United Arab Emirates
Publications: 2019-11, ISPOR Europe 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Lebanon
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3122/95423
Condition	Year	Language	Analysis type
, Neurological disorders	2019	English	, Budget impact, Cost utility


The cost effectiveness of enoxaparin in the prevention of venous thromboembolism in patients undergoing major surgery in egypt
Authors: Farag A1, Abdel Moety H1, Hassan L2, Pathak P3, Lamotte M4, Levorsen A5
Affiliations: 1Cairo University, Cairo, Egypt, 2Alexandria University, Alexandria, Egypt, 3QuintilesIMS, Dubai, United Arab Emirates, 4IQVIA, Zaventem, VBR, Belgium, 5Sanofi, Global, France
Publications: 2019-11, ISPOR Europe 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Egypt
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3118/94222
Condition	Year	Language	Analysis type
, Cardiovascular disease	2019	English	, Cost effectiveness, Literature Review


THE COST OF STIGMA ASSOCIATED WITH HIV- A COST-CONSEQUENCE ANALYSIS TO EVALUATE HIV TESTING AND PREVENTION INTERVENTIONS IN KSA
Authors: Filemban S1, Elrashied S1, Assiri A1, Hakawi A1, Snehanshu S2, Mansour E3, Vemer P4, Awad N5
Affiliations: 1Ministry of Health, Riyadh, Saudi Arabia, 2Gilead Sciences Middle East, Dubai Health Care City, United Arab Emirates, 3Gilead, Dubai, United Arab Emirates, 4Groningen University, Groningen, Netherlands, 5IQVIA, Dubai, United Arab Emirates
Publications: 2019-11, ISPOR Europe 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Saudi Arabia
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3120/97847
Condition	Year	Language	Analysis type
, HIV AIDS	2019	English	, Predictive analytics, Quality of life


An assessment of physician reasons for prescribing insulin lispro 200 units/ml in a prefilled pen in Germany
Authors: Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4 & Dirk Lennartz5
Affiliations: 1Lilly and Company, Indianapolis, USA; 2Eli Lilly and Company Deutschland GmbH, Bad Homburg, Germany; 3Eli Lilly and Company, Surrey, United Kingdom; 4IQVIA, Real-World Evidence Solutions, Barcelona, Spain; 5IQVIA, Real-World Evidence Solutions, Munich, Germany.
Publications: Endocrine Abstracts (2019) 63 P207 \| DOI: 10.1530/endoabs.63.P207
Document Types: , Article
Countries: , Germany
Abstract: https://www.endocrine-abstracts.org/ea/0063/ea0063P207
Condition	Year	Language	Analysis type
, Diabetes	2019	English	, Compliance, Survey research


Budget impact analysis of tofacitinib in adult rheumatoid arthritis patients in Iraq
Authors: N. AlAni1, N. Sunna2, A. Ghorab3, A. AlJabban4, N. Awad5, O. Mohamed5
Affiliations: Baghdad College of Medicine, Baghdad, Iraq, Pfizer, Amman, Jordan, ; Pfizer, Dubai, United Arab Emirates; Pfizer, Baghdad, NJ, USA; IQVIA, Dubai, United Arab Emirates; IQVIA, Dubai, United Arab Emirates
Publications: DOI: https://doi.org/10.1016/j.jval.2019.04.705
Document Types: , Article
Countries: , Iraq
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)30897-6/abstract
Condition	Year	Language	Analysis type
, Musculoskeletal disease	2019	English	, Budget impact, Prospective study


Budget Impact Analysis Of Golimumab In Adult Rheumatoid Arthritis Patients In Kingdom Of Saudi Arabia
Authors: A. Al Jedai1, H. AL-Mudaiheem1, P. Pathak2, N. Awad2, O. Mohamed2, N. Alghanim1, W. Hussain1, A. Qamar1, T. Alama1
Affiliations: Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; IQVIA, Dubai, United Arab Emirates; IQVIA, Dubai, United Arab Emirates; IQVIA, Dubai, United Arab Emirates; Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia
Publications: DOI: https://doi.org/10.1016/j.jval.2019.04.087
Document Types: , Article
Countries: , Saudi Arabia
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)30279-7/fulltext
Condition	Year	Language	Analysis type
, Musculoskeletal disease	2019	English	, Budget impact, Predictive analytics


Cost of treating iron deficiency anaemia (ida) with ferric carboxymaltose versus iron saccharate in heavy uterine bleeding (hub) patients in the kingdom of Saudi Arabia
Authors: A. Alhejazi1, O. Mohamed2, M. Alhowimel1, M. Al Adham1
Affiliations: Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia; IQVIA, Dubai, United Arab Emirates; Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia; Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia
Publications: DOI: https://doi.org/10.1016/j.jval.2019.04.824
Document Types: , Article
Countries: , Saudi Arabia
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)31016-2/abstract
Condition	Year	Language	Analysis type
, Hematology, Womens Health	2019	English	, Budget impact, Predictive analytics


A network meta analysis comparing C1 and kallikrein inhibitors approved for prophylaxis of hereditary angioedema in the United States
Authors: P. Saharia1, P. Soni2, M. Chatterjee3
Affiliations: IQVIA, Gurugram, HR, India; IQVIA, Delhi, India; IQVIA, Gurugram, India
Publications: DOI: https://doi.org/10.1016/j.jval.2019.04.1641
Document Types: , Article
Countries: , USA
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)31833-9/fulltext
Condition	Year	Language	Analysis type
, Cardiovascular disease, Rare Diseases	2019	English	, Literature Review, Meta analysis


Cost effectiveness of cladribine tablets for treatment of RRMS in the Netherlands
Authors: de Francesco M1, Mahajan K2, Michels RE3, Schiffers K4, Budhia S5, Harty G6, Krol M3
Affiliations: 1IQVIA, Zaventem, Belgium, 2IQVIA, Gurgaon, India, 3IQVIA, Amsterdam, The Netherlands, 4Merck B.V., an affiliate of Merck KGaA, Schiphol-Rijk, The Netherlands, 5PAREXEL International, Waltham, MA, USA, 6EMD Serono, Billerica, MA, USA
Publications: 2018-11, ISPOR Europe 2018, Barcelona, Spain
Document Types: , Article
Countries: , Netherlands
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-europe-2018/cost-effectiveness-of-cladribine-tablets-for-treatment-of-rrms-in-the-netherlands
Condition	Year	Language	Analysis type
, Neurological disorders	2019	English	, Cost effectiveness, Predictive analytics


Mid-upper arm circumference as a substitute of the body mass index for assessment of nutritional status among adult and adolescent females: learning from an impoverished Indian state.
Authors: Das A, Sai Mala G, Reddy N, Mishra P, Giri R, Kumar A, Raj A, Kumar G, Chaturvedi S, Babu S, Srikantiah S, Mahapatra T.
Affiliations: Lead author: Epidemiology and Outcomes Research, Real World Solutions, Scientific Services (At the time of publication, the author was with CARE India Solutions for Sustainable Development)
Publications: Public Health
Document Types: , Article
Countries: , India
Abstract: https://www.sciencedirect.com/science/article/pii/S0033350619302963
Condition	Year	Language	Analysis type
, Health policy, Nutritional Disorders	2019	English	, Cost minimization, Epidemiological study, Observational study, Population Based Study, Public Health


Prelacteal feeding practice and maintenance of exclusive breast feeding in Bihar, India â€“ identifying key demographic sections for childhood nutrition interventions: a cross-sectional study.
Authors: Das A, Sai Mala G, Singh RS, Majumdar A, Chatterjee R, Chaudhuri I
Affiliations: Lead author: Epidemiology and Outcomes Research, Real World Solutions, Scientific Services (At the time of publication, the author was with CARE India Solutions for Sustainable Development)
Publications: Gates Open Research
Document Types: , Article
Countries: , India
Abstract: https://gatesopenresearch.org/articles/3-1
Condition	Year	Language	Analysis type
, Pediatrics	2019	English	, Observational study, Population Based Study, Public Health


Where there is no nurse: an observational study of large-scale mentoring of auxiliary nurses to improve quality of care during childbirth at primary health centres in India.
Authors: Rao KD, Srivastava S, Warren N, Mayra K, Gore A, Das A, Ahmed S.
Affiliations: Lead author: Department of International Health, Johns Hopkins University Bloomberg School of Public Health. One of the contributing author is Aritra Das who is affiliated to Epidemiology and Outcomes Research, Real World Solutions, Scientific Services (he was formerly with CARE India Solutions for Sustainable Development)
Publications: BMJ Open
Document Types: , Article
Countries: , India
Abstract: https://bmjopen.bmj.com/content/bmjopen/9/7/e027147.full.pdf
Condition	Year	Language	Analysis type
, Health policy	2019	English	, Observational study, Public Health


Pregnancy and Infant Outcomes with Interferon Beta: Data from the European Interferon Beta Pregnancy Registry and MS Pregnancy study conducted in Finland and Sweden
Authors: "Kerstin Hellwig*, Yvonne Geissbuehler2, Meritxell SabidÃ³3, Catrinel Popescu4, Alessandra Adamo5, Joachim Klinger6, Peter Huppke7, Asher Ornoy8, Pasi Korhonen9, Kjell-Morten Myhr10, Scott Montgomery11, Sarah Burkill11, European Interferon Beta Pregnancy Study Group"
Affiliations: *Katholisches Klinikum Bochum, St Josef-Hospital Universitatsklinikum, Bochum, Germany; 9StatFinn & EPID Research, Espoo, Finland
Publications: AAN, Philadelphia, USA, 4-10 May 2019
Document Types: , Oral presentation
Countries: , Europe, Finland, Nordic, Sweden
Abstract: https://n.neurology.org/content/92/15_Supplement/S49.005
Condition	Year	Language	Analysis type
, Neurological disorders	2019	English	, Epidemiological study, Population Based Study


No increased risk of spontaneous abortion and ectopic pregnancy after exposure to interferon-beta prior to or during pregnancy: Results from register-based Nordic study among women with MS
Authors: R. Juuti1, K. M. Hakkarainen 1, S. Burkill 2, Y. Geissbuehler 3, M. SabidÃ³ 4, C. Popescu 5, A. Adamo 6, J. Hillert 2, S. Cnattingius 2, M. Artama 7, A. Verkkoniemi-Ahola 8, K.-M. Myhr 9, J. MehtÃ¤lÃ¤ 1, S. Bahmanyar 2, S. Montgomery 2,10, P. Korhonen 1 and the European Interferon Beta Pregnancy Study Group
Affiliations: 1StatFinn-EPID Research, Espoo, Finland
Publications: EAN, Oslo, Norway, June 29-2 July, 2019
Document Types: , Oral presentation
Countries: , Finland, Germany, Norway, Sweden, Switzerland, UK
Abstract: https://www.ean.org/fileadmin/_files/AbstractBook/EAN_Journal_2019_Book.pdf
Condition	Year	Language	Analysis type
, Neurological disorders	2019	English	, Epidemiological study, Population Based Study, Retrospective database analysis


Prevalence of infant outcomes at birth after exposure to interferon beta prior to or during pregnancy: A register-based cohort study in Finland and Sweden among women with MS
Authors: Pia Vattulainen1, Sarah Burkill2, Yvonne Geissbuehler3, Meritxell SabidÃ³4, Catrinel Popescu5, Kiliana Suzart-Woischnik6, Kjell-Morten Myhr7, Scott Montgomery2,8, Pasi Korhonen1 the European Interferon Beta Pregnancy Study Group and the Nordic MS Pregnancy & Interferon Beta study group
Affiliations: 1StatFinn-EPID Research, Espoo, Finland
Publications: ECTRIMS, Stockholm, Sweden, 11-13 September, 2019
Document Types: , Poster
Countries: , Finland, Nordic, Sweden
Abstract: https://onlinelibrary.ectrims-congress.eu/ectrims/2019/stockholm/278346/pasi.korhonen.prevalence.of.infant.outcomes.at.birth.after.exposure.to.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dmontgomery
Condition	Year	Language	Analysis type
, Neurological disorders	2019	English	, Epidemiological study, Population Based Study, Retrospective cohort analysis


Real-world data confirming the efficacy and safety of decitabine in acute myeloid leukaemia - results from a retrospective Belgian registry study.
Authors: Meers S1, Bailly B2, Vande Broek I3, Malfait B4, Van Hoorenbeeck S4, Geers J4, Braakman J5, Van Kouwenhove M6, Doyle M7, Diels J8, Caekelbergh K9, Chevalier P9, Dierickx D10.
Affiliations: 1 Department Oncology, AZ Klina , Brasschaat , Belgium. 2 Department Haematology, Groupe Jolimont , Haine Saint-Paul , Belgium. 3 Department Oncology, AZ Nikolaas , Haematology, Sint Niklaas , Belgium. 4 Department Market Access, Janssen-Cilag NV , Beerse , Belgium. 5 Department Market Access, Janssen-Cilag BV , Breda , The Netherlands. 6 Department Medical, Janssen-Cilag BV , Breda , The Netherlands. 7 Department Medical, Janssen Ireland , Dublin 24 , Ireland. 8 Department Statistics and Modelling, Janssen Pharmaceutica NV , Beerse , Belgium. 9 Department Real-World Solutions, IQVIA , Zaventem , Belgium. 10 Department Haematology, UZ Leuven , Leuven , BelgiumDepartment Haematology.
Publications:
Document Types: , Abstract
Countries: , Belgium
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31551014
Condition	Year	Language	Analysis type
, Infectious disease, Oncology	2019	English	, Retrospective database analysis


Epidemiology of Ankle Sprains and Chronic Ankle Instability.
Authors: Herzog MM, Kerr ZY, Marshall SW, Wikstrom EA
Affiliations: Department of Epidemiology, University of North Carolina at Chapel Hill; Real-World Analytics Solutins, IQVIA; University of North Carolina Injury Prevention Research Center
Publications: J Athl Train. 2019 Jun;54(6):603-610. doi: 10.4085/1062-6050-447-17
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31135209
Condition	Year	Language	Analysis type
, Injuries, Orthopedics	2019	English	, Epidemiological study


Ankle Sprains in the National Basketball Association, 2013-2014 Through 2016-2017
Authors: Herzog MM, Mack CD, Dreyer NA, Wikstrom EA, Padua DA, Kocher MS, DiFiori JP, Marshall SW.
Affiliations: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill; University of North Carolina Injury Prevention Research Center; Injury Surveillance and Analytics, Real-World Analytics Solutins, IQVIA
Publications: Am J Sports Med. 2019 Sep;47(11):2651-2658
Document Types: , Article
Countries: , USA
Abstract: ncbi.nlm.nih.gov/pubmed/31389712
Condition	Year	Language	Analysis type
, Injuries, Orthopedics	2019	English	, Epidemiological study


The Establishment and Refinement of the National Basketball Association Player Injury and Illness Database
Authors: Mack CD, Meisel P, Herzog MM, Callahan L, Oakkar EE, Walden T, Sharpe J, Dreyer NA, DiFiori J
Affiliations: IQVIA Real-World & Analytics Solutions, Research Triangle Park, Durham, NC. University of North Carolina at Chapel Hill. National Basketball Association, New York, NY. Hospital for Special Surgery, New York, NY. National Basketball Athletic Trainers Association, Charlotte, NC.
Publications: ncbi.nlm.nih.gov/pubmed/31074633
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31074633
Condition	Year	Language	Analysis type
, Database Validity and methodology, Injuries, Orthopedics	2019	English	, Epidemiological study, Observational study, Retrospective database analysis


Assessing the Outcomes for Orphan Status or Accelerated Assessment EMA Approved Medicines: A Comparison of Health Technology Assessment in Denmark, Finland, Norway and Sweden
Authors: Falla, Edel; Pitcher, Ashley; Acs, Annabel; Heller, Vincent; Zhang, Rongrong
Affiliations: IQVIA, Real-World Insights, London, LON, UK IQVIA, Real-World Insights, Copenhagen, Denmark IQVIA, Real-World Insights, Copenhagen, Denmark IQVIA, Real-World Insights, Solna, AB, Sweden IQVIA, Real-World Insights, Stockholm, Sweden
Publications: ISPOR Europe 2019, November 5, 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Denmark, Finland, Nordic, Norway, Sweden
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)34089-6/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301519340896%3Fshowall%3Dtrue#%20
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment	2019	English	, Review


Projected long-term clinical benefit and cost-effectiveness of empagliflozin compared to glimepiride in patients with type 2 diabetes in China
Authors: Lamotte M1, Salem A2, Mettam S2, Ustyugova A2, Zhang YJ3, Ramos M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 Boehringer Ingelheim International, GmbH, Germany 3 Boehringer Ingelheim, Beijing, China
Publications: ADA, San Francisco, US, 07-11 June 2019
Document Types: , Poster
Countries: , China
Abstract: https://doi.org/10.2337/db19-1292-P
Condition	Year	Language	Analysis type
, Diabetes	2019	English	, Cost effectiveness, Population Based Study


Contrasting Framingham Risk Equations in Type 2 Diabetes Using the IQVIA Core Diabetes Model
Authors: Monteiro S1, Ramos M2, Altrabsheh E1, Gurjar K3, Olivieri A4, Lamotte M2
Affiliations: 1 IQVIA, London, UK 2 IQVIA, Zaventem, Belgium 3 IQVIA, Gurgaon, India 4 IQVIA, Basel, Switzerland
Publications: ISPOR, New Orleans, 18-22 May 2019
Document Types: , Poster
Countries: , UK
Abstract: https://doi.org/10.1016/j.jval.2019.04.585
Condition	Year	Language	Analysis type
, Diabetes	2019	English	, Cost effectiveness, Population Based Study


Contrasting three type 2 diabetes cardiovascular risk equations for East Asia with UKPDS82 using the IQIVA core diabetes model
Authors: Olivieri A1, Ramos M2, Monteiro S3, Altrabsheh E3, Gurjar K4, Lamotte M2
Affiliations: 1 IQVIA, Basel, Switzerland 2 IQVIA, Zaventem, Belgium 3 IQVIA, London, UK 4 IQVIA, Gurgaon, India
Publications: ISPOR, New Orleans, 18-22 May 2019
Document Types: , Poster
Countries: , China
Condition	Year	Language	Analysis type
, Diabetes	2019	English	, Cost effectiveness, Population Based Study


Body mass index associated utility approaches in the IQVIA core diabetes model
Authors: Ramos M1, Olivieri A2, Monteiro S3, Altrabsheh E3, Gurjar K4, Lamotte M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 IQVIA, Basel, Switzerland 3 IQVIA, London, UK 4 IQVIA, Gurgaon, India
Publications: ISPOR, New Orleans, 18-22 May 2019
Document Types: , Poster
Countries: , UK
Abstract: https://doi.org/10.1016/j.jval.2019.04.573
Condition	Year	Language	Analysis type
, Diabetes	2019	English	, Cost effectiveness, Population Based Study


Comparability of results using two alternative versions of the IQVIA CORE Diabetes Model
Authors: Gurjar K1, Ramos M2, Monteiro S3, Altrabsheh E3, Olivieri A4, Lamotte M2
Affiliations: 1 IQVIA, Gurgaon, India 2 IQVIA, Zaventem, Belgium 3 IQVIA, London, UK 4 IQVIA, Basel, Switzerland
Publications: ISPOR, New Orleans, 18-22 May 2019
Document Types: , Poster
Countries: , UK
Abstract: https://doi.org/10.1016/j.jval.2019.04.580
Condition	Year	Language	Analysis type
, Diabetes	2019	English	, Cost effectiveness, Population Based Study


Association Between Cardiovascular Disease Risk Factors and Hypoglycaemic events in Type 2 Diabetes Using the IQVIA Core Diabetes Model
Authors: Altrabsheh E1, Monteiro S1, Ramos M2, Gurjar K3, Olivieri A4, Lamotte M2
Affiliations: 1 IQVIA, London, UK 2 IQVIA, Zaventem, Belgium 3 IQVIA, Gurgaon, India 4 IQVIA, Basel, Switzerland
Publications: ISPOR, New Orleans, 18-22 May 2019
Document Types: , Poster
Countries: , UK
Abstract: https://doi.org/10.1016/j.jval.2019.04.613
Condition	Year	Language	Analysis type
, Diabetes	2019	English	, Cost effectiveness, Population Based Study


Real-world treatment patterns of patients diagnosed with complicated urinary tract infections, complicated intra-abdominal infections, and hospital acquired and ventilator-associated bacterial pneumonia attributable to carbapenem-resistant Gram-negative bacilli in Spain
Authors: Ferrer R1, FariÃ±as MC2, Bou Arevalo G3, Maseda E4, Salavert M5, GÃ³mez Ulloa D6, Fenoll R6, SÃ¡nchez E6, Doshi I7, Diaz-RegaÃ±on J8, Mccann E7
Affiliations: 1 Hospital Universitari Vall dâ€™Hebron, Barcelona, Spain 2 Hospital MarquÃ©s de Valdecilla, Santander, Spain 3 Hospital Universitario A CoruÃ±a, La CoruÃ±a, Spain 4 Hospital Universitario La Paz, Madrid, Spain 5 Hospital Universitario y PolitÃ©cnico La Fe, Valencia, Spain 6 IQVIA, Barcelona, Spain 7 Merck & Co., Inc., Kenilworth, NJ, US 8 Merck Sharp & Dohme Corp., Madrid, Spain
Publications: ECCMID, Amsterdam, Netherlands, 13-16 April 2019
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Infectious disease	2019	English	, Observational study, Retrospective database analysis


An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in a Prefilled Pen in Germany
Authors: Chen J1, Perez-Nieves M1, Piras De Oliveira C1, Spaepen E2, Osumili B3, Ling Poon J1, Schloot N2, Lara N4, Garcia Alvarez L4, Roset M4, Lennartz D5
Affiliations: 1 Lilly and Company, Indianapolis, US 2 Eli Lilly and Company Deutschland GmbH, Bad Homburg, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Barcelona, Spain 5 IQVIA, Munich, Germany
Publications: ECE, Lyon, France, 18-21 May 2019
Document Types: , Poster
Countries: , Germany
Abstract: htpps://doi.org/10.1530/endoabs.63.P207
Condition	Year	Language	Analysis type
, Endocrinology	2019	English	, Survey research


Health economic effects of the updated foot ulcer submodel
Authors: Monteiro S1, Ramos M2, Lamotte M2
Affiliations: 1 IQVIA, London, UK 2 IQVIA, Zaventem, Belgium
Publications: ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: , UK
Abstract: https://doi.org/10.1016/j.jval.2019.09.899
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2019	English	, Cost effectiveness


The clinical and economic impact of adding an adherence module to the IQVIAcore diabetes model
Authors: Ramos M1, Monteiro S2, Altrabsheh E2, Lamotte M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 IQVIA, London, UK
Publications: ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: , Germany
Abstract: https://doi.org/10.1016/j.jval.2019.09.943
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2019	English	, Cost effectiveness, Survey research


Biological Treatment Patterns with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up
Authors: CaÃ±ete JD1, Naranjo A2, Calvo J3, OrdÃ¡s C4, AragÃ³n B5, Nocea G5, Roset M6, FernÃ¡ndez-Nebro A7
Affiliations: 1 Servicio de ReumatologÃa, Hospital ClÃnic e IDIBAPS, Barcelona, Spain 2 Departamento de ReumatologÃa, Hospital Dr. NegrÃn, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain 3 Departamento de ReumatologÃa, Hospital General Universitario de Valencia, Valencia, Spain 4 Departamento de ReumatologÃa, Hospital de CabueÃ±es, GijÃ³n, Spain 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, Spain 6 IQVIA, Barcelona, Spain 7 Departamento de ReumatologÃa, Instituto de InvestigaciÃ³n BiomÃ©dica (IBIMA), Hospital Regional Universitario de MÃ¡laga, Universidad de MÃ¡laga, MÃ¡laga, Spain
Publications: Reumatol Clin. 2019 Jan 28. pii: S1699-258X(18)30259-6
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30704919
Condition	Year	Language	Analysis type
, Rheumatology	2019	Spanish	, Population Based Study, Survey research


The cost effectiveness of Enoxaparin in the previon of venous thromboembolism in patients undergoing major surgery in Egypt
Authors: Farag A1, Abdel Moety H1, Hassan L2, Pathak P3, Lamotte M4, Levorsen A5
Affiliations: 1 Cairo University, Cairo, Egypt 2 Alexandria University, Alexandria, Egypt 3 IQVIA, Dubai, United Arab Emirates 4 IQVIA, Zaventem, Belgium 5 Sanofi, Global, France
Publications: ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: , Egypt
Abstract: https://doi.org/10.1016/j.jval.2019.09.2604
Condition	Year	Language	Analysis type
, Health economics, Orthopedics	2019	English	, Cost effectiveness


Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients
Authors: Goodall G1, Lamotte M2, Ramos M2, Maunoury F3, Pejchalova B1, de Pouvourville G4
Affiliations: 1 Edwards Lifesciences S.A., Nyon, Switzerland 2 IQVIA, Zaventem, Belgium 3 Statesia, Le Mans, France 4 ESSEC Business School, Cergy Pontoise, France
Publications: J Med Econ. 2019 Apr;22(4):289-296. doi: 10.1080/13696998.2018
Document Types: , Article
Countries: , France
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30547704
Condition	Year	Language	Analysis type
, Cardiovascular disease, Health economics	2019	English	, Cost effectiveness


Health economic value of blood in Ivory coast: The case of maternal bleeding
Authors: Sekongo YM1, Asamoah-Akuoko L2, Owusu-Ofori SPO3, Lamotte M4, Bah A5, Dierick K5
Affiliations: 1 DEA Biologie Humaine et Tropicale UnitÃ© de ThÃ©rapeutique Transfusionnelle Centre National de Tranfusion Sanguine DU de Biologie Transfusionnelle DU Gestion des infections et soins complementaires en Onco-HÃ©matologie DU BIOSAS DU Reparation juridique du Do, Abidjan,Yvory Coast 2 National Blood Service, Accra, Ghana 3 Komfo Anokye Teaching Hospital, Kumasi, Ghana 4 IQVIA, Zaventem, Belgium 5 Terumo BCT, Zaventem, Belgium
Publications: ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: , Ivory Coast
Abstract: https://doi.org/10.1016/j.jval.2019.09.1429
Condition	Year	Language	Analysis type
, Health economics, Hematology	2019	English	, Cost analysis, Literature Review


Health economic vale of blood in Ghana: The case of maternal bleeding
Authors: Owusu-Ofori SPO1, Asamoah-Akuoko L2, Lamotte M3, Bah A4, Dierick K4
Affiliations: 1 Komfo Anokye Teaching Hospital, Kumasi, Ghana 2 National Blood Service, Accra, Ghana 3 IQVIA, Zaventem, Belgium 4 Terumo BCT, Zaventem, Belgium
Publications: ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries:
Abstract: https://doi.org/10.1016/j.jval.2019.09.1964
Condition	Year	Language	Analysis type
, Health economics, Hematology	2019	English	, Cost analysis, Survey research


Cross-sectional study estimating the psychosocial impact of genital warts and other anogenital diseases in South Korea
Authors: Lee TS1, Kothari-Talwar S2, Singhal PK2, Yee K3, Kulkarni A2, Lara N4, Roset M4, Giuliano AR5, Garland SM6, Ju W7
Affiliations: 1 Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center, Seoul, South Korea 2 Merck and Co Inc, Kenilworth, NJ, US 3 Cubist Pharmaceuticals Inc, Lexington, MA, US 4 IQVIA, Barcelona, Spain 5 Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, US 6 Microbiology and Infectious Diseases Department, The Royal Women's Hospital, Parkville, Victoria, Australia 7 School of Medicine, Ewha Womans University, Seoul, South Korea
Publications: BMJ Open. 2019 Mar 20;9(3):e025035
Document Types: , Article
Countries: , South Korea
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30898815
Condition	Year	Language	Analysis type
, Infectious disease	2019	English	, Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care


Health economic value of blood in Sub-Saharan: The case of maternal bleeding
Authors: Owusu-Ofori SPO1, Sekongo YM2, Rajab JA3, Asamoah-Akuoko L4, Magutu V5, Lamotte M6, Bah A7, Dierick K7
Affiliations: 1 Komfo Anokye Teaching Hospital, Kumasi, Ghana 2 DEA Biologie Humaine et Tropicale UnitÃ© de ThÃ©rapeutique Transfusionnelle Centre National de Tranfusion Sanguine DU de Biologie Transfusionnelle DU Gestion des infections et soins complementaires en Onco-HÃ©matologie DU BIOSAS DU Reparation juridique du Do, Abidjan, Yvory Coast 3 Haematology & Blood Transfusion Unit, Department of Human Pathology, School of Medicine, College of Health Sciences, University of Nairobi, Kenya 4 National Blood Service, Accra, Ghana 5 Department of Pathology Agar Khan Hospital, Nairobi, 110, Kenya 6 IQVIA, Zaventem, Belgium 7 Terumo BCT, Zaventem, Belgium
Publications: ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries:
Abstract: https://doi.org/10.1016/j.jval.2019.09.2059
Condition	Year	Language	Analysis type
, Health economics, Hematology	2019	English	, Cost analysis, Survey research


Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe
Authors: Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Amarenco P4, Annemans L5
Affiliations: 1 Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK 2 IQVIA, Zaventem, Belgium 3 Amgen (Europe) GmbH, Rotkreuz, Switzerland 4 Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France 5 University of Ghent, Belgium
Publications: Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157.
Document Types: , Article
Countries: , Belgium, France, Poland, Portugal, Spain, Switzerland, UK
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30955367
Condition	Year	Language	Analysis type
, Cardiovascular disease, Health economics	2019	English	, Burden of illness, Clinical setting: Primary care, direct to patient research, Observational study


The value of blood in sub-Saharan Africa
Authors: Magutu V1, Rajab A2, Asamoah-Akuoko L3, Lamotte M4, Bah A5, Dierick K5
Affiliations: 1 Department of Pathology Agar Khan Hospital, Nairobi, 110, Kenya 2 Haematology & Blood Transfusion Unit, Department of Human Pathology, School of Medicine, College of Health Sciences, University of Nairobi, Nairobi, Kenya 3 National Blood Service, Accra, Ghana 4 IQVIA, Zaventem, Belgium 5 Terumo BCT, Zaventem, Belgium
Publications: ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries:
Abstract: https://doi.org/10.1016/j.jval.2019.09.2084
Condition	Year	Language	Analysis type
, Health economics, Hematology	2019	English	, Cost analysis, Survey research


Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis
Authors: Lau E1, Salem A2, Chan JCN1, So WY1, Kong A1, Lamotte M2, Luk A1
Affiliations: 1 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, SAR China 2 IQVIA, Zaventem, Belgium
Publications: Cost Eff Resour Alloc. 2019 Jul 2;17:13.
Document Types: , Article
Countries: , Hong Kong
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31303866
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2019	English	, Cost effectiveness


Patient characteristics and treatment patterns in multiple myeloma by treatment administration route and disease status: EASEMENT observational study
Authors: Rabin N1, Kotb R2, Zomas A3, Gonzalez F3, Fernandez-Nistal A3, Dâ€™Ambrosio R3, Bent-Ennakhil N3, Roset M4, Annibali O5
Affiliations: 1 University College Hospital, London, UK 2 Cancer Care Manitoba, Canada 3 Takeda Pharmaceuticals International AG, Switzerland 4 IQVIA, Barcelona, Spain 5 UniversitÃ Campus Bio-Medico di Roma, Italy
Publications: IMW, Boston, US, 12-15 September 2019
Document Types: , Poster
Countries: , Canada, Italy, UK
Abstract: https://doi.org/10.1016/j.clml.2019.09.456
Condition	Year	Language	Analysis type
, Clinical practice, Hematology	2019	English	, Epidemiological study, Observational study


Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY
Authors: Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9
Affiliations: 1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 HÃ´pital EuropÃ©en Georges-Pompidou UniversitÃ© Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US
Publications: EUROGIN, Monaco, France, 4-7 December 2019
Document Types: , Oral presentation
Countries: , China, France, Germany, Italy, Japan, Spain, UK, USA
Abstract: http://merck.creative.studios.s3-website-us-east-1.amazonaws.com/EUROGIN_2019/2019_EUROGIN_Pedros_NaturalHistory.pdf
Condition	Year	Language	Analysis type
, Clinical practice, Infectious disease, Methodology	2019	English	, Epidemiological study, Observational study, Population Based Study


The clinical and cost impact of switching to fingolimod versus other first line injectable disease-modifying therapies in patients with relapsing multiple sclerosis
Authors: Freedman MS1, Duquette P2, Grand'Maison F3, Lee L4, Vorobeychik G5, Lara N6, Khurana V7, Nakhaipour HR8, Schecter R8, Haddad P8
Affiliations: 1 University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada 2 Notre Dame Hospital, UniversitÃ© de MontrÃ©al, Montreal, Quebec , Canada 3 Neuro-Rive Sud Clinic , Greenfield Park , Quebec , Canada 4 Sunnybrook Health Sciences Centre , University of Toronto , Toronto , Ontario , Canada 5 Fraser Health Multiple Sclerosis Clinic Burnaby Hospital , Burnaby , British Columbia , Canada 6 IQVIA , Barcelona , Spain 7 Novartis Healthcare Private Limited , Hyderabad , India 8 Novartis Pharmaceuticals Canada Inc., Dorval, Quebec, Canada
Publications: Curr Med Res Opin. 2019 May;35(5):767-776
Document Types: , Article
Countries: , Canada
Abstract: doi: 10.1080/03007995.2019.1565818. Epub 2019 Jan 21.
Condition	Year	Language	Analysis type
, Neurological disorders	2019	English	, Burden of illness, Retrospective Field Study


The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood
Authors: Kent S1, Becker F1, Feenstra T2,3, Tran-Duy A4, Schlackow I1, Tew M4, Zhang P5, Ye W6, Lizheng S7, Herman W6, McEwan P8, Schramm W9, Gray A1, Leal J1, Lamotte M10, Willis M11, Palmer AJ4,12, Clarke P13,14
Affiliations: 1 Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK 2 National Institute for Public Health and the Environment (RIVM), Centre for Nutrition, Prevention and Health Services Research, Bilthoven, The Netherlands 3 University of Groningen, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, Groningen, The Netherlands 4 Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia 5 Division of Diabetes Translation, Centres for Disease Control and Prevention, Atlanta, US 6 School of Public Health, University of Michigan, Ann Arbor, US 7 Department of Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, New Orleans, US 8 Centre for Health Economics, Swansea University, Swansea, UK 9 GECKO Institute, Heilbronn University, Heilbronn, Germany 10 IQVIA, Zaventem, Belgium 11 The Swedish Institute for Health Economics, Lund, Sweden 12 Menzies Institute for Medical Research, The University of Tasmania, Hobart, Australia 13 Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK 14 Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
Publications: Pharmacoeconomics. 2019 Nov;37(11):1305-1312.
Document Types: , Article
Countries:
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31347104
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2019	English	, Retrospective database analysis


Real-world treatment patterns and clinical outcomes in patients receiving second-line (2L) treatment for advanced or metastatic gastric cancer (GC)
Authors: Amonkar M1, Gomez-Ulloa D2, Smita Kothari1, Cheung WY3, Chau I4, Zalcberg JR5, Lara N2, Falcone A6
Affiliations: 1 Merck & Co., Inc., Kenilworth, NJ, USA 2 IQVIA, Barcelona, Spain 3 British Columbia Cancer Agency, Vancouver, BC, Canada 4 Royal Marsden Hospital, London, UK 5 Alfred Health, Melbourne, Australia 6 University of Pisa, Pisa, Italy
Publications: BMC Gastroenterology volume 20, Article number: 133 (2020)
Document Types: , Poster
Countries: , Australia, Canada, Italy, UK
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Retrospective cohort analysis


Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach
Authors: Foos V1, Wang K2, McEwan P3, Zhang Y2, Xin P2, Jiang X2, Qu S4, Xiong T4, De Moor R1, Ramos M1, Lamotte M1, Ji L5
Affiliations: 1 IQVIA, Zaventem, Belgium 2 Lilly Suzhou Pharmaceutical Co, Ltd, Shanghai, China 3 Centre for Health Economics, Swansea University, Wales, England, UK 4 RWE Solutions & HEOR, QuintilesIMS, Shanghai, China 5 Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China
Publications: Value Health Reg Issues. 2019 May;18:36-46.
Document Types: , Article
Countries: , China
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30419449
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2019	English	, Cost effectiveness


The cost-effectiveness of physical activity in the management of COPD patients in the UK
Authors: Ramos M1, Lamotte M1, Gerlier L1, Svangren P2, Miquel-Cases A3, Haughney J4
Affiliations: 1 IQVIA, Zaventem, Belgium 2 Core Respiratory, Global Product and Portfolio Strategy - Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, MÃ¶lndal, Sweden 3 Global Price and Reimbursement, Global Payer Evidence and Pricing, AstraZeneca Gothenburg R&D, Cambridge, UK 4 Academic Primary Care Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
Publications: Int J Chron Obstruct Pulmon Dis. 2019 Jan 15;14:227-239
Document Types: , Article
Countries: , Scotland
Abstract: doi: 10.2147/COPD.S181194. eCollection 2019
Condition	Year	Language	Analysis type
, Health economics, Respiratory disease	2019	English	, Cost effectiveness


Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease
Authors: Ramos M1, Foos V1, Ustyugova A2, Hau N3, Gandhi P4, Lamotte M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 Boehringer Ingelheim International GmbH, Ingelheim, Germany 3 Boehringer Ingelheim Ltd, Bracknell, UK 4 Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, US
Publications: Diabetes Ther. 2019 Dec;10(6):2153-2167
Document Types: , Article
Countries: , UK
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31602601
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2019	English	, Cost effectiveness


Estimating the burden of illness related to genital warts in the Philippines: a nationally representative cross-sectional study
Authors: Buenconsejo L1, Kothari-Talwar S2, Yee K3, Kulkarni A2, Lara N4, Roset M4, Giuliano AR5, Garland S6
Affiliations: 1 Makati Medical Center, Makati, Philippines 2 Merck & Co. Inc., Kenilworth, NJ, US 3 Cubist Pharmaceuticals, Lexington, MA, US 4 IQVIA, Barcelona, Spain 5 Center for Infection Research in Cancer (CIRC) at Moffitt Cancer Center, Tampa, FL US 6 Royal Women's Hospital, Melbourne, Australia
Publications: Infect Agent Cancer. 2019 Oct 7;14:26.
Document Types: , Article
Countries: , Philippines
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31624494
Condition	Year	Language	Analysis type
, Infectious disease	2019	English	, Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care, Observational study


Advancing glycemic management in people with diabetes
Authors: Aitken M1, Villa P1, Lamotte M1, Tewary V1, Ramos M1
Affiliations: 1 IQVIA, Zaventem, Belgium
Publications: with paper on the IQVIA institute web page
Document Types: , Article
Countries:
Abstract: https://www.iqvia.com/insights/the-iqvia-institute/reports/advancing-glycemic-management-in-people-with-diabetes
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2019	English	, Cost effectiveness


MULTI-NATIONAL NORDIC PHARMACOEPIDEMIOLOGIC STUDIES: OPPORTUNITIES AND CHALLENGES
Authors: SvanstrÃ¶m, Henrik [ 1 ]; Trojcakova, Iveta [ 1 ]; Pitcher, Ashley [ 1 ]
Affiliations: IQVIA, Copenhagen, Denmark
Publications:
Document Types: , Abstract
Countries: , Nordic
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1098301519343153?via%3Dihub
Condition	Year	Language	Analysis type
, Public Health	2019	English	, Database Study, Epidemiological study, Longitudinal study, Observational study, Survey research


Clinical characteristics, treatment patterns, and thromboembolic risk of patients with cold agglutinin disease (CAD) in Japan
Authors: Toyomi Kamesaki 1, Jun-ichi Nishimura 2, Hideho Wada 3, Eric Yu 4, Elisa Tsao 5, Jaime Morales 5, Yuzuru Kanakura 2 (rwesheorj 4)
Affiliations: 1) Jichi Medical University 2) Osaka University, Osaka, Japan 3) Kawasaki Medical School, Kurashiki, Japan 4) IQVIA, Tokyo, Japan 5) Sanofi, Waltham, MA, USA
Publications: European Hematology Association 2019 Conference
Document Types: , Abstract, Poster
Countries: , Japan
Abstract: https://library.ehaweb.org/eha/2019/24th/266231/jun-ichi.nishimura.clinical.characteristics.treatment.patterns.and.html
Condition	Year	Language	Analysis type
, Hematology	2019	English	, Epidemiological study, Retrospective database analysis


Verihiutaleidenâ€…estÃ¤jÃ¤hoitoâ€…toteutuuâ€…vajavaisestiâ€…sepelvaltimotautikohtauksenâ€…jÃ¤lkeen
Authors: Eeva Reissell, Ville KytÃ¶, Juha Halme, Tuire Prami, Sonja Lumme, Juhani Airaksinen
Affiliations: Eeva Reissell: National Institute for Health and Welfare
Publications: LÃ¤Ã¤kÃ¤rilehti.2019; 43: 2449-54.
Document Types: , Article
Countries: , Finland
Abstract: https://www.laakarilehti.fi/tieteessa/alkuperaistutkimukset/verihiutaleiden-estajahoito-toteutuu-vajavaisesti-sepelvaltimotautikohtauksen-jalkeen/
Condition	Year	Language	Analysis type
, Cardiovascular disease	2019	Finnish	, Population Based Study, Retrospective database analysis


Usage of PCI and long-term cardiovascular risk in post-myocardial infarction patients: a nationwide registry cohort study from Finland
Authors: Ville KytÃ¶, Tuire Prami, Houssem Khanfir, PÃ¥l Hasvold, Eeva Reissell, Juhani Airaksinen
Affiliations: Ville KytÃ¶: Turku University Hospital and University of Turku
Publications: BMC Cardiovascular Disorders (2019) 19:123
Document Types: , Article
Countries: , Finland
Abstract: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-019-1101-8
Condition	Year	Language	Analysis type
, Cardiovascular disease	2019	English	, Population Based Study, Retrospective database analysis


MULTI-NATIONAL NORDIC PHARMACOEPIDEMIOLOGIC STUDIES: OPPORTUNITIES AND CHALLENGES
Authors: H.SvanstrÃ¶mI.TrojÄÃ¡kovÃ¡A.Pitcher
Affiliations: IQVIA, Copenhagen, Denmark
Publications: Journal: VALUE IN HEALTH Volume: 22 Pages: S768-S768 Supplement: 3
Document Types: , Abstract
Countries: , Nordic
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1098301519343153?via%3Dihub
Condition	Year	Language	Analysis type
, Public Health	2019	English	, Population Based Study


Cost-offsets in relapsed/refractory multiple myeloma and resource consumption derived from Italian real practice
Authors: Ripellino C, Pegoraro V, Heiman F
Affiliations: Ripellino C: HEOR Consultant Freelance, Milan, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy
Publications: CLINICO ECONOMICS ITALIAN ARTICLES ON OUTCOMES RESEARCH / VOL 14 / YEAR 2019 / PAG. 55-64
Document Types: , Article
Countries: , Italy
Abstract: http://www.clinicoeconomics.eu/articles/flipbook/14_2019_55-64/
Condition	Year	Language	Analysis type
, Health economics, Oncology	2019	Italian	, Cost analysis


Impact of Stable Angina on health status and quality of life perception of currently treated patients. The BRIDGE 2 survey
Authors: Manolis AJ, Ambrosio G, Collins P, Dechend F, Lopez-Sendon J, Pegoraro V, Camm AJ
Affiliations: Manolis AJ: Department of Cardiology, Asklepeion General Hospital, Athens, Greece. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy.
Publications: Eur J Intern Med. 2019 Dec;70:60-67. doi: 10.1016/j.ejim.2019.09.013
Document Types: , Article
Countries: , Germany, Italy, Spain, UK
Abstract: https://www.sciencedirect.com/science/article/pii/S0953620519303267?via%3Dihub
Condition	Year	Language	Analysis type
, Cardiovascular disease	2019	English	, Quality of life, Survey research


Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use
Authors: Jouaville LS, Ehrhardt C, KÃ¼rzinger ML, de Voogd H, Toussi M
Affiliations: IQVIA
Publications: Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372
Document Types: , Article
Countries: , France, Greece, Italy, Portugal
Abstract: https://www.omicsonline.org/open-access/evaluation-of-the-effectiveness-of-risk-minimisation-measures-targeting-physicians-on-prescribing-practices-of-thiocolchicoside-co-2161-1165-1000372-108159.html
Condition	Year	Language	Analysis type
, Musculoskeletal disease, Rheumatology, Risk Management & REMS	2019	English	, Survey research


Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis
Authors: DamiÃ¡n GarcÃa-Olmo 1, Gert Van Assche 2, Ignacio Tagarro 3, Mary Carmen Diez 4, Marie Paule Richard 4, Javaria Mona Khalid 5, Marc van Dijk 5, Dimitri Bennett 6 7, Suvi R K Hokkanen 8, JuliÃ¡n PanÃ©s 9
Affiliations: 1Hospital Universitario FundaciÃ³n JimÃ©nez DÃaz, Av de los Reyes CatÃ³licos, 2, 28040, Madrid, Spain. damian.garcia@uam.es. 2Department of Gastroenterology and Hepatology, University Hospitals Leuven and Katholic University Leuven, Leuven, Belgium. 3Takeda Spain, Madrid, Spain. 4TiGenix (Takeda Group), Madrid, Spain. 5Takeda Development Centre Europe, London, UK. 6Department of Pharmacoepidemiology, Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. 7Center for Clinical Epidemiology and Biostatistics, Adjunct, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 8IQVIA, London, UK. 9Hospital Clinic, IDIBAPS, CIBERehd, Barcelona, Spain.
Publications: Adv Ther . 2019 Dec;36(12):3503-3518. doi: 10.1007/s12325-019-01117-y. Epub 2019 Oct 26.
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/31656013/
Condition	Year	Language	Analysis type
, Database Validity and methodology	2019	English	, Epidemiological study, Retrospective database analysis


Prevalence of anal fistula in the United Kingdom
Authors: Suvi Rk Hokkanen 1, Naomi Boxall 1, Javaria Mona Khalid 2, Dimitri Bennett 3, Haridarshan Patel 4
Affiliations: 1Real World Evidence Solutions, IQVIA, London N19JY, United Kingdom. 2Evidence and Value Generation, Global Medical Affairs, Takeda Pharmaceuticals International Inc., London WC2B 4AE, United Kingdom. 3Department of Epidemiology, Takeda Pharmaceuticals International Inc., Cambridge, MA 02139, United States; Adjunct, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States. 4Evidence and Value Generation, Global Medical Affairs, Takeda Pharmaceuticals International Inc., Deerfield, IL 6001, United States. hari.patel@takeda.com.
Publications: World J Clin Cases . 2019 Jul 26;7(14):1795-1804. doi: 10.12998/wjcc.v7.i14.1795.
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/31417925/
Condition	Year	Language	Analysis type
, Database Validity and methodology	2019	English	, Database Study, Retrospective database analysis


Seizure frequency, healthcare resource utilisation and mortality in childhood epilepsy: a retrospective cohort study using the THIN database
Authors: Melissa Myland 1, Brian Buysse 1, Wan Tsong 2, G Sarah Power 1, Douglas Nordli 3, Richard F M Chin 4 5
Affiliations: 1IQVIA, London, UK. 2Eisai Inc, Woodcliff Lake, UK. 3Children's Hospital of Los Angeles, Los Angeles, USA. 4Muir Maxwell Epilepsy Centre, Edinburgh, UK. 5Paediatric Neurosciences, Royal Hospital for Sick Children, Edinburgh, UK.
Publications: Arch Dis Child . 2019 Nov;104(11):1070-1076. doi: 10.1136/archdischild-2019-316910. Epub 2019 Jul 4.
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/31272968/
Condition	Year	Language	Analysis type
, Database Validity and methodology	2019	English	, Database Study, Retrospective database analysis


Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real-world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN)
Authors: Edward B Jude 1, Caroline O'Leary 2, Melissa Myland 2, Mark Nixon 2, Nick Gooch 3, Alka Shaunik 4, Elisheva Lew 5
Affiliations: 1Diabetes Centre Tameside General Hospital Ashton-under-Lyne UK. 2IQVIA London UK. 3Sanofi Guildford UK. 4Sanofi Bridgewater NJ USA. 5Sanofi Chilly-Mazarin France.
Publications: Endocrinol Diabetes Metab . 2019 Sep 29;3(1):e00094. doi: 10.1002/edm2.94. eCollection 2020 Jan.
Document Types: , Article
Countries: , UK
Abstract: https://www.imsrwebibliography.com/Admin/addbibliography.php
Condition	Year	Language	Analysis type
, Database Validity and methodology	2019	English	, Database Study, Retrospective database analysis


PIN151 PATIENTS TREATED FOR HEPATITIS C: AN OBSERVATIONAL STUDY WITH THE FRENCH ADMINISTRATIVE HEALTH CARE DATABASE (SNDS)
Authors: Pol S,1 Rodriguez I,2 Fouad F,3 Lemaitre M,3 Ansolabehere X,4 Lada O,2 Roudot-Thoraval F
Affiliations: 1 Hopital Cochin - APHP, Paris, France, 2 Gilead Sciences, Paris, France, 3 IQVIA, COURBEVOIE, France, 4 QuintilesIMS, Paris La DÃ©fense, France, 5 Henri Mondor hospital, CrÃ©teil, France
Publications: DOI:https://doi.org/10.1016/j.jval.2019.09.1391
Document Types: , Abstract
Countries: , France
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)33769-6/fulltext
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Infectious disease	2019	English	, Observational study, Population Based Study, Predictive analytics


Ã‰volution de la prise en charge de lâ€™hÃ©patite C en France : Ã©tude observationnelle rÃ©alisÃ©e Ã partir des donnÃ©es du SystÃ¨me national des donnÃ©es de santÃ©
Authors: F. Fayssoil , M. Lemaitre , X. Ansolabehere , I. Rodriguez
Affiliations: a IQVIA, Courbevoie, France b Gilead Sciences, Boulogne Billancourt, France
Publications: Doi : 10.1016/j.respe.2019.04.025
Document Types: , Abstract
Countries: , France
Abstract: https://www.em-consulte.com/article/1292586/article/evolution-de-la-prise-en-charge-de-l-hepatite-c-en
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Infectious disease	2019	French	, Methodology, Observational study, Population Based Study


Ã‰tude FRANTALGIC â€“ Intensification du traitement par opioÃ¯de chez les utilisateurs douloureux chroniques : analyse des donnÃ©es de remboursement de l'assurance maladie.
Authors: C. Collin a, N. Coulombel a, A. Trouvin b, I. Bardoulat a, M. Lemaitre a, C. Le-Pen c, M. Maravic d
Affiliations: a IQVIA France, Innovation et croissance, Courbevoie, France b Centre dâ€™Ã©valuation et traitement de la douleur, hÃ´pital Ambroise ParÃ©, Boulogne Billancourt, UnitÃ© Inserm U987, Boulogne Billancourt, France c UniversitÃ© Paris Dauphine, LEDa/LEGOS, Paris, France d IQVIA France, Real World Insights, Courbevoie, hÃ´pital LariboisiÃ¨re (APâ€“HP), Rhumatologie, Paris, France
Publications: Doi : 10.1016/j.respe.2019.04.026
Document Types: , Article
Countries: , France
Abstract: https://www.em-consulte.com/article/1292588/etude-frantalgic%C2%A0%E2%80%93%C2%A0intensification-du-traitement-p
Condition	Year	Language	Analysis type
, Pain	2019	French	, Observational study, Population Based Study


SWITCH TO STRONG OPIOIDS IN CHRONIC OPIOID USERS: ANALYSIS OF THE FRENCH NATIONAL HEALTH INSURANCE DATABASE. THE FRANTALGIC STUDY
Authors: Anne-Priscille Trouvin, CÃ©dric Collin, Nicolas Coulombel, Nadine Attal, Julien Nizard, Isabelle Bardoulat, Milka Maravic, Claude Le-Pen, Serge Perrot.
Affiliations: 1 HÃ´pital Ambroise ParÃ© APHP, Centre d'Etude et Traitement de la Douleur, Boulogne Billancourt, France, 2 INSERM U 987, Boulogne Billancourt, France 3 IQVIA France, Advanced analytics, Innovation & Growth, La DÃ©fense, France, 4 CHU Nantes, Centre d'Etude et Traitement de la Douleur, Nantes, France, 5 IQVIA France, Real World Insights, La DÃ©fense, France, 6 HÃ´pital LariboisiÃ¨re APHP, Rhumatologie, Paris, France, 7 UniversitÃ© Paris Dauphine, LEDa/LEGOS, Paris, France, 8 HÃ´pital Cochin, APHP, Centre d'Etude et Traitement de la Douleur, Paris, France.
Publications: https://doi.org/10.26226/morressier.5d402f9e8f2158d25ec1247b
Document Types: , Abstract
Countries: , France
Abstract: https://www.morressier.com/o/event/5d3f070f8f2158d25ec123c9/article/5d402f9e8f2158d25ec1247b
Condition	Year	Language	Analysis type
, Pain	2019	English	, Observational study, Population Based Study


Dose increase beyond labelled dose of biologics is associated with incremental pharmacy costs: results from a real-world study in the UK
Authors: Anthony Bewley 1, Cristiana Miglio 2, Haijun Tian 3, Isabelle Gilloteau 4, Joannah Whitehead 5, Ruben Hermans 2
Affiliations: 1a Whipps Cross University Hospital , London , UK. 2b IQVIA , London , UK. 3c Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA. 4d Novartis Pharma AG , Novartis Campus , Basel , Switzerland. 5e Novartis UK Pharmaceuticals Ltd , Frimley, Camberley , UK.
Publications: J Dermatolog Treat . 2019 Jun;30(4):376-382. doi: 10.1080/09546634.2018.1524820. Epub 2018 Nov 19.
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/30256686/
Condition	Year	Language	Analysis type
, Dermatology, Guidelines, Health status & patient reported outcomes, Infectious disease, Infectious disease	2019	English	, Burden of illness, Clinical setting: Primary care, direct-to-patient research, Observational study


PRS72 DRUG TREATMENT PATTERNS FOR PULMONARY ARTERIAL HYPERTENSION PATIENTS IN ENGLAND: A RETROSPECTIVE ANALYSIS USING HOSPITAL TREATMENT INSIGHTS DATABASE
Authors: A. Beaudet A. Yesufu-Udechuku E.W. Davies L.H. Taylor S. Sikander-Rehman R. Ogley F. Exposto
Affiliations: Actelion Pharmaceuticals Ltd., Allschwill, BL, Switzerland Actelion Pharmaceuticals UK Ltd, London, UK Actelion Pharmaceuticals Ltd., Allschwill, BL, Switzerland IQVIA, London, UK
Publications: Open ArchiveDOI:https://doi.org/10.1016/j.jval.2019.09.2561
Document Types: , Poster
Countries: , England
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)34939-3/fulltext
Condition	Year	Language	Analysis type
, Cardiovascular disease, Drug safety, Drug Utlization Study, Health status & patient reported outcomes	2019	English	, Public Health, Real World Data, Retrospective cohort analysis, Retrospective Field Study


Determinants of shingles vaccine acceptance in the United Kingdom
Authors: HÃ©lÃ¨ne Bricout 1, Laurence Torcel-Pagnon 1, Coralie Lecomte 2, Mariana F Almas 3, Ian Matthews 4, Xiaoyan Lu 5, Ana Wheelock 6, Nick Sevdalis 7
Affiliations: Sanofi Pasteur, LYON, France. 2IQVIA, Ouen cedex, France. 3IQVIA, Berkshire, United Kingdom. 4MSD Ltd, Maidenhead, United Kingdom. 5MSD Vaccins, LYON, France. 6Department of Surgery and Cancer, National Institute for Health Research Imperial Patient Safety Translational Research Centre, Imperial College London, London, United Kingdom. 7Centre for Implementation Science, King's College London, London, United Kingdom
Publications: PLoS One. 2019 Aug 1;14(8):e0220230
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/31369608/
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2019	English	, Clinical setting: Primary care, Patient questionnaire, Public Health


Dose increase beyond labelled dose of biologics is associated with incremental pharmacy costs: results from a real-world study in the UK
Authors: Anthony Bewley 1, Cristiana Miglio 2, Haijun Tian 3, Isabelle Gilloteau 4, Joannah Whitehead 5, Ruben Hermans 2
Affiliations: 1a Whipps Cross University Hospital , London , UK. 2b IQVIA , London , UK. 3c Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA. 4d Novartis Pharma AG , Novartis Campus , Basel , Switzerland. 5e Novartis UK Pharmaceuticals Ltd , Frimley, Camberley , UK.
Publications: PMID: 30256686 DOI: 10.1080/09546634.2018.1524820
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/30256686/
Condition	Year	Language	Analysis type
, Drug safety, Drug Utlization Study, Guidelines, Health status & patient reported outcomes	2019	English	, direct-to-patient research, Methodology, Survey research


Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis
Authors: Thirusha Lane 1, Marianna Fontana 1, Ana Martinez-Naharro 1, Candida Cristina Quarta 1, Carol J Whelan 1, Aviva Petrie 1, Dorota M Rowczenio 1, Janet A Gilbertson 1, David F Hutt 1, Tamer Rezk 1, Svetla G Strehina 1, Joan Caringal-Galima 1, Richa Manwani 1, Faye A Sharpley 1, Ashutosh D Wechalekar 1, Helen J Lachmann 1, Shameem Mahmood 1, Sajitha Sachchithanantham 1, Edmund P S Drage 2, Harvey D Jenner 2, Rosie McDonald 2, Ottavia Bertolli 2, Alan Calleja 2, Philip N Hawkins 1, Julian D Gillmore 1
Affiliations: National Amyloidosis Centre, Division of Medicine, University College London, United Kingdom (T.H., M.F., A.M.-N., C.C.Q., C.J.W., D.M.R., J.A.G., D.F.H., T.R., S.G.S., J.C.-G., R. Manwani, F.A.S., A.D.W., H.J.L., S.M., S.S., P.N.H., J.D.G.). 2Eastman Dental Institute, University College London, United Kingdom (A.P.). IQVIA, London, United Kingdom (E.P.S.D., H.D.J., R. McDonald, O.B., A.C.).
Publications:
Document Types: , Article
Countries: , UK
Abstract: https://pubmed.ncbi.nlm.nih.gov/31109193/
Condition	Year	Language	Analysis type
, Cardiovascular disease	2019	English	, Observational study, Patient questionnaire, Quality of life


Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension
Authors: David G. Kiely,1,2,3 Orla Doyle,4 Edmund Drage,4 Harvey Jenner,4 Valentina Salvatelli,4 Flora A. Daniels,4 John Rigg,4 Claude Schmitt,5 Yevgeniy Samyshkin,5 Allan Lawrie,2,3,* and Rito Bergemann6,*
Affiliations: Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK 2Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK 3INSIGNEO, University of Sheffield, Sheffield, UK 4Real-World & Analytical Solutions, IQVIA, London, UK 5GSK, Middlesex, UK 6Evalueserve UK Ltd, London, UK David G. Kiely, Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield S10 2JF, UK. Email: ten.shn@1yleik.divad Allan Lawrie, Infection, Immunity & Cardiovascular Disease, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK
Publications: Pulm Circ. 2019 Oct-Dec; 9(4): 2045894019890549. Published online 2019 Nov 20. doi: 10.1177/2045894019890549
Document Types: , Article
Countries: , England
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868581/
Condition	Year	Language	Analysis type
, Cardiovascular disease	2019	English	, Machine Learning/Artificial Intelligence


A Retrospective Study of Comorbidities and Complications Among Acute Myeloid Leukemia Patients and Non-cancer Controls in the US.
Authors: Near A, Iqbal S, Huang H, Dhopeshwarkar N, Lang K, Wallis N.
Affiliations:
Publications: ASH 59th Annual Meeting and Exposition
Document Types:
Countries: , USA
Condition	Year	Language	Analysis type
	2018	English


Real-world clinical responses in patients with type 2 diabetes mellitus adding exenatide BID (EBID) or mealtime insulin to basal insulin: a retrospective study using electronic medical record data
Authors: Kathleen Lang, Hiep Nguyen, Huan Huang, Elise Bauer, Philip Levin
Affiliations: Huan Huang, IQVIA
Publications: Current Medical Research and Opinion
Document Types: , Article
Countries: , USA
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2018.1437027
Condition	Year	Language	Analysis type
, Diabetes	2018	English	, Population Based Study, Retrospective database analysis


US Multicenter Study of Time, Operational and Economic Efficiences Associated with Using a New Preloaded IOL Delivery System
Authors: Damien Goldberg, Katharine Coyle, Michael Jones, Stephen Lane, Terry Kim. Michael Keith
Affiliations: Damien Goldberg, Wolstan and Goldberg Eye Associates, Katharine Coyle, IQVIA
Publications: Conference
Document Types: , Abstract
Countries: , USA
Abstract: plyvnas02heorCLIENT2017_Alcon Lens ObservationalAbstractAAOAlcon-AAO-pstr-2017.pdf
Condition	Year	Language	Analysis type
, Ophthalmology	2018	English	, Observational study


Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for systemic candida infections in China
Authors: Dechang Chen, Xianyao Wan, Eliza Kruger, Can Chen, Xiaomeng Yue, Liang Wang, Jiuhong Wu
Affiliations: IQVIA, Department of Critical Care Medicine, Shanghai Ruijin Hospital Affiliated To Jiaotong University, School of Medicine, Shanghai
Publications: Journal of Medical Economics
Document Types: , Article
Countries: , China
Abstract: http://www.tandfonline.com/doi/abs/10.1080/13696998.2017.1417312
Condition	Year	Language	Analysis type
, Health economics, Infectious disease	2018	English	, Cost effectiveness


Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease
Authors: Huan Huang, Sharash Shetty, Elise Bauer, Kathleen Lang
Affiliations: Huan Huang, IQVIA
Publications: Current Medical Research and Opinion
Document Types: , Article
Countries: , USA
Abstract: http://www.tandfonline.com/eprint/PqtzuUz9tjZ3mSt7AaIz/full
Condition	Year	Language	Analysis type
, Diabetes	2018	English	, Population Based Study, Retrospective database analysis


Rare disease development programs: An update
Authors: Wu J, Want C, Horton DB, Petersen I, Oliveria S, Blackburn S, Jiang J, LoCasale R.
Affiliations:
Publications: Pharmacoepidemiol Drug Saf 2018; 27 (2):5.
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Rare Diseases	2018	English


Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data.
Authors: Husereau D1, Goodfield J2, Leigh R3, Borrelli R2, Cloutier M2, Gendron A4,5.
Affiliations: 1Department of Epidemiology and Community Medicine, School of Epidemiology and Public Health, University of Ottawa, Room 101, 600 Peter Morand Crescent, Ottawa, ON K1G 5Z3 Canada 2IQVIA, Mississauga, ON Canada 3Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB Canada 4AstraZeneca Canada Inc, Mississauga, ON Canada 5Department of Medicine, University of Montreal, Montreal, QC Canada
Publications: Allergy Asthma Clin Immunol. 2018 Apr 24;14:15.
Document Types: , Article
Countries: , Canada
Condition	Year	Language	Analysis type
	2018	English	, Retrospective database analysis


Identification of a hereditary angioedema cohort in a US ambulatory EMR database
Authors: Brouwer E, Bratton E, Near A, Lang K, Mack C
Affiliations:
Publications: Pharmacoepidemiol Drug Saf 2018; 27 (2): 136-137.
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Rare Diseases	2018	English


Child growth and development outcomes following in-utero exposure to metformin versus insulin for treatment of gestational diabetes.
Authors: Landi SN, Radke S, Engel SM, Sturmer T, Boggess K, Howe A, Jonsson Funk M
Affiliations:
Publications: Pharmacoepidemiol Drug Saf 2018: 27 (2):351-351.
Document Types:
Countries:
Condition	Year	Language	Analysis type
, Pregnancy	2018	English


Child growth and development outcomes following in-utero exposure to metformin versus insulin for treatment of gestational diabetes.
Authors: Landi SN, Radke S, Engel SM, Sturmer T, Boggess K, Howe A, Jonsson Funk M
Affiliations:
Publications: Pharmacoepidemiol Drug Saf 2018: 27 (2):351-351.
Document Types:
Countries:
Condition	Year	Language	Analysis type
, Diabetes	2018	English


EHR-driven evidence for health and wellness research: Lessons from the NBA
Authors: Mack C, Herzog M, Oakkar E, Shiue K, Meisel P, Dreyer N, DiFiori.
Affiliations:
Publications: Pharmacoepidemiol Drug Saf 2018; 27 (2):329-330.
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Injuries	2018	English


Can patients accurately report their drugs? -A comparison of self-reported medication with a national register in Denmark in a subset of the protect pregnancy cohort.
Authors: Bourke A, Laursen M, Dreyer N, Hallgreen CE, Blackburn S
Affiliations:
Publications: Pharmacoepidemiol Drug Saf 2018; 27 (2):87
Document Types: , Poster
Countries: , Nordic
Condition	Year	Language	Analysis type
, Pregnancy, Womens Health	2018	English


Methodologic considerations for non-interventional studies evaluating outcomes of originator-to-biosimilar switching
Authors: Desai R, Kim S, Gagne J, Curtis J, Bosco J, Bradbury B.
Affiliations:
Publications: Pharmacoepidemiol Drug Saf 2018; 27 (2): 4-5
Document Types: , Symposium
Countries:
Condition	Year	Language	Analysis type
, Methodology	2018	English


When and where to use blinding in pragmatic trials.
Authors: Christian J, Brouwer E, Davis K, Bennett D, Dreyer N, Girman C.
Affiliations:
Publications: Pharmacoepidemiol Drug Saf 2018; 27 (2):203-204.
Document Types:
Countries:
Condition	Year	Language	Analysis type
, Methodology	2018	English


Bringing patient-generated data into pharmacoepidemiology: The who, what, why, where, when and how.
Authors: Dixon WG, Bartels DB, Curtis J, Bourke A, Martin D, Lin KJ.
Affiliations:
Publications: Pharmacoepidemiol Drug Saf 2018; 27 (2):22-23.
Document Types: , Workshop
Countries:
Condition	Year	Language	Analysis type
, Health status & patient reported outcomes	2018	English


Lessons learned on enhanced passive safety surveillance of influenza vaccines.
Authors: Khalife N., Almas M, Stam Morago, M, Negreiro F, Costa L, Projetto, S
Affiliations: 1IQVIA, Reading, UK; 2IQVIA, Geneva, Switzerland; 3IQVIA, Lisbon, Portugal; 4IQVIA, Dublin, Ireland; 5IQVIA, Milan, Italy
Publications: Pharmacoepidemiol & Drug Saf 2018;27(2):495
Document Types: , Poster
Countries:
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/pds.4629
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2018	English	, Clinical setting: Primary care, Database Study, direct to patient research, Epidemiological study


A costâ€“benefit analysis of smoking cessation prescription coverage from a US payer perspective
Authors: Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P. A
Affiliations: Baker, Subedi: Pfizer; Ferrufino, Kowal and Tan: IQVIA
Publications: ClinicoEconomics and outcomes research
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052927/pdf/ceor-10-359.pdf
Condition	Year	Language	Analysis type
, Health economics	2018	English	, Cost benefit


The Effect of Medicare's Annual Wellness Visit on Preventive Care for the Elderly
Authors: Miao Jiang; Danny Hughes; Wenyi Wang
Affiliations: Miao Jiang (IQVIA); Danny Hughes (Georgia Tech and Neiman HPI); Wenyi Wang (Medstar)
Publications: Preventive Medicine
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Health economics, Health policy	2018	English	, Observational study, Population Based Study, Public Health, Retrospective cohort analysis


Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries
Authors: Stella Kang; Miao Jiang; Richard Duszak, Jr.; Samantha Heller; Danny Hughes; Linda Moy
Affiliations: Stella Kang (Department of Radiology, NYU School of Medicine); Miao Jiang (IQVIA);
Publications: Radiology
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29869958
Condition	Year	Language	Analysis type
, Health policy, Oncology	2018	English	, Observational study, Population Based Study, Public Health, Retrospective cohort analysis


Available resources for the management of chronic obstructive pulmonary disease exacerbations in Spain
Authors: Soler-CataluÃ±a JJ1, FernÃ¡ndez Villar A2, PiÃ±era SalmerÃ³n PL3, RomÃ¡n-RodrÃguez M4, Huerta HernÃ¡ndez A5, Roset Gamisans M6
Affiliations: 1 Servicio de NeumologÃa, Hospital de Arnau de Vilanova-Lliria, Valencia, EspaÃ±a. 2 Servicio de NeumologÃa, Hospital Ãlvaro Cunqueiro. Instituto de InvestigaciÃ³n BiomÃ©dica Galicia Sur, Vigo (Pontevedra), EspaÃ±a. 3 Servicio de Urgencias, Hospital General Universitario Reina SofÃa, Murcia, EspaÃ±a. 4 MÃ©dico de familia, Centro de Salud Son PisÃ , Islas Baleares, Mallorca, EspaÃ±a. 5 Departamento de EvaluaciÃ³n de Medicamentos, GlaxoSmithKline, Tres Cantos, Madrid, EspaÃ±a. 6 Health Economics and Outcomes Research, IQVIA, Barcelona, EspaÃ±a.
Publications: Semergen. 2018 Oct;44(7):449-457
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30206038
Condition	Year	Language	Analysis type
, Clinical practice	2018	Spanish	, Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Observational study


A HEALTH STATE UTILITY MODEL ESTIMATING THE IMPACT OF IVOSIDENIB ON QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Authors: Wehler EA, Storm M, Kowal S, Campbell C, Boscoe A
Affiliations: IQVIA
Publications: European Hematology Association
Document Types: , Poster
Countries: , USA
Abstract: https://learningcenter.ehaweb.org/eha/2018/stockholm/215730/michael.storm.a.health.state.utility.model.estimating.the.impact.of.ivosidenib.html?f=ce_id=1346ot_id=19069media=3*speaker=664497
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Utility analysis


HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH PERSISTENT ASTHMA BY ATTAINMENT OF HEALTHCARE EFFECTIVENESS AND DATA INFORMATION SET (HEDIS) MEASURES
Authors: Mosnaim G, Ariely R, Depietro M, Near A, Huang H, Batista A, Lang K
Affiliations: Huan Huang and Aimee Near are at IQVIA
Publications: ISPOR
Document Types: , Poster
Countries: , USA
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(18)31892-8/abstract
Condition	Year	Language	Analysis type
, Respiratory disease	2018	English	, Population Based Study


A Retrospective Real-World Study of Dapagliflozin Versus Other Oral Antidiabetic Therapies Added to Metformin in Patients with Type 2 Diabetes (T2D).
Authors: Huang H, Bell K, Gani R, Tugwell C, Eudicone J, Krukasâ€Hampel MR
Affiliations: Huan Huang is at IQVIA
Publications: Am J Manag Care
Document Types: , Article
Countries: , USA
Abstract: https://www.ajmc.com/journals/supplement/2018/real-world-evidence-type2-diabetes-sglt2-inhibitors/retrospective-realworld-study-dapagliflozin-vs-oral-antidiabetic
Condition	Year	Language	Analysis type
, Diabetes	2018	English	, Population Based Study


Real-World Study of Comorbidities and Complications in Relapsed/Refractory Acute Myeloid Leukemia Patients Identified Using a Claims-based Algorithm
Authors: Shahed Iqbal, Aimee Near, Neil Dhopeshwarkar, Huan Huang, Maribel Salas, Kathy Lang
Affiliations: Huan Huang and Aimee Near are IQVIA authors
Publications: ICPE (International Conference on Pharmacoepidemiology and Therapeutic Risk Management)
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Population Based Study, Retrospective database analysis


Real-world Treatment Patterns for Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Treated with Immuno-oncology Therapy
Authors: Huan Huang, Rahul Shenolikar, Brian Seal, Jenny Tse, Chakkarin Burudpakdee
Affiliations: Huan Huang, Jenny Tse and Chakkarin Burudpakdee are IQVIA authors
Publications: ISPOR
Document Types: , Poster
Countries: , USA
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(18)30588-6/fulltext
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Population Based Study, Retrospective database analysis


"Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice"
Authors: "Marcello Arca, David Ansell , Maurizio Averna, Francesca Fanelli, Katherine Gorcyca, Serban R. Iorga, Aldo P. Maggioni, Georges Paizis, Radovan Tomic, Alberico L. Catapano"
Affiliations: Sanofi
Publications:
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	English	, Retrospective database analysis


"Risk of chronic kidney disease in young adults with impaired glucose tolerance/ impaired fasting glucose: a retrospective cohort study using electronic primary care records"
Authors: Ferozkhan Jadhakhan, Tom Marshall, Ronan Ryan and Paramjit Gill.
Affiliations: University of Birmingham
Publications:
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Diabetes	2018	English	, Retrospective database analysis


Contemporary real-world evidences on ALK+ NSCLC patients in Italy
Authors: Tucci C1, Trimarchi C1, Urbinati D1, Demma F2, Fico M2, Fioravanti L2
Affiliations: 1 IQVIA, RWI, Milan, Italy 2 Takeda, Italy
Publications: ISPOR 21th Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Database Study, Real World Data, Real World Evidence


Lipid modifying therapy and LDL-C achievements in a very high cardiovascular risk cohort of patients managed by general practitioners in Italy
Authors: Fanelli F1, Gazzi L1, Heiman F2, Peduto I2, Pegoraro V2
Affiliations: 1 Sanofi SpA, Milan, Italy 2 IQVIA, RWI, Milan, Italy
Publications: ISPOR 21tst Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	English	, Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


Patients with idiopathic pulmonary fibrosis (IPF): what happens before the diagnosis? A real-world, retrospective, primary care database analysis
Authors: Cipelli R1, Heiman F1, Acciai V2, Berardo P2, Olivi I2
Affiliations: 1 IQVIA, RWI, Milan, Italy 2 Boehringer Ingelheim Italia S.p.A, Milan, Italy
Publications: ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Respiratory disease	2018	English	, Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


Characterization of preventive treatment in episodic and chronic migraine patients managed by general practitioners in Italy
Authors: Pegoraro V1, Heiman F1, di Nola L2, Pulimeno S2, Burgio L2
Affiliations: 1 IQVIA, RWI, Milan, Italy 2 Teva Italia Srl, Assago, Milan, Italy
Publications: ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Neurological disorders, Pain	2018	English	, Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


Lipid modifying therapy and LDL-C achievements in a very high cardiovascular risk cohort of statin intolerant patients managed by general practitioners in Italy
Authors: Gazzi L1, Fanelli F1, Heiman F2, Di Filippo A2, Pegoraro V2
Affiliations: 1 Sanofi SpA, Milan, Italy 2 IQVIA, RWI, Milan, Italy
Publications: ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	English	, Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


A cost estimation of management of allergic asthma in Italy
Authors: Ariemma F1, Trimarchi C1, Canonica GW2, Senna G3, Scichilone N4, Pelaia G5, Paggiaro P6, Griffiths S7, Urbinati D1
Affiliations: 1 IQVIA, RWI, Milan, Italy 2 Humanitas Research Hospital, Milan, Italy 3 Azienda Ospedaliera Universitaria Integrata, Verona Italy 4 Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy 5 Azienda Ospedaliera Universitaria Mater Domini, Catanzaro, Italy 6 Azienda Ospedaliero Universitaria, Pisa, Italy 7 Alk AbellÃ², Milan Italy
Publications: ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Respiratory disease	2018	English	, Cost analysis, Real World Data, Real World Evidence, Retrospective cohort analysis


Emerging trends in the management of NSCLC PD-L1+ patients in Italy
Authors: Trimarchi C1, Arenga A1, De Santo E1, Urbinati D1
Affiliations: 1 IQVIA, RWI, Milan, Italy
Publications: ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Database Study, Real World Data, Real World Evidence


The impact of the new innovative algorithm in Italy
Authors: Rova A1, Cioni L1, Urbinati D1
Affiliations: 1 IQVIA, RWI, Milan, Italy
Publications: ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Health policy, Public Health, Regulatory	2018	English


The evolution of standard monitoring registries in the Italian market
Authors: Cioni L1, Rova A1, Urbinati D1
Affiliations: 1 IQVIA, RWI, Milan, Italy
Publications: ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Health policy, Public Health, Regulatory	2018	English


Cost-offsets associated with the new triplets available for the treatment of relapsed/refractory multiple myeloma and resource consumption derived from Italian real practice
Authors: Ripellino C1, Peduto I2, Heiman F2, Fioravanti L3, Rea M3, Demma F3
Affiliations: 1 HEOR Consultant Freelance, Milan, Italy 2 IQVIA, RWI, Milan, Italy 3 Takeda Italia S.p.a., Rome, Italy
Publications: ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Cost analysis, Economic evaluation


Non-persistence risk and health care resource utilization of Italian patients with non-valvular atrial fibrillation
Authors: Cataldo N1, Pegoraro V1, Ripellino C2, Bertasi V3, Di Turi R4, Pastorello M5, Gambera M6
Affiliations: 1 IQVIA, RWI, Milan, Italy 2 RWE HEOR Consultant, Milan, Italy 3 Azienda ULSS 22 Bussolengo, Italy 4 ASL Roma 3, italy 5 ASP di Palermo, Italy 6 ATS di Bergamo, Italy
Publications: Recenti Prog Med. 2018 Feb;109(2):113-121
Document Types: , Article
Countries: , Italy
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/?term=Non-persistence+risk+and+health+care+resource+utilization+of+Italian+patients+with+non-valvular+atrial+fibrillation
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	English	, Database Study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy
Authors: Malfertheiner P1, Ripellino C2, Cataldo N3
Affiliations: 1 Klinik fÃ¼r Gastroenterologie, Hepatologie und Infektiologie, Otto-von-Guericke UniversitÃ¤t, Magdeburg, Germany 2 2HEOR Consultant Freelance, Milan, Italy 3 IQVIA, RWI, Milan, Italy
Publications: Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):581-586
Document Types: , Article
Countries: , Germany, Italy
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29457309
Condition	Year	Language	Analysis type
, Gastrointestinal disorders	2018	English	, Database Study, Epidemiological study, Observational study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


Basic characteristics and representativeness of the German Disease Analyzer Database
Authors: Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K.
Affiliations: Institute of Biometrics, Epidemiology, German Diabetes Center, DÃ¼sseldorf, Real World Insights, IQVIA, Frankfurt, Germany
Publications: Int J Clin Pharmacol Ther. 2018 Aug 31. doi: 10.5414/CP203320â€©.
Document Types: , Article
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/?term=Basic+characteristics+and+representativeness+of+the+German+Disease+Analyzer+Database%E2%80%A9.
Condition	Year	Language	Analysis type
, Database Validity and methodology	2018	English	, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective cohort analysis


A retrospective study to assess resource utilization and costs in patients with post-stroke spasticity in the United Kingdom
Authors: Raluy-Callado M, Cox A, MacLachlan S, Bakheit AM, Moore AP, Dinet J & Gabriel S
Affiliations: Evidera
Publications: Current Medical Research and Opinion
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Health economics	2018	English	, Retrospective database analysis


"Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice"
Authors: Arca M, Ansell D, Averna M, Fanelli F, Gorcyca K, Iorga ÅžR, Maggioni AP, Paizis G, Tomic R & Catapano AL
Affiliations: Sanofi
Publications: Atherosclerosis
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	English	, Retrospective database analysis


Dementia prevalence and incidence in a federation of European Electronic Health Record databases: The European Medical Informatics Framework resource
Authors: Perera G, Pedersen L, Ansell D, Alexander M, Arrighi HM, Avillach P, Foskett N, Gini R, Gordon MF, Gungabissoon U, Mayer MA, Novak G, Rijnbeek P, TrifirÃ² G, van der Lei J, Visser PJ & Stewart R
Affiliations: The European Medical Information Framework
Publications: Alzheimerâ€™s & Dementia
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Mental health	2018	English	, Retrospective database analysis


Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (OptafluÂ® ) among adults in THIN database of electronic UK primary healthcare records
Authors: Hall GC, Davies PTG, Karim MY, Haag MDM & O'Leary C
Affiliations: Seqirus
Publications: Pharmacoepidemiology and Drug Safety
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2018	English	, Retrospective database analysis


5-ASA Prescription Trends over Time in Inflammatory Bowel Disease 1996 to 2015-A UK Population-Based Study
Authors: Jaraith, V, S Hokkanen, L Guizzetti, N Boxall, S Campbell-Hill, and H Patel
Affiliations: Western University, Department of Medicine, London, Ontario, Canada, Robarts Clinical Trials Inc., London, Ontario, Canada, IQVIA, London, UK,
Publications: Journal of Crohn, no. Supplement 1 (February): S309â€“10
Document Types: , Abstract
Countries: , UK
Abstract: https://www.ecco-ibd.eu/publications/congress-abstract-s/abstracts-2018/item/p405-5-asa-prescription-trends-over-time-in-inflammatory-bowel-disease-1996-to-2015-x2013-a-uk-population-based-study.html
Condition	Year	Language	Analysis type
, Clinical practice, Drug Utlization Study, Gastrointestinal disorders	2018	English	, Epidemiological study, Retrospective cohort analysis


5-ASA Prescription Trends over Time in Inflammatory Bowel Disease 1996 to 2015-A UK Population-Based Study
Authors: Jaraith, V, S Hokkanen, L Guizzetti, N Boxall, S Campbell-Hill, and H Patel
Affiliations: Western University, Department of Medicine, London, Ontario, Canada, Robarts Clinical Trials Inc., London, Ontario, Canada, IQVIA, London, UK
Publications:
Document Types:
Countries:
Abstract: https://www.ecco-ibd.eu/publications/congress-abstract-s/abstracts-2018/item/p405-5-asa-prescription-trends-over-time-in-inflammatory-bowel-disease-1996-to-2015-x2013-a-uk-population-based-study.html
Condition	Year	Language	Analysis type
	2018	English


Real World Prescription Patterns of Beta-Blocker-Free Combination Treatment in the UK
Authors: Yongsoo Kim, Judit Banhazi, Alexandra Durus, Laura Rodriguez Torres, Adam Gondos, Daniel Viriato, Vladimir Bezlyak, Naomi Boxall, Tim Wintermantel, Alexandros Sagkriotis & Douglas A Hubatsch
Affiliations:
Publications: 13th EGS Congress, Florence, Italy - P4.034
Document Types: , Abstract, Poster
Countries: , UK
Abstract: http://www.egs2018.org/sites/www.egs2018.org/files/documenti/egs2018-abstract-book.pdf
Condition	Year	Language	Analysis type
, Ophthalmology	2018	English	, Retrospective database analysis


Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Authors: Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publications:
Document Types:
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085
Condition	Year	Language	Analysis type
	2018	English


Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries
Authors: Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK
Publications: ESMO 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: ESMO 2018 Congress
Condition	Year	Language	Analysis type
, Oncology	2018	English


Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis
Authors: Prentice M1, Mpima S2, Martinez S2, Nasuti P2, Davda R1, Payne H1
Affiliations: 1 University College Hospital, London, UK, 2 IQVIA , London, UK
Publications:
Document Types:
Countries: , Asia Pacific, Europe
Condition	Year	Language	Analysis type
	2018	English


Treatment Pathways of Primary Open Angle Glaucoma Prior to Laser Surgery: Real World Evidence from UK Ophthalmology Clinics
Authors: Yongsoo Kim, Judit Banhazi, Alexandra Durus, Laura Rodriguez Torres, Adam Gondos, Daniel Viriato, Vladimir Bezlyak, Naomi Boxall, Tim Wintermantel, Alexandros Sagkriotis & Douglas A Hubatsch
Affiliations:
Publications: Investigative Ophthalmology & Visual Science July 2018, Vol.59, 6109
Document Types: , Abstract
Countries: , UK
Abstract: https://iovs.arvojournals.org/article.aspx?articleid=2693261&resultClick=1
Condition	Year	Language	Analysis type
, Ophthalmology	2018	English


Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis
Authors: Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1
Affiliations: 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publications: ESMO 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: ESMO 2018 Congress
Condition	Year	Language	Analysis type
, Oncology	2018	English


Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension.
Authors: Kiely D., Lawrie A., Doyle O., Salvatelli V., Ashley Daniels F., Drage E., Jenner H., Rigg J, Schmitt C., Samyshkin Y., Bergemann R.
Affiliations:
Publications:
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	English	, Predictive analytics


Initial Management of localised prostate cancer in the Elderly: An International Data Review
Authors: Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1
Affiliations: 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publications: SIOG 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


COMPARING THE ROLE OF DIFFERENT SPECIALITIES IN THE MANAGEMENT OF PROSTATE CANCER IN FRANCE AND ITALY: INSIGHTS FROM A REAL-WORLD STUDY
Authors: Mpima S , Nasuti P , Casey V
Affiliations: IQVIA London , UK
Publications: ISPOR Europe 2018
Document Types: , Poster
Countries: , France, Italy
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Clinical setting: Primary care


Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Authors: Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publications: JCO ( ASCO 2018)
Document Types: , Abstract
Countries: , Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085
Condition	Year	Language	Analysis type
, Oncology	2018	English


EVALUATING NSCLC TREATMENT OPTIONS USING REAL WORLD DATA: FINDINGS FROM AN ONCOLOGY SURVEY ACROSS EIGHT COUNTRIES
Authors: Takeno S1, Tanaka S1, Saijo N1 Nasuti P2
Affiliations: 1IQVIA Solutions Japan K.K., Tokyo, Japan, 2IQVIA , London, UK
Publications: ISPOR 2018 APAC
Document Types: , Poster
Countries: , Asia Pacific, Europe
Condition	Year	Language	Analysis type
, Oncology	2018	English


Drug treatment in melanoma: a real-world analysis across Europe and Japan
Authors: Martinez de Pinillos, Anger C, Nasuti P
Affiliations: IQVIA London UK
Publications: ESMO 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Treatment algorithm for multiple myeloma: real-world insights across five European countries
Authors: Dr Rocci1, Bulger P1, Martinez de Pinillos A2 , Anger C2 , Nasuti P2, Manuguid F2
Affiliations: 1Manchester University NHS Foundation Trust, Manchester Royal Infirmary, 2 IQVIA London UK
Publications: ESMO 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Verification of guideline conform mCRC treatment with EGFR inhibitors with real-world evidence data from EU5 countries
Authors: Hoyer L, Schmidt N
Affiliations: IQVIA Frankfurt Germany
Publications: ESMO 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD)
Authors: Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3
Affiliations: IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ
Publications: ESMO 2018
Document Types: , Poster
Countries: , Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data
Authors: Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3
Affiliations: 1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ
Publications: ESMO 2018
Document Types: , Poster
Countries: , Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


PATTERNS OF CARE OF ADVANCED SOFT TISSUE SARCOMAS (STS) NON-GIST IN FOUR EUROPEAN COUNTRIES (EU4)
Authors: Mari E1,Martinez de Pinillos A2, Nasuti P2,Guglielmetti F1, Anger C2
Affiliations: 1IQVIA Milan Italy , 2IQVIA London UK
Publications: CTOS 2018 Rome
Document Types: , Poster
Countries: , France, Germany, Italy, Spain
Condition	Year	Language	Analysis type
, Oncology	2018	English


DESCRIPTIVE ANALYSIS OF THE USE OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKAEMIA IN EUROPE, A REAL-WORLD PERSPECTIVE
Authors: Martinez de Pinillos A1, Nasuti P1, Anger C1, Ricorte I2
Affiliations: 1 IQVIA London UK , 2IQVIA Madrid Spain
Publications: ISPOR Europe 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data
Authors: Maroun R1,2, Mitrofan L3, Benjamin L1 Nachbaur G1, Maunoury F4 Le Jeunne P3 Durand-Zaleski I2,5
Affiliations: 1GlaxoSmithKline, Health Economics and Outcomes Research,France 2INSERM, ECEVE, UMR 1123, Paris, France 3IQVIA, La DÃ©fense, France 4Statesia, Le Mans, France 5URC-ECO, APHP, Paris, France
Publications: BMC Cancer. 2018; 18: 214.
Document Types: , Article
Countries: , France
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822611/
Condition	Year	Language	Analysis type
, Oncology	2018	English


Assessing and modeling organizational impact of tilmanocept in performing sentinel lymph node biopsy in France
Authors: ClÃ©ment Le Dissez1, Pascal Paubel2, FrÃ©dÃ©ric Courbon3, RÃ©my Herve4, Mark Rance5, Marie-Aude Courteille6
Affiliations: 1IQVIA OpÃ©ration France, Paris, La DÃ©fense ; 2Inserm UMR S 1145, Institut Droit et SantÃ©, facultÃ© de pharmacie de Paris, UniversitÃ© Paris Descartes, Sorbonne Paris CitÃ©, 4 avenue de lâ€™observatoire, 75006 Paris, France ; 3 Department of Medical Imaging, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France ; 4 Department of Pharmacy, Institute of Cancerology Gustave Roussy, University of Paris-Sud, Villejuif, France ; 5Norgine, Corporate ; 6Norgine, France
Publications:
Document Types: , Poster
Countries: , France
Condition	Year	Language	Analysis type
, Clinical practice, Health economics, Oncology	2018	English	, Budget impact, Literature Review, Public Health


LIMITATIONS AND EXPECTED CHALLENGES OF CAR-T ECONOMIC EVALUATION.
Authors: Allou A, Carette J, Minacori R, Touahmia S, Bourguignon S, Troubat A, Maurel F*
Affiliations: IQVIA France - RWI
Publications: ISPOR 2018
Document Types: , Poster
Countries: , France
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Health economics, Hematology	2018	English	, Cost effectiveness, Market impact, Review


WHAT INTERPRETATION OF ICERS IN ORPHAN DISEASES? A FRENCH EXAMPLE.
Authors: Moutier HÃ©lÃ¨ne; Bourguignon Sandrine; Maurel FrÃ©dÃ©rique; Bodaghi Charles
Affiliations: RWI IQVIA France
Publications: ISPOR 2018
Document Types: , Poster
Countries: , France
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Health economics, Pricing and reimbursement, Rare Diseases	2018	English	, Cost effectiveness, Pricing & Reimbursement, Willingness to pay


A RETROSPECTIVE DATABASE STUDY TO DEFINE A PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENT COHORT AND EVALUATE THE ECONOMIC BURDEN OF ILLNESS IN FRANCE
Authors: Petrica N (1), Beaudier E(1),Exposto F (2), Beaudet A(3)
Affiliations: (1) IQVIA, Paris France (2) IQVIA, London UK (3) Actelion Pharmaceuticals Ltd, Switzerland
Publications: ISPOR 2018
Document Types: , Article, Poster
Countries: , France
Condition	Year	Language	Analysis type
, Respiratory disease	2018	English	, Cost analysis, Cost of illness, Retrospective database analysis


Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe.
Authors: Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5
Affiliations: 1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France
Publications: European Society of Cardiology (ESC) Congress, 2018, Munich, Germany
Document Types: , Poster
Countries: , Belgium, France, Poland, Portugal, Spain, Switzerland, UK
Abstract: https://esc365.escardio.org/Congress/ESC-Congress-2018/Poster-Session-3-Health-economics/176943-patient-and-caregiver-productivity-loss-and-indirect-costs-associated-with-cardiovascular-events-in-europe
Condition	Year	Language	Analysis type
, Cardiovascular disease, Health economics	2018	English	, Burden of illness, Cost of illness


Patient and caregiver indirect costs after acute cardiovascular events in Europe.
Authors: Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5
Affiliations: 1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium
Publications: ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain
Document Types: , Oral presentation
Countries: , Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84816?pdfid=58963
Condition	Year	Language	Analysis type
, Cardiovascular disease, Health economics	2018	English	, Burden of illness, Cost of illness


ECONOMIC IMPACT OF THE PATIENT BLOOD MANAGEMENT FROM A FRENCH NATIONAL PAYER AND HOSPITAL PERSPECTIVES IN FRANCE
Authors: Vasilescu L , Champs F-O1, Durand-Zaleski I
Affiliations: 1 IQVIA France - RWI, 2 URCEco - HÃ´pital de l'HÃ´tel Dieu, Paris France
Publications: ISPOR 2018
Document Types: , Poster
Countries: , France
Condition	Year	Language	Analysis type
, Health economics	2018	English	, Budget impact, Economic evaluation


EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM
Authors: Bodaghi Charles, Benque Emma, Troubat Arnaud
Affiliations: IQVIA France - RWI
Publications: ISPOR 2018
Document Types: , Poster
Countries: , France, Germany, Spain, UK
Condition	Year	Language	Analysis type
, Diabetes	2018	English	, Clinical setting: Home care, Pricing & Reimbursement


ASSESSMENT OF THE UNIT COSTS IN IMAGING ACTS: THE EXAMPLE OF MRI AND CT-SCAN ACTS IN France
Authors: Vasilescu L., Faller M., Allou A.
Affiliations: IQVIA France - RWI
Publications: ISPOR 2018
Document Types: , Poster
Countries: , France
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Methodology	2018	English	, Literature Review, Public Health, Review


Neue Krebstherapeutika: Personalisierte Medizin erÃ¶ffnet neuartige Therapieoptionen
Authors: Hoyer L , Schmidt L
Affiliations: IQVIA Frankfurt Germany
Publications: Pharmamind
Document Types: , Article
Countries: , Europe
Condition	Year	Language	Analysis type
, Oncology	2018	German


Persistence with Selective Serotonin (Norepinephrine) Reuptake Inhibitor Therapy in Germany
Authors: Kostev K, Kap EJ
Affiliations: IQVIA, Frankfurt am Main, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Medication compliance, Mental health	2018	English	, Database Study, Epidemiological study


The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China.
Authors: Salem A1, Ramos M1, Hu H2, Zhong H3, Lamotte M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 University of Macau, Macau, China 3 AstraZeneca, Shanghai, China
Publications:
Document Types: , Poster
Countries: , China
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/83455
Condition	Year	Language	Analysis type
, Health economics, Respiratory disease	2018	English	, Cost analysis, Cost effectiveness


The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China.
Authors: Salem A, Ramos M, Hu H, Zhong H, Lamotte M
Affiliations: IQVIA, Zaventem, Belgium
Publications: ISPOR Asia Pacific, 2018, September 8-11, Tokyo, Japan
Document Types: , Poster
Countries: , China
Condition	Year	Language	Analysis type
, Health economics, Respiratory disease	2018	English	, Cost effectiveness


The cost-effectiveness of physical activity in the management of COPD patients in the UK.
Authors: Ramos M, Lamotte M, Gerlier L, Svangren P, Cases A M, Haughney J
Affiliations: IQVIA, Zaventem, Belgium
Publications:
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Health economics, Respiratory disease	2018	English	, Cost effectiveness


The relationship of predicted benefits in life expectancy and quality adjusted life expectancy for improved glucose control in type 2 diabetes simulation modeling.
Authors: Ramos M, Foos V, McEwan P, Lamotte M
Affiliations: IQVIA, Zaventem, Belgium
Publications: ISPOR 20th Annual European Congress, 2017, November 4-8, Glasgow, Scotland
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2018	English	, Cost effectiveness


CHALLENGES AND OPPORTUNITIES IN CLINICAL NUTRITION IN ONCOLOGY: AVAILABLE EVIDENCE, REAL WORLD PRACTICES, AND THE WAY FORWARD
Authors: Goldwasser F, Piaggio T, Lucas J, Zalcman G, Tilleul P, Schiefke I, Marschal O, Pedrazzoli P, Caccialanza R
Affiliations: Medical Oncology, Cochin Hospital, AP-HP, IQVIA Basel
Publications: ISPOR Europe 2018
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy
Condition	Year	Language	Analysis type
, Nutritional Disorders, Oncology	2018	English	, Clinical setting: Home care, Epidemiological study


Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.
Authors: Palmer AJ1, Si L1, Tew M2, Hua X2, Willis MS3, Asseburg C3, McEwan P4, Leal J5, Gray A5, Foos V6, Lamotte M6, Feenstra T7, 8, Oâ€™Connor PC 9, Brandle M 10, Smolen HJ11, Gahn JC11, Valentine WJ12, Pollock RF12, Breeze P13, Brennan A13, Pollard D13, Ye W14, Herman WH15, Isaman DJ14, Kuo S16, Laiteerapong N17, Tran-Duy A2, Clarke PM2
Affiliations: 1 University of Tasmania, Hobart, Tasmania, Australia 2 University of Melbourne, Melbourne, Victoria, Australia 3 The Swedish Institute for Health Economics, Lund, Sweden 4 Health Economics and Outcomes Research Ltd., Cardiff, UK 5 University of Oxford, Oxford, UK 6 IQVIA, Zaventem, Belgium 7 National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands 8 Groningen University, Groningen, The Netherlands 9 HealthPartners Institute and HealthPartners Center for Chronic Care Innovation, Minneapolis, MN, USA 10 Kantonsspital St. Gallen, St. Gallen, Switzerland 11 Medical Decision Modeling Inc., Indianapolis, IN, USA 12 Ossian Health Economics and Communications, Basel, Switzerland 13 University of Sheffield, Sheffield, UK 14 University of Michigan, Ann Arbor, MI, USA 15 University of Michigan, Ann Arbor, MI, USA 16 University of Michigan, Ann Arbor, MI, USA 17 University of Chicago, Chicago, IL, USA
Publications: Value in Health, 2018, 21(6): 724-731
Document Types: , Article
Countries: , International
Abstract: https://doi.org/10.1016/j.jval.2018.02.002
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2018	English	, Cost effectiveness


Review and Validation of Cardiovascular Risk Prediction Models in East Asian Populations.
Authors: Foos V, McEwan P, Lamotte M
Affiliations: IQVIA, Zaventem, Belgium
Publications: Value in Health, Volume 21, Supplement 1, May 2018, Page S220
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2018	English	, Cost effectiveness


The Prescription Patterns of Selective Serotonin (Norepinephrine) Reuptake IInhibitors in Germany
Authors: Kap EJ1, Konrad M2, Bohlken J3, Kostev K1
Affiliations: 1IQVIA, Frankfurt am Main, Germany, 2FOM University of Applied Sciences, Frankfurt am Main, Germany, 3Praxis fÃ¼r Neurologie und Psychiatrie, Berlin, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health	2018	English	, Database Study, Epidemiological study


The Prevalence of Multimorbidity and Polypharmacy in Elderly Patients Followed in General Practices in Germany
Authors: Kostev K, Kap EJ, Jacob L
Affiliations: IQVIA, Frankfurt am Main, Germany, University of Paris 5, Paris, France
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Patient Registries & Real-World Study Methods	2018	English	, Epidemiological study, Retrospective database analysis


Depression is Associated with Chronic Disorders in Children and Adolescents
Authors: Kostev K, Dombrowski S, Konrad M
Affiliations: IQVIA, Frankfurt am Main, Germany, FOM University of Applied Sciences, Frankfurt am Main, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Health status & patient reported outcomes, Mental health, Pediatrics	2018	English	, Database Study, Epidemiological study, Retrospective database analysis


Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions?
Authors: F Christiaan K Dolk, Koen B Pouwels, David R M Smith, Julie V Robotham, Timo Smieszek
Affiliations: Public Health England
Publications:
Document Types:
Countries: , UK
Condition	Year	Language	Analysis type
, Miscellaneous	2018	English	, Retrospective database analysis


Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care
Authors: David R M Smith,F Christiaan K Dolk, Koen B Pouwels, Morag Christie, Julie V Robotham, Timo Smieszek
Affiliations: Public Health England
Publications:
Document Types: , Article
Countries: , England
Condition	Year	Language	Analysis type
, Miscellaneous	2018	English	, Retrospective database analysis


Actual versus â€˜idealâ€™ antibiotic prescribing for common conditions in English primary care
Authors: Koen B Pouwels, F Christiaan K Dolk, David R M Smith, Julie V Robotham, Timo Smieszek
Affiliations: Public Health England
Publications:
Document Types: , Article, Article
Countries: , England
Condition	Year	Language	Analysis type
, Miscellaneous	2018	English	, Retrospective database analysis


Explaining variation in antibiotic prescribing between general practices in the UK
Authors: Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham
Affiliations: Public Health England
Publications:
Document Types:
Countries:
Condition	Year	Language	Analysis type
	2018	English


Explaining variation in antibiotic prescribing between general practices in the UK
Authors: Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham
Affiliations: Public Health England
Publications:
Document Types: , Article
Countries: , England
Condition	Year	Language	Analysis type
	2018	English


Explaining variation in antibiotic prescribing between general practices in the UK
Authors: Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham
Affiliations: Public Health England
Publications:
Document Types: , Article
Countries: , England
Condition	Year	Language	Analysis type
	2018	English


Explaining variation in antibiotic prescribing between general practices in the UK
Authors: Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham
Affiliations: Public Health England
Publications:
Document Types: , Article
Countries: , England
Condition	Year	Language	Analysis type
	2018	English


Explaining variation in antibiotic prescribing between general practices in the UK
Authors: Koen B Pouwels,F Christiaan K Dolk,David R M Smith, Timo Smieszek, Julie V Robotham
Affiliations: Public Health England
Publications:
Document Types: , Article
Countries: , England
Condition	Year	Language	Analysis type
	2018	English


Potential for reducing inappropriate antibiotic prescribing in English primary care
Authors: Timo Smieszek, Koen B Pouwels, F Christiaan K Dolk, David R M Smith, Susan Hopkins, Mike Sharland, Alastair D Hay, Michael V Moore, Julie V Robotham
Affiliations: Public Health England
Publications:
Document Types: , Article
Countries: , England
Condition	Year	Language	Analysis type
, Miscellaneous	2018	English	, Retrospective database analysis


Comparative Analysis of the Market Penetration of Personalised Medicine Drugs Under the Conditions of AMNOG
Authors: Fischer T, Bonduelle D, Antoni B
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics, Health policy	2018	German	, Market impact


Guidelines in Germany Early Benefit Assessment - Which Guidelines are Considerend by Federal Joint Committee for Determing the Appropriate Comparator?
Authors: Scheler E, Stratil AS, Roxlau T, Bonduelle D
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Guidelines, Health policy	2018	German	, Review


Success Factors for Â§137h SGB V Assessment of Medical Devices in Germany
Authors: Bonduelle, Doreen; von Hein, Mirko; Scheler, Elisabeth
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2018	English	, Review


Overview of German AMNOG Dossiers with Price Analysis Before and After Early Benefit Assessment
Authors: Tremmel M, Batscheider A, Bocuk D, Roxlau T, Antoni B, Elena Mihaylova, Bonduelle D
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany IQVIA RDS Bulgaria EOOD, Sofia, Bulgaria
Publications:
Document Types: , Abstract
Countries:
Condition	Year	Language	Analysis type
, Health economics, Health policy, Pricing and reimbursement	2018	English	, Pricing & Reimbursement, Review


The Impact of Label Extensions on the Reimbursed Price of Pharmaceutical Products Assessed According to Â§35A SGB V in Germany Oncological and Metabolic Diseases
Authors: Schmalhofer C, Eheberg D, Tremmel M, Bocuk D, Roxlau T, Antoni B, Bonduelle D
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics, Health policy, Metabolic Disorders , Oncology, Pricing and reimbursement	2018	English	, Cost analysis, Pricing & Reimbursement


DERMATOLOGY AS AN EXAMPLE Originator and Generic Market Access Pretection Strategies in Germany Using Dermatology as an Example
Authors: Greiner RA, Antoni B, Batscheider A, Bonduelle D Roxlau T, Stratil AS
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Dermatology, Health economics	2018	English	, Market impact


Off-Label Prescription of Drugs Compared to Prescription After Label Extension in Children for Germany
Authors: Gohlke A, Kostev K, Kuschel AS
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications:
Document Types:
Countries:
Condition	Year	Language	Analysis type
, Health policy, Pediatrics, Regulatory	2018	English	, Utility analysis


Duration of Inability to Work in Depression Patients Treated in General or Psychiatric Practices in Germany
Authors: Kostev K, Dombrowski S, Konrad M, Bohlken J
Affiliations: IQVIA, Frankfurt am Main, Germany FOM University of Applied Sciences, Frankfurt am Main, Germany Praxis fÃ¼r Neurologie und Psychiatrie, Berlin, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics, Mental health	2018	English	, Real World Data, Retrospective cohort analysis


Early Insights into the Characteristics and Evolution of Clinical Parameters in a Cohort of Patients Prescribed Sacubitril/Valsartan in Germany
Authors: Wachter R, Viriato D, Klebs S, Grunow SS, Schindler M, Engelhard J, Proenca CC, Calado F, Schlienger R, Dworak M, Balas B, Bruce Wirta S.
Affiliations:
Publications:
Document Types:
Countries:
Condition	Year	Language	Analysis type
	2018	English


Schwindeldiagnosen in HNO-Praxen in Deutschland -Demografische Daten und Saisonale Variation
Authors: Seidel DU, Kostev K, Sesterhenn A
Affiliations:
Publications:
Document Types:
Countries:
Condition	Year	Language	Analysis type
	2018	German


Persistence and Compliance Amongst Sacubitril/Valsartan Patients in Germany, a Retrospective Cohort Study a Longitudinal Pharmacy Database
Authors: WIRTA SB WACHTER R, BALAS B, KLEBS S, FONSECA AF, PROENCA CC, DWORAK M, SCHLIENGER R, ENGELHARD J, MAIER T, KOSTEV K
Affiliations: Wirta SB, Wachter R, Balas B, Klebs S, Fonseca AF, Proenca CC, Dworak M, Schlienger R, Engelhard J, Maier T, Kostev K
Publications:
Document Types:
Countries: , Germany
Condition	Year	Language	Analysis type
	2018	English	, Retrospective cohort analysis


Concomitant use of Heart Failure Medication AMongst Patients with Sacubitril/Valsartan Therapy in Germany, A Retrospective Cohort Study Using a Longitudinal Pharmacy Database
Authors: Wachter R, Fonsenca AF, Klebs S, Balas B, Proenca CC, Dworak M, Schlienger R, Engelhard J, Maier T, Wirta SB, Kostev K
Affiliations:
Publications:
Document Types: , Conference
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	German	, Retrospective cohort analysis


Real-World Titration and Treatment Patterns of Sacubitril/Valsartan in Germany, Retrospective Cohort Study Using a Longitudinal Pharmacy Database
Authors: Wachter R, Klebs S, Balas B, Proenca CC, Dworak M, Schlienger R, Engelhard J, Maier T, Wirta SB, Klostev K
Affiliations:
Publications:
Document Types: , Conference
Countries: , Germany
Condition	Year	Language	Analysis type
	2018	English	, Retrospective cohort analysis


Changes in Patient Characteristics, Glucose Lowering Treatment, Glycemic Control and Complications in Type 2 Diabetes in General Practices (Disease Analyzer, Germany: 2008-2016)
Authors: Rathmann W, Scheerer M, Rohwedder K, Busch S, Kostev K
Affiliations:
Publications:
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2018	English


Increased Depression Symptom Score in Newly Diagnosed Type 2 Diabetes Patients
Authors: Rathmann W, Engelhard J, ANderson D, Kostev K, Zou M, Busch S, Kuss O, Hahn M
Affiliations:
Publications:
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Diabetes, Mental health	2018	English


Frequency of Blood Pressure and Estimated Glomerular Filtration Rate Monitoring in Patients Affected by Hypertension - A Retrospective Study with 176.565 Patients in Germany
Authors: Jacob L, Seitz F, Kostev K
Affiliations:
Publications:
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	English	, Retrospective cohort analysis


Persistence with Antihypertensive Drugs in Hypertension Patients with Depression in Germany
Authors: Jacob L, Kostev K
Affiliations:
Publications:
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	English


PREVALENCE AND TREATMENT OF SEXUALLY TRANSMITTED DISEASES IN GYNECOLOGICAL PRACTICES IN GERMANY- A RETROSPECTIVE STUDY WITH MORE THAN 1,000,000 PATIENTS
Authors: Prevalence and Treatment of Sexuality Transmitted Diseases in Gynecological Practices in Germany - A Retrospective Study with more than 1,000,000 Patients
Affiliations:
Publications: INT J CLIN PHARMACOL THER. 2018 FEB 2.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Infectious disease	2018	German	, Retrospective cohort analysis


Frequency of Thyroid-Stimulating Hormone Monitoring in Patients After Thyroidectomy: A Retrospective Study in Primary Care Practices in Germany
Authors: Kostev K, Winiarski M,SchÃ¼ller L, Sesterhenn Am, Jacob L
Affiliations:
Publications: EXP CLIN ENDOCRINOL DIABETES. 2018 FEB 2.
Document Types:
Countries:
Condition	Year	Language	Analysis type
	2018	English	, Retrospective cohort analysis


Seasonal Variation of Epistaxis in Germany
Authors: Seidel DU, Sesterhenn AM, Kostev K
Affiliations:
Publications: J CRANIOFAC SURG. 2018 FEB 12.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
	2018	English


Potential Delay in the Diagnosis of Vulvar Cancer and Associated Risk Factors in Women Treated in German Gynecological Practices
Authors: Muigai J, Jacob L, Klostev K, Kalder M
Affiliations:
Publications: ONCOTARGET. 2018 JAN 3;9(9):8725-8730
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology, Womens Health	2018	English


Diagnoses of Dizziness- and Vertigo-Related in ENT Practices in Germany
Authors: Seidel DU, Park JJH, Sesterhenn AM, Kostev K
Affiliations:
Publications:
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Neurological disorders	2018	English


Diagnosis and Treating Dementia in German Primary and Specialized Care Between 2011 and 2015
Authors: Michalowsky B, Kostev K, Iliffe S, Hoffmann W, Bohlken J
Affiliations:
Publications: INT J CLIN PHARMACOL THER. 2018 APR 27.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Neurological disorders	2018	English


Frequency of Blood Pressure and Estimated Glomerular Filtration Rate Testing in Type 2 Diabetes Mellitus: A Retrospective Study with 43,509 Patients
Authors: Kostev K, Lucas A, Jacob L
Affiliations:
Publications: EXP CLIN ENDOCRINOL DIABETES. 2018 MAR 12.
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Diabetes, Metabolic Disorders , Vascular disease	2018	English	, Retrospective cohort analysis


Inzidenz und Behandlung des Nicht Stoffgebundenen Delirs in Deutschen Haus- und Facharztpraxen
Authors: Bohlken J, Hewer W, Kostev K
Affiliations:
Publications:
Document Types:
Countries:
Condition	Year	Language	Analysis type
	2018	German


Impact of Tobacco Smoking on the Risk of Developing 25 Different Cancer

Selection from HEOR Bibliography